CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
Accession: CHEBI:147285
browse the term
Definition: An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69).
Synonyms: related_synonym: 3C-like protease inhibitor; 3C-like protease inhibitors; 3cLpro inhibitor; 3cLpro inhibitors; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitors; EC 3.4.22.69 inhibitor; EC 3.4.22.69 inhibitors; Mpro inhibitor; Mpro inhibitors; SARS 3C-like protease inhibitor; SARS 3C-like protease inhibitors; SARS coronavirus 3CL protease inhibitor; SARS coronavirus 3CL protease inhibitors; SARS coronavirus main peptidase inhibitor; SARS coronavirus main peptidase inhibitors; SARS coronavirus main protease inhibitor; SARS coronavirus main protease inhibitors; SARS coronavirus main proteinase inhibitor; SARS coronavirus main proteinase inhibitors; SARS-CoV 3CLpro enzyme inhibitor; SARS-CoV 3CLpro enzyme inhibitors; SARS-CoV Mpro inhibitor; SARS-CoV Mpro inhibitors; SARS-CoV main protease inhibitor; SARS-CoV main protease inhibitors; coronavirus 3C-like protease inhibitor; coronavirus 3C-like protease inhibitors; severe acute respiratory syndrome coronavirus main protease inhibitor; severe acute respiratory syndrome coronavirus main protease inhibitors
xref: Wikipedia:C30_Endopeptidase
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of FOS protein]
CTD
PMID:24161485
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Il1b
interleukin 1 beta
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]
CTD
PMID:24161485
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]
CTD
PMID:24161485
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of JUN protein]
CTD
PMID:24161485
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:24161485
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; [5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]] which results in decreased abundance of Nitric Oxide
CTD
PMID:24161485
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]; [5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]] which results in decreased abundance of Dinoprostone
CTD
PMID:24161485
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]
CTD
PMID:24161485
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Stat1
signal transducer and activator of transcription 1
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT1 protein]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT1 protein]
CTD
PMID:24161485
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT3 protein]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT3 protein]
CTD
PMID:24161485
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tnf
tumor necrosis factor
multiple interactions
ISO
5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; 5,6,7-trimethoxyflavone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]
CTD
PMID:24161485
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression multiple interactions increases activity
ISO
baicalein results in increased expression of ABCB1 protein baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; baicalein inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]]; baicalein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] baicalein results in increased activity of ABCB1 protein
CTD
PMID:34217736
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
decreases activity
ISO
baicalein results in decreased activity of ABCC1 protein
CTD
PMID:15670588
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Acta2
actin alpha 2, smooth muscle
decreases expression multiple interactions
ISO
baicalein results in decreased expression of ACTA2 protein baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; MIR21 mRNA inhibits the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; SPRY1 protein affects the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]
CTD
PMID:30201452
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Afp
alpha-fetoprotein
affects binding
EXP
baicalein binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Ahr
aryl hydrocarbon receptor
multiple interactions affects response to substance increases activity increases expression
ISO
AHR protein affects the reaction [baicalein results in decreased phosphorylation of RB1 protein]; baicalein binds to and results in increased activity of AHR protein AHR protein affects the susceptibility to baicalein baicalein results in increased activity of AHR protein baicalein results in increased expression of AHR protein
CTD
PMID:14644660 PMID:17869316 PMID:22820424
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions
ISO
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]]; baicalein inhibits the reaction [Bleomycin affects the expression of and affects the localization of AIFM1 protein]
CTD
PMID:37783230
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation affects binding increases phosphorylation multiple interactions
ISO
baicalein results in decreased phosphorylation of AKT1 protein baicalein binds to AKT1 protein baicalein results in increased phosphorylation of AKT1 protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of AKT1 mRNA]; Lithium Chloride inhibits the reaction [baicalein results in decreased phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [baicalein results in increased phosphorylation of AKT1 protein]
CTD
PMID:18025287 PMID:22820424 PMID:36988316 PMID:38230788
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alox12
arachidonate 12-lipoxygenase, 12S type
multiple interactions decreases activity
ISO
baicalein inhibits the reaction [ALOX12 protein results in increased chemical synthesis of 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid] baicalein results in decreased activity of ALOX12 protein
CTD
PMID:17027136 PMID:23238474
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alox15
arachidonate 15-lipoxygenase
decreases activity
ISO
baicalein results in decreased activity of ALOX15 protein
CTD
PMID:23238474
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
G
App
amyloid beta precursor protein
multiple interactions
EXP
baicalein inhibits the reaction [APP protein binds to APP protein]
CTD
PMID:17323972
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Ascl3
achaete-scute family bHLH transcription factor 3
affects expression
ISO
baicalein affects the expression of ASCL3 protein
CTD
PMID:36055377
NCBI chr 1:163,755,306...163,755,951
Ensembl chr 1:163,754,956...163,759,682
G
Ascl4
achaete-scute family bHLH transcription factor 4
affects expression
ISO
baicalein affects the expression of ASCL4 protein
CTD
PMID:36055377
NCBI chr 7:17,940,972...17,943,215
Ensembl chr 7:17,941,709...17,942,146
G
Atf4
activating transcription factor 4
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF4 protein]
CTD
PMID:33779329
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf5
activating transcription factor 5
increases expression multiple interactions
EXP
baicalein results in increased expression of ATF5 protein [Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF5 protein
CTD
PMID:33779329
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
G
Atf6
activating transcription factor 6
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 protein]
CTD
PMID:33779329
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atf7
activating transcription factor 7
multiple interactions
EXP
[Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF7 protein
CTD
PMID:33779329
NCBI chr 7:133,660,491...133,750,902
Ensembl chr 7:133,663,294...133,750,848
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of BAX protein]]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of BAX protein modified form]; baicalein inhibits the reaction [Bleomycin results in increased expression of BAX protein] baicalein results in increased expression of BAX protein
CTD
PMID:20850421 PMID:21457722 PMID:37783230
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein]]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]; baicalein inhibits the reaction [Bleomycin results in decreased expression of BCL2 protein] baicalein results in decreased expression of BCL2 protein MIR3663 mRNA promotes the reaction [baicalein results in decreased expression of BCL2 protein]
CTD
PMID:20850421 PMID:33838155 PMID:37783230
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
multiple interactions increases expression
EXP
[Carbon Tetrachloride co-treated with baicalein] results in increased expression of BECN1 protein baicalein results in increased expression of BECN1 protein
CTD
PMID:33779329
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions decreases expression
ISO
SB 203580 inhibits the reaction [baicalein results in decreased expression of BIRC5 protein]; wortmannin promotes the reaction [baicalein results in decreased expression of BIRC5 protein]
CTD
PMID:18025287
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Casp3
caspase 3
multiple interactions
ISO
5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased cleavage of CASP3 protein]]; baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP3 protein modified form]; baicalein inhibits the reaction [Bleomycin results in increased cleavage of CASP3 protein]
CTD
PMID:20850421 PMID:37783230
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CASP8 protein modified form]
CTD
PMID:20850421
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Ccna2
cyclin A2
decreases expression
ISO
baicalein results in decreased expression of CCNA2 protein
CTD
PMID:21457722
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
baicalein results in decreased expression of CCNB1 protein
CTD
PMID:18025287
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions decreases expression increases expression
ISO
Lithium Chloride inhibits the reaction [baicalein results in decreased expression of CCND1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA]
CTD
PMID:19160421 PMID:21457722 PMID:22820424 PMID:24560969 PMID:36988316
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
decreases expression
ISO
baicalein results in decreased expression of CCNE1 protein
CTD
PMID:24560969
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cdk1
cyclin-dependent kinase 1
decreases phosphorylation multiple interactions
ISO
baicalein results in decreased phosphorylation of CDK1 protein SB 203580 inhibits the reaction [baicalein results in decreased phosphorylation of CDK1 protein]; wortmannin promotes the reaction [baicalein results in decreased phosphorylation of CDK1 protein]
CTD
PMID:18025287
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk4
cyclin-dependent kinase 4
increases expression
ISO
baicalein results in increased expression of CDK4 protein
CTD
PMID:22820424
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
baicalein inhibits the reaction [Mitomycin results in increased expression of CDKN1A protein]
CTD
PMID:34624459
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cebpa
CCAAT/enhancer binding protein alpha
decreases expression
ISO
baicalein results in decreased expression of CEBPA protein
CTD
PMID:24560969
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
decreases expression
ISO
baicalein results in decreased expression of CEBPB mRNA
CTD
PMID:24560969
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Cebpg
CCAAT/enhancer binding protein gamma
decreases expression
ISO
baicalein results in decreased expression of CEBPG mRNA
CTD
PMID:24560969
NCBI chr 1:87,683,060...87,692,772
Ensembl chr 1:87,684,019...87,694,569
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions
ISO
baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein]
CTD
PMID:20850421
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Cftr
CF transmembrane conductance regulator
increases activity
ISO
baicalein results in increased activity of CFTR protein
CTD
PMID:15234961
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
ISO
baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein] 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]]; baicalein inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]
CTD
PMID:30201452 PMID:37783230
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
EXP
baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA]
CTD
PMID:19474275
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Csf2
colony stimulating factor 2
decreases expression
ISO
baicalein results in decreased expression of CSF2 mRNA
CTD
PMID:10718847
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Ctnnb1
catenin beta 1
decreases expression multiple interactions
ISO
baicalein results in decreased expression of CTNNB1 protein STMN1 protein inhibits the reaction [baicalein results in decreased expression of CTNNB1 protein]
CTD
PMID:38317500
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] affects the localization of CYCS protein]
CTD
PMID:20850421
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression decreases expression multiple interactions increases chemical synthesis decreases activity
ISO
baicalein results in increased expression of CYP1A1 protein baicalein results in decreased expression of CYP1A1 mRNA [CYP1A1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; baicalein inhibits the reaction [benz(a)anthracene results in increased expression of CYP1A1 mRNA]; baicalein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] CYP1A1 protein results in increased chemical synthesis of baicalein baicalein results in decreased activity of CYP1A1 protein
CTD
PMID:12224597 PMID:14644660 PMID:18451504 PMID:19666078 PMID:21053930 PMID:21482471 More...
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity increases chemical synthesis multiple interactions
ISO
baicalein results in decreased activity of CYP1A2 protein CYP1A2 protein results in increased chemical synthesis of baicalein [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein
CTD
PMID:19666078 PMID:21053930 PMID:29753067
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity increases chemical synthesis multiple interactions
ISO
baicalein results in decreased activity of CYP1B1 protein CYP1B1 protein results in increased chemical synthesis of baicalein [CYP1B1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; baicalein binds to and results in decreased activity of CYP1B1 protein; baicalein inhibits the reaction [benz(a)anthracene results in increased expression of CYP1B1 mRNA]
CTD
PMID:12224597 PMID:19666078 PMID:21053930 PMID:21482471
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
increases expression
ISO
baicalein results in increased expression of CYP2B6 mRNA
CTD
PMID:25625231
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
baicalein results in decreased activity of CYP2C19 protein
CTD
PMID:29753067
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
ISO
baicalein results in decreased activity of CYP2E1 protein
CTD
PMID:29753067
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
baicalein results in decreased activity of CYP3A4 protein
CTD
PMID:21053930 PMID:29753067
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of DDIT3 protein]
CTD
PMID:33779329
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dgat1
diacylglycerol O-acyltransferase 1
decreases expression
ISO
baicalein results in decreased expression of DGAT1 protein
CTD
PMID:24560969
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dlk1
delta like non-canonical Notch ligand 1
increases expression
ISO
baicalein results in increased expression of DLK1 mRNA
CTD
PMID:24560969
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
G
Egf
epidermal growth factor
multiple interactions
ISO
baicalein inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baicalein inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
CTD
PMID:25625231
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
multiple interactions affects binding decreases phosphorylation
ISO
baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of EGFR mRNA]; baicalein inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of EGFR protein] baicalein binds to EGFR protein
CTD
PMID:25625231 PMID:33838155 PMID:38230788
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr2
early growth response 2
decreases expression
ISO
baicalein results in decreased expression of EGR2 mRNA
CTD
PMID:24560969
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of EIF2AK3 protein]
CTD
PMID:33779329
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Elk1
ETS transcription factor ELK1
multiple interactions
ISO
baicalein inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
CTD
PMID:25625231
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Epo
erythropoietin
increases expression
ISO
baicalein results in increased expression of EPO mRNA
CTD
PMID:37348668
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions decreases expression
ISO
baicalein results in decreased expression of and results in decreased phosphorylation of ERBB2 protein baicalein results in decreased expression of ERBB2 mRNA
CTD
PMID:36988316
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ERN1 protein]
CTD
PMID:33779329
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Esr1
estrogen receptor 1
affects binding multiple interactions
ISO
baicalein binds to ESR1 protein baicalein inhibits the reaction [Cholesterol, LDL analog results in decreased expression of ESR1 mRNA]
CTD
PMID:38230788
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fabp4
fatty acid binding protein 4
decreases expression
ISO
baicalein results in decreased expression of FABP4 protein
CTD
PMID:24560969
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fasn
fatty acid synthase
decreases expression
ISO
baicalein results in decreased expression of FASN protein
CTD
PMID:24560969
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fn1
fibronectin 1
multiple interactions
ISO
baicalein inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]
CTD
PMID:30201452
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Glb1
galactosidase, beta 1
multiple interactions
ISO
baicalein inhibits the reaction [Mitomycin results in increased activity of GLB1 protein]
CTD
PMID:34624459
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
Gli1
GLI family zinc finger 1
decreases expression
ISO
baicalein results in decreased expression of GLI1 mRNA; baicalein results in decreased expression of GLI1 protein
CTD
PMID:20395211
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
Gpat3
glycerol-3-phosphate acyltransferase 3
decreases expression
ISO
baicalein results in decreased expression of GPAT3 protein
CTD
PMID:24560969
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpx4
glutathione peroxidase 4
affects expression multiple interactions
ISO
baicalein affects the expression of GPX4 protein baicalein inhibits the reaction [Polymyxin B results in decreased expression of GPX4 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of GPX4 protein]]
CTD
PMID:36055377 PMID:37354967
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gsk3b
glycogen synthase kinase 3 beta
decreases phosphorylation multiple interactions
ISO
baicalein results in decreased phosphorylation of GSK3B protein baicalein inhibits the reaction [Mitomycin results in increased phosphorylation of GSK3B protein]
CTD
PMID:22820424 PMID:34624459 PMID:36988316
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Hes1
hes family bHLH transcription factor 1
multiple interactions increases expression
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA]
CTD
PMID:19160421
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
multiple interactions increases expression
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA]
CTD
PMID:19160421
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
G
Hey2
hes-related family bHLH transcription factor with YRPW motif 2
multiple interactions increases expression
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA]
CTD
PMID:19160421
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions increases expression
ISO
baicalein results in decreased degradation of and results in increased expression of HIF1A protein modified form baicalein results in increased expression of HIF1A mRNA; baicalein results in increased expression of HIF1A protein
CTD
PMID:37348668
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO
baicalein results in increased expression of HMOX1 mRNA; baicalein results in increased expression of HMOX1 protein baicalein inhibits the reaction [Polymyxin B results in decreased expression of HMOX1 protein]; baicalein inhibits the reaction [Polymyxin B results in increased expression of HMOX1 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of HMOX1 protein]] Hemin promotes the reaction [baicalein results in increased expression of HMOX1 protein]; HMOX1 protein promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]]
CTD
PMID:14563492 PMID:37354967
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions increases activity
ISO
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid inhibits the reaction [baicalein results in increased activity of HSD11B2 protein]
CTD
PMID:18032417
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of HSPA5 protein]
CTD
PMID:33779329
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
baicalein inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]
CTD
PMID:17458902
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il1b
interleukin 1 beta
multiple interactions
ISO
baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B protein] baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of IL1B protein]
CTD
PMID:22369883 PMID:38230788
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of IL6 protein]
CTD
PMID:38230788
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins2
insulin 2
multiple interactions increases secretion
ISO
baicalein promotes the reaction [Glucose results in increased secretion of INS protein] baicalein results in increased secretion of INS protein
CTD
PMID:17192482
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions affects binding
ISO
baicalein inhibits the reaction [[IGF1 protein co-treated with Estradiol] results in increased expression of JUN protein]; baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of JUN mRNA] baicalein binds to JUN protein
CTD
PMID:17458902 PMID:38230788
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Klf2
KLF transcription factor 2
increases expression
ISO
baicalein results in increased expression of KLF2 mRNA
CTD
PMID:24560969
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klf5
KLF transcription factor 5
decreases expression
ISO
baicalein results in decreased expression of KLF5 mRNA
CTD
PMID:24560969
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
G
Lpin1
lipin 1
decreases expression
ISO
baicalein results in decreased expression of LPIN1 protein
CTD
PMID:24560969
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Mapk1
mitogen activated protein kinase 1
multiple interactions affects binding decreases phosphorylation
ISO
baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of MAPK1 mRNA]; baicalein results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of MAPK1 protein] baicalein binds to MAPK1 protein baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK1 protein modified form]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:10718847 PMID:20850421 PMID:31811862 PMID:33838155 PMID:38230788
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation
ISO
baicalein results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of MAPK3 protein] baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of MAPK3 protein modified form]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:10718847 PMID:20850421 PMID:31811862 PMID:33838155
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
baicalein results in decreased phosphorylation of and results in decreased activity of MAPK8 protein
CTD
PMID:10718847
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mir1224
microRNA 1224
increases expression
ISO
baicalein results in increased expression of MIR1224 mRNA
CTD
PMID:33838155
NCBI chr11:80,306,902...80,306,986
Ensembl chr11:80,306,902...80,306,986
G
Mir21
microRNA 21
multiple interactions
ISO
baicalein inhibits the reaction [TGFB1 protein results in increased expression of MIR21 mRNA]; MIR21 mRNA inhibits the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]
CTD
PMID:30201452
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
G
Mir322
microRNA 322
increases expression
ISO
baicalein results in increased expression of MIR424 mRNA
CTD
PMID:33838155
NCBI chr X:132,806,594...132,806,688
Ensembl chr X:132,806,594...132,806,688
G
Mmp2
matrix metallopeptidase 2
decreases activity multiple interactions
ISO
baicalein results in decreased activity of MMP2 protein baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP2 mRNA]
CTD
PMID:21803068 PMID:22369883 PMID:36988316
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression decreases activity
ISO
baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of MMP9 protein] baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of MMP9 mRNA] baicalein results in decreased activity of MMP9 protein
CTD
PMID:19804834 PMID:21803068 PMID:22369883 PMID:38317500
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
multiple interactions
ISO
baicalein inhibits the reaction [[Ethanol co-treated with Hydrochloric Acid] results in increased activity of MPO protein]
CTD
PMID:27780710
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
baicalein results in decreased phosphorylation of and results in decreased activity of MTOR protein
CTD
PMID:24560969
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nat1
N-acetyltransferase 1
decreases expression
ISO
baicalein results in decreased expression of NAT1 mRNA; baicalein results in decreased expression of NAT1 protein
CTD
PMID:15796204
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
G
Nfkb1
nuclear factor kappa B subunit 1
decreases localization
ISO
baicalein results in decreased localization of NFKB1 protein
CTD
PMID:21803068
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions decreases phosphorylation
ISO
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of NFKBIA protein] baicalein results in decreased phosphorylation of NFKBIA protein
CTD
PMID:20850421
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbib
NFKB inhibitor beta
decreases phosphorylation
ISO
baicalein results in decreased phosphorylation of NFKBIB protein
CTD
PMID:21803068
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
G
Nos2
nitric oxide synthase 2
multiple interactions decreases expression
ISO
baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein]; baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Hemin promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; HMOX1 protein promotes the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]]; tin protoporphyrin IX inhibits the reaction [baicalein inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]] baicalein results in decreased expression of NOS2 protein
CTD
PMID:14563492 PMID:20850421 PMID:22369883
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
increases activity increases expression
ISO
baicalein results in increased activity of NOTCH1 protein baicalein results in increased expression of NOTCH1 mRNA
CTD
PMID:19160421
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
affects localization
ISO
baicalein affects the localization of NR1I3 protein
CTD
PMID:25625231
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Pcna
proliferating cell nuclear antigen
multiple interactions decreases expression
ISO
STMN1 protein inhibits the reaction [baicalein results in decreased expression of PCNA protein]
CTD
PMID:38317500
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pik3c3
phosphatidylinositol 3-kinase, catalytic subunit type 3
multiple interactions
EXP
[Carbon Tetrachloride co-treated with baicalein] results in increased expression of PIK3C3 protein
CTD
PMID:33779329
NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
affects binding multiple interactions
ISO
baicalein binds to PIK3CA protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of PIK3CA mRNA]
CTD
PMID:38230788
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
G
Pkm
pyruvate kinase M1/2
increases activity
ISO
baicalein results in increased activity of PKM protein
CTD
PMID:25388478
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Pla2g2a
phospholipase A2 group IIA
multiple interactions
ISO
baicalein inhibits the reaction [PLA2G2A protein results in increased expression of PTGS2 protein]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK1 protein]; baicalein inhibits the reaction [PLA2G2A protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:31811862
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
G
Plau
plasminogen activator, urokinase
decreases activity
ISO
baicalein results in decreased activity of PLAU protein
CTD
PMID:21803068
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
multiple interactions
ISO
baicalein inhibits the reaction [Fenretinide results in increased expression of PMAIP1 mRNA]
CTD
PMID:17216584
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
baicalein results in decreased expression of PPARG protein
CTD
PMID:24560969
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Prkca
protein kinase C, alpha
decreases phosphorylation
ISO
baicalein results in decreased phosphorylation of PRKCA protein
CTD
PMID:21803068
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA]; baicalein inhibits the reaction [PLA2G2A protein results in increased expression of PTGS2 protein]; baicalein inhibits the reaction [Polymyxin B results in increased expression of PTGS2 protein]
CTD
PMID:19804834 PMID:22369883 PMID:31811862 PMID:37354967
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pygb
glycogen phosphorylase B
decreases activity
ISO
baicalein results in decreased activity of PYGB protein
CTD
PMID:37277066
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
G
Pygl
glycogen phosphorylase L
decreases activity
ISO
baicalein results in decreased activity of PYGL protein
CTD
PMID:37277066
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Rb1
RB transcriptional corepressor 1
multiple interactions decreases phosphorylation
ISO
AHR protein affects the reaction [baicalein results in decreased phosphorylation of RB1 protein]; Lithium Chloride inhibits the reaction [baicalein results in decreased phosphorylation of RB1 protein]
CTD
PMID:22820424
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases phosphorylation affects localization decreases localization
ISO
baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] affects the localization of RELA protein]; baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of RELA protein] baicalein results in decreased phosphorylation of RELA protein MIR3663 mRNA promotes the reaction [baicalein results in decreased phosphorylation of RELA protein]; NKILA mRNA promotes the reaction [baicalein affects the localization of RELA protein] baicalein results in decreased localization of RELA protein
CTD
PMID:20850421 PMID:21803068 PMID:22369883 PMID:29481769 PMID:33838155
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
baicalein results in decreased phosphorylation of and results in decreased activity of RPS6KB1 protein
CTD
PMID:24560969
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sh3gl1
SH3 domain containing GRB2 like 1, endophilin A2
decreases expression multiple interactions
ISO
baicalein results in decreased expression of SH3GL1 mRNA; baicalein results in decreased expression of SH3GL1 protein MIR3663 mRNA promotes the reaction [baicalein results in decreased expression of SH3GL1 protein]
CTD
PMID:33838155
NCBI chr 9:842,285...869,753
Ensembl chr 9:842,288...869,716
G
Sirt1
sirtuin 1
multiple interactions
ISO
baicalein inhibits the reaction [Polymyxin B results in decreased expression of SIRT1 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of GPX4 protein]]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of HMOX1 protein]]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in increased acetylation of TP53 protein]]
CTD
PMID:37354967
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Slc22a6
solute carrier family 22 member 6
decreases activity
ISO
baicalein results in decreased activity of SLC22A6 protein
CTD
PMID:32159797
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
ISO
baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]]
CTD
PMID:37354967
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Snca
synuclein alpha
multiple interactions
ISO
baicalein inhibits the reaction [SNCA protein binds to SNCA protein] baicalein inhibits the reaction [Rotenone promotes the reaction [SNCA protein binds to SNCA protein]]; baicalein inhibits the reaction [Rotenone results in increased expression of SNCA protein]
CTD
PMID:27425033
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Spry1
sprouty RTK signaling antagonist 1
multiple interactions
ISO
baicalein inhibits the reaction [TGFB1 protein results in decreased expression of SPRY1 protein]; SPRY1 protein affects the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]
CTD
PMID:30201452
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
affects binding multiple interactions
ISO
baicalein binds to SRC protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of SRC mRNA]
CTD
PMID:38230788
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
baicalein results in decreased expression of SREBF1 protein
CTD
PMID:24560969
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
baicalein inhibits the reaction [TGFB1 protein results in increased phosphorylation of STAT3 protein]
CTD
PMID:30201452
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stmn1
stathmin 1
decreases expression multiple interactions
ISO
baicalein results in decreased expression of STMN1 protein STMN1 protein inhibits the reaction [baicalein results in decreased expression of CTNNB1 protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of MMP9 protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of PCNA protein]; STMN1 protein inhibits the reaction [baicalein results in decreased expression of WNT3A protein]
CTD
PMID:38317500
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
EXP ISO
baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] 5-hydroxydecanoic acid inhibits the reaction [baicalein inhibits the reaction [Bleomycin results in increased expression of TGFB1 protein]] baicalein inhibits the reaction [TGFB1 protein results in decreased expression of SPRY1 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; baicalein inhibits the reaction [TGFB1 protein results in increased expression of MIR21 mRNA]; baicalein inhibits the reaction [TGFB1 protein results in increased phosphorylation of STAT3 protein]; MIR21 mRNA inhibits the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; SPRY1 protein affects the reaction [baicalein inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]
CTD
PMID:19474275 PMID:30201452 PMID:37783230
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
multiple interactions
ISO
baicalein inhibits the reaction [Rotenone results in decreased expression of TH protein]
CTD
PMID:27425033
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
decreases expression multiple interactions
ISO
baicalein results in decreased expression of TNF protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of TNF protein] baicalein inhibits the reaction [Benzo(a)pyrene results in increased expression of TNF protein]
CTD
PMID:20850421 PMID:22369883 PMID:38230788
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases expression affects binding multiple interactions
ISO
baicalein results in increased expression of TP53 protein baicalein binds to TP53 protein baicalein inhibits the reaction [Cholesterol, LDL analog results in increased expression of TP53 mRNA]; baicalein inhibits the reaction [Polymyxin B results in increased acetylation of TP53 protein]; SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in increased acetylation of TP53 protein]]
CTD
PMID:21457722 PMID:37354967 PMID:38230788
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
baicalein results in decreased expression of VEGFA protein
CTD
PMID:16638750 PMID:36988316
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Wnt3a
Wnt family member 3A
decreases expression multiple interactions
ISO
baicalein results in decreased expression of WNT3A protein STMN1 protein inhibits the reaction [baicalein results in decreased expression of WNT3A protein]
CTD
PMID:38317500
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
G
Xbp1
X-box binding protein 1
multiple interactions
EXP
baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of XBP1 protein]
CTD
PMID:33779329
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
baicalein inhibits the reaction [[Biological Products co-treated with potassium oxonate] results in increased activity of XDH protein]
CTD
PMID:34044073
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased activity of XIAP protein]
CTD
PMID:20850421
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Ache
acetylcholinesterase
multiple interactions increases expression
EXP
baicalin results in increased expression of and results in increased activity of ACHE protein baicalin results in increased expression of ACHE mRNA
CTD
PMID:27019979
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ahr
aryl hydrocarbon receptor
increases activity
ISO
baicalin results in increased activity of AHR protein
CTD
PMID:17869316 PMID:26204831
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aif1
allograft inflammatory factor 1
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein]
CTD
PMID:38016618
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Alb
albumin
multiple interactions
ISO
baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of ALB protein]
CTD
PMID:35088608
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions
EXP
baicalin inhibits the reaction [Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein]
CTD
PMID:20139896
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Angpt1
angiopoietin 1
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in decreased expression of ANGPT1 mRNA]
CTD
PMID:34414639
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Atf2
activating transcription factor 2
multiple interactions
EXP
baicalin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of ATF2 protein]
CTD
PMID:24312512
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
ISO EXP
baicalin results in increased expression of BAX protein baicalin affects the reaction [Rotenone results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Rotenone results in increased expression of BAX protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX protein] baicalin inhibits the reaction [Rotenone affects the expression of BAX protein]
CTD
PMID:21457722 PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982 More...
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
EXP ISO
baicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein] baicalin results in decreased expression of BCL2 protein baicalin affects the reaction [Rotenone results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein]
CTD
PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp1
caspase 1
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]
CTD
PMID:38016618
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
multiple interactions
EXP ISO
baicalin inhibits the reaction [Rotenone affects the expression of CASP3 protein] baicalin affects the reaction [Rotenone results in decreased activity of CASP3 protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; baicalin inhibits the reaction [Gentamicins results in increased cleavage of CASP3 protein]
CTD
PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
ISO
baicalin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]
CTD
PMID:34333357 PMID:35088608
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccna2
cyclin A2
decreases expression
ISO
baicalin results in decreased expression of CCNA2 protein
CTD
PMID:21457722
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnd1
cyclin D1
increases expression decreases expression multiple interactions
ISO
baicalin results in increased expression of CCND1 mRNA baicalin results in decreased expression of CCND1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA]
CTD
PMID:19160421 PMID:21457722
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
EXP
baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA]
CTD
PMID:19474275
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression
ISO
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 protein]; baicalin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] baicalin results in increased expression of CYP1A1 mRNA; baicalin results in increased expression of CYP1A1 protein
CTD
PMID:18451504 PMID:26204831
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression
ISO
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] baicalin results in increased expression of CYP1A2 mRNA; baicalin results in increased expression of CYP1A2 protein
CTD
PMID:26204831
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Egf
epidermal growth factor
multiple interactions
ISO
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
CTD
PMID:25625231
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]
CTD
PMID:25625231
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Elk1
ETS transcription factor ELK1
multiple interactions
ISO
baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein]
CTD
PMID:25625231
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
baicalin inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein]
CTD
PMID:29031535
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Foxa2
forkhead box A2
decreases expression
ISO
baicalin results in decreased expression of FOXA2 mRNA; baicalin results in decreased expression of FOXA2 protein
CTD
PMID:32687838
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions
EXP
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]
CTD
PMID:15645217
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP ISO
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein] baicalin inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein]
CTD
PMID:15645217 PMID:35088608
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Hes1
hes family bHLH transcription factor 1
increases expression multiple interactions
ISO
baicalin results in increased expression of HES1 mRNA N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]
CTD
PMID:19160421
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
increases expression multiple interactions
ISO
baicalin results in increased expression of HEY1 mRNA N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA]
CTD
PMID:19160421
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
G
Hey2
hes-related family bHLH transcription factor with YRPW motif 2
multiple interactions increases expression
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA]
CTD
PMID:19160421
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO EXP
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HMOX1 protein]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 mRNA]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein] baicalin results in increased expression of HMOX1 mRNA; baicalin results in increased expression of HMOX1 protein
CTD
PMID:16824337 PMID:18187930 PMID:38016618
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf1a
HNF1 homeobox A
multiple interactions decreases expression
ISO
baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF1A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein] baicalin results in decreased expression of HNF1A mRNA; baicalin results in decreased expression of HNF1A protein
CTD
PMID:32687838
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression multiple interactions
ISO
baicalin results in decreased expression of HNF4A protein baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein]; HNF4A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens] baicalin results in decreased expression of HNF4A mRNA; baicalin results in decreased expression of HNF4A protein
CTD
PMID:32687838
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hspb1
heat shock protein family B (small) member 1
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of HSPB1 protein]
CTD
PMID:34414639
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Il1b
interleukin 1 beta
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]] baicalin inhibits the reaction [Rotenone results in increased expression of IL1B protein]
CTD
PMID:29031535 PMID:35088608 PMID:36446982 PMID:38016618
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases expression multiple interactions
EXP ISO
baicalin results in decreased expression of IL6 mRNA; baicalin results in decreased expression of IL6 protein baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]
CTD
PMID:22019745 PMID:29031535 PMID:34333357 PMID:35088608 PMID:38016618
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein]
CTD
PMID:34414639
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Itga4
integrin subunit alpha 4
multiple interactions
EXP
baicalin inhibits the reaction [ITGA4 protein results in increased expression of KDR protein]; baicalin inhibits the reaction [ITGA4 protein results in increased expression of VEGFA protein]
CTD
PMID:36731809
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Jak2
Janus kinase 2
multiple interactions
ISO
baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JAK2 protein]
CTD
PMID:35088608
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kdr
kinase insert domain receptor
multiple interactions
EXP
baicalin inhibits the reaction [ITGA4 protein results in increased expression of KDR protein]
CTD
PMID:36731809
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein]
CTD
PMID:38016618
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:34414639
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:34414639
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Myd88
MYD88, innate immune signal transduction adaptor
decreases expression
EXP
baicalin results in decreased expression of MYD88 protein
CTD
PMID:22019745
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]]
CTD
PMID:38016618
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
increases expression
EXP
baicalin results in increased expression of NFKBIA protein
CTD
PMID:22019745
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]
CTD
PMID:29031535 PMID:38016618
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nos2
nitric oxide synthase 2
multiple interactions decreases expression
EXP ISO
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; mifobate inhibits the reaction [baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] baicalin results in decreased expression of NOS2 mRNA; baicalin results in decreased expression of NOS2 protein baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]
CTD
PMID:18187930 PMID:22019745 PMID:24312512
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
increases activity increases expression
ISO
baicalin results in increased activity of NOTCH1 protein baicalin results in increased expression of NOTCH1 mRNA
CTD
PMID:19160421
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
increases expression
ISO
Baicalin increases expression of NR1H3 mRNA and protein in foam cells
RGD
PMID:27389392
RGD:401842390
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Pkm
pyruvate kinase M1/2
increases activity
ISO
baicalin results in increased activity of PKM protein
CTD
PMID:25388478
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein]
CTD
PMID:24312512
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Prima1
proline rich membrane anchor 1
increases expression
EXP
baicalin results in increased expression of PRIMA1 mRNA
CTD
PMID:27019979
NCBI chr 6:122,338,365...122,390,955
Ensembl chr 6:122,338,370...122,389,921
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
EXP
baicalin results in decreased expression of PTGS2 mRNA; baicalin results in decreased expression of PTGS2 protein
CTD
PMID:22019745
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pycard
PYD and CARD domain containing
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]
CTD
PMID:38016618
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP ISO
baicalin affects the localization of and results in decreased expression of RELA protein baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RELA protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]]
CTD
PMID:22019745 PMID:34333357 PMID:38016618
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Snca
synuclein alpha
multiple interactions
ISO
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]]
CTD
PMID:38016618
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of STAT3 protein]
CTD
PMID:35088608
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tek
TEK receptor tyrosine kinase
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in decreased expression of TEK mRNA]
CTD
PMID:34414639
NCBI chr 5:109,607,077...109,733,805
Ensembl chr 5:109,607,077...109,733,804
G
Tfam
transcription factor A, mitochondrial
decreases expression multiple interactions
ISO
baicalin results in decreased expression of TFAM mRNA baicalin inhibits the reaction [Rotenone results in decreased expression of TFAM mRNA]
CTD
PMID:36446982
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in decreased expression of TGFB1 mRNA]; baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA]
CTD
PMID:19474275 PMID:34414639
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
multiple interactions
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TH protein]
CTD
PMID:38016618
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
G
Tlr4
toll-like receptor 4
decreases expression multiple interactions
EXP ISO
baicalin results in decreased expression of TLR4 protein baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TLR4 protein] baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]
CTD
PMID:22019745 PMID:24312512 PMID:34333357
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
ISO EXP
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TNF protein]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein] baicalin results in decreased expression of TNF mRNA; baicalin results in decreased expression of TNF protein baicalin inhibits the reaction [Paraquat results in increased expression of TNF protein]
CTD
PMID:16824337 PMID:18187930 PMID:22019745 PMID:34333357 PMID:35088608 PMID:38016618 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases expression
ISO
baicalin results in increased expression of TP53 protein
CTD
PMID:21457722
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Txnip
thioredoxin interacting protein
multiple interactions
ISO
baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]; dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]]
CTD
PMID:29031535
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Usp27x
ubiquitin specific peptidase 27, X-linked
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in increased expression of USP27X protein]
CTD
PMID:34414639
NCBI chr X:15,123,620...15,126,855
Ensembl chr X:15,124,596...15,125,912
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
baicalin inhibits the reaction [ITGA4 protein results in increased expression of VEGFA protein]
CTD
PMID:36731809
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
multiple interactions
EXP
baicalin inhibits the reaction [Streptozocin results in decreased expression of VEGFC mRNA]
CTD
PMID:34414639
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
baicalin inhibits the reaction [[Biological Products co-treated with potassium oxonate] results in increased activity of XDH protein]
CTD
PMID:34044073
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
CTD
PMID:16757516
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Adam9
ADAM metallopeptidase domain 9
multiple interactions
ISO
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein]
CTD
PMID:17018608
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Afp
alpha-fetoprotein
multiple interactions
EXP
ebselen inhibits the reaction [Aflatoxin B1 results in increased expression of AFP mRNA]
CTD
PMID:11133813
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Alad
aminolevulinate dehydratase
multiple interactions decreases activity
EXP ISO
Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein] ebselen inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein]
CTD
PMID:14630126 PMID:17624921 PMID:23933410
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Alox5
arachidonate 5-lipoxygenase
decreases activity
ISO
ebselen results in decreased activity of ALOX5 protein
CTD
PMID:7590103
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
ebselen inhibits the reaction [sodium arsenite results in increased expression of BAX protein]
CTD
PMID:30558456
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]
CTD
PMID:30558456
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions increases activity
ISO EXP
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP3 protein] ebselen inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; ebselen inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] ebselen results in increased activity of CASP3 protein
CTD
PMID:21300091 PMID:23649643 PMID:25068500 PMID:30558456
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO EXP
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein]
CTD
PMID:18629305 PMID:23649643
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases activity multiple interactions
EXP
ebselen results in increased activity of CAT protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]
CTD
PMID:27282967 PMID:30558456
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cox4i1
cytochrome c oxidase subunit 4i1
increases expression
ISO
ebselen results in increased expression of COX4I1 protein
CTD
PMID:27385396
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
G
Cs
citrate synthase
multiple interactions
ISO EXP
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] ebselen inhibits the reaction [Cisplatin results in decreased activity of CS protein]
CTD
PMID:27385396 PMID:32860823
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA]
CTD
PMID:11903743
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation
EXP
ebselen results in increased phosphorylation of EIF2S1 protein
CTD
PMID:27282967
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Ephx2
epoxide hydrolase 2
multiple interactions
ISO
ebselen binds to and results in decreased activity of EPHX2 protein
CTD
PMID:23219563
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Fmr1
fragile X messenger ribonucleoprotein 1
multiple interactions
ISO
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein]
CTD
PMID:27385396
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein]
CTD
PMID:14572605
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
multiple interactions
EXP
ebselen inhibits the reaction [Cisplatin results in increased activity of G6PC1 protein]
CTD
PMID:32860823
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gck
glucokinase
multiple interactions
ISO
[ebselen co-treated with Glucose] results in increased activity of GCK protein
CTD
PMID:23795780
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
G
Gfap
glial fibrillary acidic protein
increases phosphorylation
EXP
ebselen results in increased phosphorylation of GFAP protein
CTD
PMID:27282967
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gja1
gap junction protein, alpha 1
multiple interactions
EXP
ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein]
CTD
PMID:12958040
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] ebselen inhibits the reaction [Methylmercury Compounds results in decreased activity of GPX1 protein]
CTD
PMID:23795780 PMID:28383113
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gsr
glutathione-disulfide reductase
increases activity multiple interactions
EXP
ebselen results in increased activity of GSR protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
CTD
PMID:27282967 PMID:30558456
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
multiple interactions
EXP
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein]
CTD
PMID:8147899
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta3
glutathione S-transferase alpha 3
multiple interactions
EXP
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein]; ebselen binds to and results in decreased activity of GSTA3 protein
CTD
PMID:8147899
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein]
CTD
PMID:8147899
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
multiple interactions
EXP
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein]
CTD
PMID:8147899
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
EXP
ebselen binds to and results in decreased activity of GSTP1 protein
CTD
PMID:8147899
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]
CTD
PMID:19374849
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
[ebselen affects the abundance of Reactive Oxygen Species] which results in decreased expression of HMOX1 protein; [ebselen affects the abundance of Reactive Oxygen Species] which results in increased activity of HMOX1 protein
CTD
PMID:16959961
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hpgds
hematopoietic prostaglandin D synthase
increases expression
ISO
ebselen results in increased expression of HPGDS mRNA
CTD
PMID:21669866
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
ebselen results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Ifng
interferon gamma
multiple interactions
ISO
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein]
CTD
PMID:12794164
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il6
interleukin 6
multiple interactions
EXP
ebselen inhibits the reaction [sodium arsenite results in increased expression of IL6 protein]
CTD
PMID:30558456
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
ISO
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein]
CTD
PMID:23795780
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation increases activity
ISO EXP
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen analog results in increased phosphorylation of MAPK1 protein; ebselen results in increased phosphorylation of MAPK1 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen results in increased activity of MAPK1 protein
CTD
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation increases activity
ISO EXP
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen analog results in increased phosphorylation of MAPK3 protein; ebselen results in increased phosphorylation of MAPK3 protein ebselen results in increased activity of MAPK3 protein
CTD
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
EXP
ebselen results in increased phosphorylation of MAPK9 protein
CTD
PMID:27282967
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mmp13
matrix metallopeptidase 13
multiple interactions
EXP
ebselen inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP13 mRNA]
CTD
PMID:11903743
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Ngf
nerve growth factor
multiple interactions
ISO
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
CTD
PMID:20495008
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nos2
nitric oxide synthase 2
multiple interactions decreases activity
ISO EXP
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] ebselen results in decreased activity of NOS2 protein
CTD
PMID:7590103 PMID:12794164
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
decreases activity
EXP
ebselen results in decreased activity of NQO1 protein
CTD
PMID:7590103
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Pdx1
pancreatic and duodenal homeobox 1
multiple interactions
ISO
[ebselen co-treated with Glucose] results in increased expression of PDX1 protein
CTD
PMID:23795780
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
G
Phospho1
phosphoethanolamine/phosphocholine phosphatase 1
decreases activity
ISO
ebselen results in decreased activity of PHOSPHO1 protein
CTD
PMID:17227223
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein]
CTD
PMID:14572605
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Slc11a2
solute carrier family 11 member 2
multiple interactions
ISO
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron]
CTD
PMID:16984886
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc2a2
solute carrier family 2 member 2
multiple interactions
ISO EXP
[ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein ebselen inhibits the reaction [Cisplatin results in increased expression of SLC2A2 protein]
CTD
PMID:23795780 PMID:32860823
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
G
Smad3
SMAD family member 3
multiple interactions
ISO
ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
CTD
PMID:21131394
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Sod1
superoxide dismutase 1
decreases response to substance multiple interactions
ISO
ebselen results in decreased susceptibility to SOD1 protein mutant form ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]
CTD
PMID:16702190 PMID:23795780
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions
EXP
ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
CTD
PMID:20495008
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tat
tyrosine aminotransferase
multiple interactions
EXP
ebselen inhibits the reaction [Cisplatin results in increased activity of TAT protein]
CTD
PMID:32860823
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
EXP ISO
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]
CTD
PMID:11903743 PMID:16757516 PMID:21131394
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Timp1
TIMP metallopeptidase inhibitor 1
multiple interactions
EXP
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]
CTD
PMID:11903743
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
multiple interactions
EXP
ebselen inhibits the reaction [sodium arsenite results in increased expression of TNF protein]
CTD
PMID:30558456
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Txnrd1
thioredoxin reductase 1
multiple interactions
ISO
ebselen results in increased expression of and results in increased activity of TXNRD1 protein
CTD
PMID:28383113
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Ucp2
uncoupling protein 2
multiple interactions
ISO
[ebselen co-treated with Glucose] results in decreased expression of UCP2 protein
CTD
PMID:23795780
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Xbp1
X-box binding protein 1
increases phosphorylation
EXP
ebselen results in increased phosphorylation of XBP1 protein
CTD
PMID:27282967
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xpa
XPA, DNA damage recognition and repair factor
multiple interactions
ISO
ebselen inhibits the reaction [Zinc binds to XPA protein]
CTD
PMID:15265038
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of BAX mRNA]
CTD
PMID:36198566
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA]
CTD
PMID:36198566
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of CASP3 mRNA]
CTD
PMID:36198566
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]
CTD
PMID:36198566
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Fasn
fatty acid synthase
multiple interactions
ISO
herbacetin inhibits the reaction [Dietary Fats results in increased activity of FASN protein]
CTD
PMID:29653099
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
ISO
herbacetin inhibits the reaction [Dietary Fats results in increased activity of G6PD protein]
CTD
PMID:29653099
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
herbacetin inhibits the reaction [Dietary Fats results in increased activity of GPT protein]
CTD
PMID:29653099
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in decreased activity of GSR protein]
CTD
PMID:36198566
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of HAVCR1 protein]
CTD
PMID:36198566
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Il1b
interleukin 1 beta
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of IL1B protein]
CTD
PMID:36198566
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of IL6 protein]
CTD
PMID:36198566
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lcn2
lipocalin 2
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of LCN2 protein]
CTD
PMID:36198566
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein]
CTD
PMID:36198566
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of PTGS2 protein]
CTD
PMID:36198566
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
herbacetin inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
CTD
PMID:29653099
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
herbacetin inhibits the reaction [Dietary Fats results in increased expression of SREBF2 mRNA]
CTD
PMID:29653099
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Tnf
tumor necrosis factor
multiple interactions
EXP
herbacetin inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]
CTD
PMID:36198566
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
A2m
alpha-2-macroglobulin
affects expression
ISO
Vitamin K 3 affects the expression of A2M mRNA
CTD
PMID:20044591
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
ISO
Vitamin K 3 results in decreased expression of ABCB11 mRNA
CTD
PMID:34767876
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb7
ATP binding cassette subfamily B member 7
affects expression
ISO
Vitamin K 3 affects the expression of ABCB7 mRNA
CTD
PMID:20044591
NCBI chr X:69,295,598...69,436,775
Ensembl chr X:69,295,552...69,436,858
G
Abcc3
ATP binding cassette subfamily C member 3
affects expression
ISO
Vitamin K 3 affects the expression of ABCC3 mRNA
CTD
PMID:20044591
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcd4
ATP binding cassette subfamily D member 4
decreases expression
ISO
Vitamin K 3 results in decreased expression of ABCD4 mRNA
CTD
PMID:25270620
NCBI chr 6:104,246,459...104,260,965
Ensembl chr 6:104,246,468...104,280,276
G
Abcg2
ATP binding cassette subfamily G member 2
affects expression
ISO
Vitamin K 3 affects the expression of ABCG2 mRNA
CTD
PMID:20044591
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abhd14b
abhydrolase domain containing 14b
affects expression
ISO
Vitamin K 3 affects the expression of ABHD14B mRNA
CTD
PMID:20044591
NCBI chr 8:107,087,157...107,092,122
Ensembl chr 8:107,088,069...107,092,119
G
Abhd4
abhydrolase domain containing 4, N-acyl phospholipase B
increases expression
ISO
Vitamin K 3 results in increased expression of ABHD4 mRNA
CTD
PMID:25270620
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
G
Abhd5
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of ABHD5 mRNA
CTD
PMID:20044591
NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
G
Abr
ABR activator of RhoGEF and GTPase
affects expression
ISO
Vitamin K 3 affects the expression of ABR mRNA
CTD
PMID:20044591
NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505
G
Acat2
acetyl-CoA acetyltransferase 2
affects expression
ISO
Vitamin K 3 affects the expression of ACAT2 mRNA
CTD
PMID:20044591
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Aco1
aconitase 1
affects activity
ISO
Vitamin K 3 affects the activity of ACO1 protein
CTD
PMID:10037708
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Aco2
aconitase 2
affects expression
ISO
Vitamin K 3 affects the expression of ACO2 mRNA
CTD
PMID:20044591
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
G
Acot13
acyl-CoA thioesterase 13
affects expression
ISO
Vitamin K 3 affects the expression of ACOT13 mRNA
CTD
PMID:20044591
NCBI chr17:40,240,378...40,252,851
Ensembl chr17:40,240,378...40,252,851
G
Acsl1
acyl-CoA synthetase long-chain family member 1
affects expression
ISO
Vitamin K 3 affects the expression of ACSL1 mRNA
CTD
PMID:20044591
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acss1
acyl-CoA synthetase short-chain family member 1
affects expression
ISO
Vitamin K 3 affects the expression of ACSS1 mRNA
CTD
PMID:20044591
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
G
Actr3b
actin related protein 3B
affects expression
ISO
Vitamin K 3 affects the expression of ACTR3B mRNA
CTD
PMID:20044591
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
G
Adam19
ADAM metallopeptidase domain 19
decreases expression
ISO
Vitamin K 3 results in decreased expression of ADAM19 mRNA
CTD
PMID:25270620
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
G
Adam9
ADAM metallopeptidase domain 9
affects expression
ISO
Vitamin K 3 affects the expression of ADAM9 mRNA
CTD
PMID:23410634
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Adcy3
adenylate cyclase 3
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of ADCY3 mRNA Vitamin K 3 results in decreased expression of ADCY3 mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
G
Add3
adducin 3
affects expression
ISO
Vitamin K 3 affects the expression of ADD3 mRNA
CTD
PMID:20044591
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgra3
adhesion G protein-coupled receptor A3
affects expression
ISO
Vitamin K 3 affects the expression of ADGRA3 mRNA
CTD
PMID:20044591
NCBI chr14:60,874,719...60,976,341
Ensembl chr14:60,874,715...60,976,332
G
Adgrv1
adhesion G protein-coupled receptor V1
affects expression
ISO
Vitamin K 3 affects the expression of ADGRV1 mRNA
CTD
PMID:20044591
NCBI chr 2:11,331,434...11,911,713
Ensembl chr 2:11,331,442...11,911,688
G
Adk
adenosine kinase
affects expression
ISO
Vitamin K 3 affects the expression of ADK mRNA
CTD
PMID:20044591
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Ago1
argonaute RISC component 1
affects expression
ISO
Vitamin K 3 affects the expression of AGO1 mRNA
CTD
PMID:20044591
NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546
G
Agpat3
1-acylglycerol-3-phosphate O-acyltransferase 3
affects expression
ISO
Vitamin K 3 affects the expression of AGPAT3 mRNA
CTD
PMID:20044591
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
affects expression
ISO
Vitamin K 3 affects the expression of AGR2 mRNA
CTD
PMID:20044591
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Ahr
aryl hydrocarbon receptor
affects expression
ISO
Vitamin K 3 affects the expression of AHR mRNA
CTD
PMID:20044591
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Aire
autoimmune regulator
decreases expression
ISO
Vitamin K 3 results in decreased expression of AIRE mRNA
CTD
PMID:25270620
NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060
G
Akap12
A-kinase anchoring protein 12
affects expression
ISO
Vitamin K 3 affects the expression of AKAP12 mRNA
CTD
PMID:23410634
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akap9
A-kinase anchoring protein 9
affects expression
ISO
Vitamin K 3 affects the expression of AKAP9 mRNA
CTD
PMID:20044591
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akip1
A-kinase interacting protein 1
affects expression
ISO
Vitamin K 3 affects the expression of AKIP1 mRNA
CTD
PMID:20044591
NCBI chr 1:163,734,730...163,743,648
Ensembl chr 1:163,734,798...163,743,648
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Vitamin K 3 results in increased expression of AKR1B10 mRNA
CTD
PMID:23410634 PMID:34767876
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
affects expression
ISO
Vitamin K 3 affects the expression of AKR1C1 mRNA
CTD
PMID:20044591
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Vitamin K 3 results in increased expression of AKR1C2 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akr7a2
aldo-keto reductase family 7, member A2
multiple interactions increases metabolic processing decreases response to substance
ISO
AKR7A2 protein inhibits the reaction [Vitamin K 3 results in decreased abundance of Glutathione]; AKR7A2 protein inhibits the reaction [Vitamin K 3 results in increased abundance of Reactive Oxygen Species] AKR7A5 protein results in increased metabolism of Vitamin K 3 AKR7A2 protein results in decreased susceptibility to Vitamin K 3
CTD
PMID:22001351 PMID:24590062
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Alb
albumin
affects expression
ISO
Vitamin K 3 affects the expression of ALB mRNA
CTD
PMID:20044591
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
affects expression
ISO
Vitamin K 3 affects the expression of ALDH18A1 mRNA
CTD
PMID:20044591
NCBI chr 1:239,375,657...239,407,956
Ensembl chr 1:239,375,669...239,407,890
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
affects expression
ISO
Vitamin K 3 affects the expression of ALDH1A1 mRNA
CTD
PMID:23410634
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
affects expression
ISO
Vitamin K 3 affects the expression of ALDH1A3 mRNA
CTD
PMID:20829426
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
G
Aldh2
aldehyde dehydrogenase 2 family member
affects expression
ISO
Vitamin K 3 affects the expression of ALDH2 mRNA
CTD
PMID:20044591
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
decreases response to substance
ISO
ALDH3B1 protein results in decreased susceptibility to Vitamin K 3
CTD
PMID:20699116
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
affects expression
ISO
Vitamin K 3 affects the expression of ALDH6A1 mRNA
CTD
PMID:20044591
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Alpl
alkaline phosphatase, biomineralization associated
decreases secretion
ISO
Vitamin K 3 results in decreased secretion of ALPL protein
CTD
PMID:30453296
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Alyref
Aly/REF export factor
affects expression
ISO
Vitamin K 3 affects the expression of ALYREF mRNA
CTD
PMID:20044591
NCBI chr10:105,871,424...105,875,076
Ensembl chr10:105,871,306...105,875,069
G
Amotl2
angiomotin like 2
affects expression
ISO
Vitamin K 3 affects the expression of AMOTL2 mRNA
CTD
PMID:20044591
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
G
Anapc1
anaphase promoting complex subunit 1
affects expression
ISO
Vitamin K 3 affects the expression of ANAPC1 mRNA
CTD
PMID:20044591
NCBI chr 3:115,850,117...115,930,259
Ensembl chr 3:115,850,185...115,930,273
G
Ang
angiogenin
affects expression
ISO
Vitamin K 3 affects the expression of ANG mRNA
CTD
PMID:20044591
NCBI chr15:24,312,711...24,323,361
G
Ank3
ankyrin 3
affects expression
ISO
Vitamin K 3 affects the expression of ANK3 mRNA
CTD
PMID:20044591
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
G
Ankra2
ankyrin repeat family A member 2
affects expression
ISO
Vitamin K 3 affects the expression of ANKRA2 mRNA
CTD
PMID:23410634
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
G
Ankrd11
ankyrin repeat domain containing 11
affects expression
ISO
Vitamin K 3 affects the expression of ANKRD11 mRNA
CTD
PMID:20044591
NCBI chr19:50,940,284...51,098,962
Ensembl chr19:50,940,299...51,098,962
G
Ankrd37
ankyrin repeat domain 37
decreases expression
ISO
Vitamin K 3 results in decreased expression of ANKRD37 mRNA
CTD
PMID:25270620
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Anks1a
ankyrin repeat and sterile alpha motif domain containing 1A
affects expression
ISO
Vitamin K 3 affects the expression of ANKS1 mRNA
CTD
PMID:20044591
NCBI chr20:5,963,658...6,117,139
Ensembl chr20:5,963,678...6,117,148
G
Anks6
ankyrin repeat and sterile alpha motif domain containing 6
affects expression
ISO
Vitamin K 3 affects the expression of ANKS6 mRNA
CTD
PMID:20044591
NCBI chr 5:61,309,183...61,350,596
Ensembl chr 5:61,309,183...61,350,596
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
affects expression
ISO
Vitamin K 3 affects the expression of ANP32B mRNA
CTD
PMID:20044591
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
G
Antkmt
adenine nucleotide translocase lysine methyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of ANTKMT mRNA
CTD
PMID:20044591
NCBI chr10:14,812,274...14,814,798
Ensembl chr10:14,812,269...14,814,193
G
Anxa13
annexin A13
affects expression
ISO
Vitamin K 3 affects the expression of ANXA13 mRNA
CTD
PMID:20044591
NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907
G
Aox1
aldehyde oxidase 1
multiple interactions decreases activity
ISO
Vitamin K 3 inhibits the reaction [AOX1 protein results in increased metabolism of zoniporide] Vitamin K 3 results in decreased activity of AOX1 protein
CTD
PMID:20040581
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Apbb2
amyloid beta precursor protein binding family B member 2
affects expression
ISO
Vitamin K 3 affects the expression of APBB2 mRNA
CTD
PMID:20044591
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases response to substance
ISO
APEX1 gene mutant form results in increased susceptibility to Vitamin K 3
CTD
PMID:11454706
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Aplp2
amyloid beta precursor like protein 2
affects expression
ISO
Vitamin K 3 affects the expression of APLP2 mRNA
CTD
PMID:20044591
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
G
Apoa1
apolipoprotein A1
affects expression
ISO
Vitamin K 3 affects the expression of APOA1 mRNA
CTD
PMID:20829426
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apoa5
apolipoprotein A5
affects expression
ISO
Vitamin K 3 affects the expression of APOA5 mRNA
CTD
PMID:23410634
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apoc3
apolipoprotein C3
affects expression
ISO
Vitamin K 3 affects the expression of APOC3 mRNA
CTD
PMID:20044591
NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
G
Apoe
apolipoprotein E
affects response to substance
ISO
APOE protein affects the susceptibility to Vitamin K 3
CTD
PMID:28728140
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Apoh
apolipoprotein H
affects expression
ISO
Vitamin K 3 affects the expression of APOH mRNA
CTD
PMID:20044591
NCBI chr10:93,342,435...93,356,334
Ensembl chr10:93,310,977...93,356,329
G
Aqp11
aquaporin 11
affects expression
ISO
Vitamin K 3 affects the expression of AQP11 mRNA
CTD
PMID:20044591
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
G
Areg
amphiregulin
increases expression
ISO
Vitamin K 3 results in increased expression of AREG mRNA
CTD
PMID:12414654
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arg2
arginase 2
affects expression
ISO
Vitamin K 3 affects the expression of ARG2 mRNA
CTD
PMID:23410634
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgef7
Rho guanine nucleotide exchange factor 7
affects expression
ISO
Vitamin K 3 affects the expression of ARHGEF7 mRNA
CTD
PMID:20044591
NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697
G
Arid3a
AT-rich interaction domain 3A
affects expression
ISO
Vitamin K 3 affects the expression of ARID3A mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
G
Arid5a
AT-rich interaction domain 5A
affects expression
ISO
Vitamin K 3 affects the expression of ARID5A mRNA
CTD
PMID:20044591
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Armcx1
armadillo repeat containing, X-linked 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of ARMCX1 mRNA
CTD
PMID:25270620
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
G
Arrdc2
arrestin domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of ARRDC2 mRNA
CTD
PMID:20044591
NCBI chr16:18,601,897...18,606,029
Ensembl chr16:18,601,897...18,606,029
G
Asf1a
anti-silencing function 1A histone chaperone
increases expression
ISO
Vitamin K 3 results in increased expression of ASF1A mRNA
CTD
PMID:23410634
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
G
Asic1
acid sensing ion channel subunit 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of ASIC1 mRNA
CTD
PMID:25270620
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
G
Atf3
activating transcription factor 3
affects expression increases expression
ISO
Vitamin K 3 affects the expression of ATF3 mRNA Vitamin K 3 results in increased expression of ATF3 mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf6
activating transcription factor 6
multiple interactions increases expression
ISO
Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]
CTD
PMID:19819344
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg5
autophagy related 5
affects response to substance
EXP ISO
ATG5 mRNA affects the susceptibility to Vitamin K 3 ATG5 protein affects the susceptibility to Vitamin K 3
CTD
PMID:18073215 PMID:18319638 PMID:20578144
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
affects expression
ISO
Vitamin K 3 affects the expression of ATIC mRNA
CTD
PMID:20044591
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
G
Atox1
antioxidant 1 copper chaperone
affects expression
ISO
Vitamin K 3 affects the expression of ATOX1 mRNA
CTD
PMID:20044591
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
G
Atp5if1
ATP synthase inhibitory factor subunit 1
affects expression
ISO
Vitamin K 3 affects the expression of ATP5IF1 mRNA
CTD
PMID:20044591
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
G
Atp5po
ATP synthase peripheral stalk subunit OSCP
affects expression
ISO
Vitamin K 3 affects the expression of ATP5PO mRNA
CTD
PMID:20044591
NCBI chr11:31,165,218...31,171,530
Ensembl chr11:31,165,217...31,171,592
G
Atp7b
ATPase copper transporting beta
affects expression
ISO
Vitamin K 3 affects the expression of ATP7B mRNA
CTD
PMID:20044591
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Atrn
attractin
affects expression
ISO
Vitamin K 3 affects the expression of ATRN mRNA
CTD
PMID:20044591
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
G
Atrx
ATRX, chromatin remodeler
affects expression
ISO
Vitamin K 3 affects the expression of ATRX mRNA
CTD
PMID:20829426
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
G
Atxn2l
ataxin 2-like
affects expression
ISO
Vitamin K 3 affects the expression of ATXN2L mRNA
CTD
PMID:20044591
NCBI chr 1:181,078,293...181,090,079
Ensembl chr 1:181,078,288...181,089,686
G
Auh
AU RNA binding methylglutaconyl-CoA hydratase
affects expression
ISO
Vitamin K 3 affects the expression of AUH mRNA
CTD
PMID:20044591
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
G
Aurkb
aurora kinase B
decreases expression
ISO
Vitamin K 3 results in decreased expression of AURKB mRNA
CTD
PMID:12414654
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Auts2
activator of transcription and developmental regulator AUTS2
affects expression
ISO
Vitamin K 3 affects the expression of AUTS2 mRNA
CTD
PMID:20044591
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
G
B3galt6
Beta-1,3-galactosyltransferase 6
affects expression
ISO
Vitamin K 3 affects the expression of B3GALT6 mRNA
CTD
PMID:20044591
NCBI chr 5:166,584,202...166,586,338
Ensembl chr 5:166,584,202...166,586,338
G
Bahd1
bromo adjacent homology domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of BAHD1 mRNA
CTD
PMID:20044591
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
G
Bak1
BCL2-antagonist/killer 1
affects expression
ISO
Vitamin K 3 affects the expression of BAK1 mRNA
CTD
PMID:20044591
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
affects expression
ISO
Vitamin K 3 affects the expression of BAMBI mRNA
CTD
PMID:23410634
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
ISO
Vitamin K 3 results in increased expression of BATF mRNA
CTD
PMID:25270620
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
G
Bax
BCL2 associated X, apoptosis regulator
affects localization increases expression multiple interactions
EXP ISO
Vitamin K 3 affects the localization of BAX protein Vitamin K 3 results in increased expression of BAX protein EUK-134 inhibits the reaction [Vitamin K 3 results in increased expression of BAX protein]
CTD
PMID:15961378 PMID:25005833
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
affects expression
ISO
Vitamin K 3 affects the expression of BBC3 mRNA
CTD
PMID:20044591
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bbs2
Bardet-Biedl syndrome 2
affects expression
ISO
Vitamin K 3 affects the expression of BBS2 mRNA
CTD
PMID:20044591
NCBI chr19:10,909,653...10,944,998
Ensembl chr19:10,909,619...10,944,993
G
Bcar3
BCAR3 adaptor protein, NSP family member
affects expression
ISO
Vitamin K 3 affects the expression of BCAR3 mRNA
CTD
PMID:20044591
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bcas1
brain enriched myelin associated protein 1
affects expression
ISO
Vitamin K 3 affects the expression of BCAS1 mRNA
CTD
PMID:20044591
NCBI chr 3:159,136,077...159,219,072
Ensembl chr 3:159,136,083...159,219,106
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO EXP
[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]; EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] Vitamin K 3 results in decreased expression of BCL2 mRNA; Vitamin K 3 results in decreased expression of BCL2 protein Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein]
CTD
PMID:19082730 PMID:19265712 PMID:25005833
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl6
BCL6, transcription repressor
affects expression
ISO
Vitamin K 3 affects the expression of BCL6 mRNA
CTD
PMID:20044591
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
G
Bcl9l
BCL9 like
decreases expression
ISO
Vitamin K 3 results in decreased expression of BCL9L protein
CTD
PMID:31238027
NCBI chr 8:44,811,977...44,840,611
Ensembl chr 8:44,811,977...44,840,611
G
Bdh2
3-hydroxybutyrate dehydrogenase 2
affects expression
ISO
Vitamin K 3 affects the expression of BDH2 mRNA
CTD
PMID:20044591
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
G
Becn1
beclin 1
affects expression
ISO
Vitamin K 3 affects the expression of BECN1 mRNA
CTD
PMID:20044591
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bet1l
Bet1 golgi vesicular membrane trafficking protein-like
affects expression
ISO
Vitamin K 3 affects the expression of BET1L mRNA
CTD
PMID:20044591
NCBI chr 1:195,931,407...195,935,072
Ensembl chr 1:195,931,411...195,935,040
G
Bglap
bone gamma-carboxyglutamate protein
decreases expression increases secretion increases expression multiple interactions
ISO
Vitamin K 3 results in decreased expression of BGLAP mRNA Vitamin K 3 results in increased secretion of BGLAP protein Vitamin K 3 results in increased expression of BGLAP protein modified form Vitamin K 3 inhibits the reaction [Estrogens deficiency results in decreased secretion of BGLAP protein]
CTD
PMID:19675304 PMID:30453296
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bik
BCL2-interacting killer
increases expression
ISO
Vitamin K 3 results in increased expression of BIK mRNA
CTD
PMID:23410634
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc5
baculoviral IAP repeat-containing 5
affects expression
ISO
Vitamin K 3 affects the expression of BIRC5 mRNA
CTD
PMID:20044591
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Blvrb
biliverdin reductase B
increases expression
ISO
Vitamin K 3 results in increased expression of BLVRB mRNA
CTD
PMID:25270620
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bms1
BMS1 ribosome biogenesis factor
affects expression
ISO
Vitamin K 3 affects the expression of BMS1 mRNA
CTD
PMID:20044591
NCBI chr 4:151,558,163...151,595,187
Ensembl chr 4:151,558,163...151,595,127
G
Bnip3
BCL2 interacting protein 3
decreases expression
ISO
Vitamin K 3 results in decreased expression of BNIP3 mRNA
CTD
PMID:25270620
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Brd8
bromodomain containing 8
affects expression
ISO
Vitamin K 3 affects the expression of BRD8 mRNA
CTD
PMID:20044591
NCBI chr18:26,204,892...26,229,999
Ensembl chr18:26,181,732...26,229,884
G
Brms1
BRMS1, transcriptional repressor and anoikis regulator
affects expression
ISO
Vitamin K 3 affects the expression of BRMS1 mRNA
CTD
PMID:20044591
NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Vitamin K 3 results in increased expression of BTG2 mRNA
CTD
PMID:12414654 PMID:21382384
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
affects expression
ISO
Vitamin K 3 affects the expression of BUB1 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bud13
BUD13 homolog
affects expression
ISO
Vitamin K 3 affects the expression of BUD13 mRNA
CTD
PMID:20044591
NCBI chr 8:46,575,124...46,590,964
Ensembl chr 8:46,575,115...46,590,958
G
C10h17orf100
similar to human chromosome 17 open reading frame 100
affects expression
ISO
Vitamin K 3 affects the expression of C17ORF100 mRNA
CTD
PMID:23410634
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
G
C11h3orf52
similar to human chromosome 3 open reading frame 52
affects expression
ISO
Vitamin K 3 affects the expression of C3ORF52 mRNA
CTD
PMID:20044591
NCBI chr11:55,166,986...55,192,273
Ensembl chr11:55,166,678...55,192,292
G
C17h6orf62
similar to human chromosome 6 open reading frame 62
affects expression
ISO
Vitamin K 3 affects the expression of C6ORF62 mRNA
CTD
PMID:23410634
NCBI chr17:40,256,211...40,267,851
Ensembl chr17:40,256,211...40,276,020
G
C1galt1c1
C1GALT1-specific chaperone 1
affects expression
ISO
Vitamin K 3 affects the expression of C1GALT1C1 mRNA
CTD
PMID:20044591
NCBI chr X:117,378,123...117,382,620
Ensembl chr X:117,375,525...117,382,787
G
C1qbp
complement C1q binding protein
affects expression
ISO
Vitamin K 3 affects the expression of C1QBP mRNA
CTD
PMID:20044591
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
G
C2cd5
C2 calcium-dependent domain containing 5
affects expression
ISO
Vitamin K 3 affects the expression of C2CD5 mRNA
CTD
PMID:20044591
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
G
C7h8orf76
similar to human chromosome 8 open reading frame 76
affects expression
ISO
Vitamin K 3 affects the expression of C8ORF76 mRNA
CTD
PMID:23410634
NCBI chr 7:89,558,890...89,569,810
Ensembl chr 7:89,558,909...89,569,810
G
C8h15orf39
similar to human chromosome 15 open reading frame 39
affects expression
ISO
Vitamin K 3 affects the expression of C15ORF39 mRNA
CTD
PMID:20044591
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
G
Cables1
Cdk5 and Abl enzyme substrate 1
affects expression
ISO
Vitamin K 3 affects the expression of CABLES1 mRNA
CTD
PMID:20044591
NCBI chr18:3,076,556...3,181,181
Ensembl chr18:3,075,524...3,181,181
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
affects expression
ISO
Vitamin K 3 affects the expression of CACNA1G mRNA
CTD
PMID:20044591
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
G
Calb1
calbindin 1
increases expression
ISO
Vitamin K 3 results in increased expression of CALB1 mRNA
CTD
PMID:30453296
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
affects expression
ISO
Vitamin K 3 affects the expression of CAMK2N1 mRNA
CTD
PMID:20044591
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Canx
calnexin
affects expression
ISO
Vitamin K 3 affects the expression of CANX mRNA
CTD
PMID:20044591
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
G
Capn2
calpain 2
affects expression
ISO
Vitamin K 3 affects the expression of CAPN2 mRNA
CTD
PMID:23410634
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Car12
carbonic anhydrase 12
affects expression
ISO
Vitamin K 3 affects the expression of CA12 mRNA
CTD
PMID:20044591
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Casp2
caspase 2
increases expression
ISO
Vitamin K 3 results in increased expression of CASP2 protein modified form
CTD
PMID:20829426
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage increases expression
ISO EXP
[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP3 protein]; Vitamin K 3 analog inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; Vitamin K 3 analog promotes the reaction [Doxorubicin results in increased activity of CASP3 protein] Vitamin K 3 results in increased activity of CASP3 protein Vitamin K 3 results in increased cleavage of CASP3 protein Buthionine Sulfoximine promotes the reaction [Vitamin K 3 results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP3 protein]; U 0126 promotes the reaction [Vitamin K 3 results in increased activity of CASP3 protein] Vitamin K 3 results in increased expression of CASP3 protein modified form
CTD
PMID:12965111 PMID:16310883 PMID:19082730 PMID:20829426 PMID:23300732 PMID:29141199 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
multiple interactions
ISO
[Metyrapone co-treated with Vitamin K 3] affects the localization of CASP4 protein; [S 3483 co-treated with Vitamin K 3] affects the localization of CASP4 protein
CTD
PMID:19819344
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp6
caspase 6
multiple interactions increases cleavage
EXP
pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased activity of CASP6 protein]; pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP6 protein]
CTD
PMID:16310883
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp9
caspase 9
multiple interactions increases cleavage
ISO EXP
[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein; Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased activity of CASP9 protein]; EUK-134 inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein]; Vitamin K 3 analog promotes the reaction [Doxorubicin results in increased activity of CASP9 protein] pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP9 protein]
CTD
PMID:16310883 PMID:19082730 PMID:25005833 PMID:29141199
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
affects expression decreases activity decreases response to substance multiple interactions
ISO EXP
Vitamin K 3 affects the expression of CAT mRNA Vitamin K 3 results in decreased activity of CAT protein CAT protein results in decreased susceptibility to Vitamin K 3 [CAT protein co-treated with SOD1 protein] results in decreased susceptibility to Vitamin K 3; [CAT protein co-treated with SOD2 protein] results in decreased susceptibility to Vitamin K 3; CAT protein inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; CAT protein inhibits the reaction [[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Hydrogen Peroxide]; CAT results in decreased susceptibility to [Vitamin K 3 co-treated with Ascorbic Acid]
CTD
PMID:12633745 PMID:14698046 PMID:15331536 PMID:20044591 PMID:21689642 PMID:22486562 PMID:28595002 PMID:30536483 More...
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cavin2
caveolae associated protein 2
affects expression
ISO
Vitamin K 3 affects the expression of CAVIN2 mRNA
CTD
PMID:23410634
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
G
Cbfb
core-binding factor subunit beta
affects expression
ISO
Vitamin K 3 affects the expression of CBFB mRNA
CTD
PMID:20044591
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
G
Cbr1
carbonyl reductase 1
multiple interactions increases metabolic processing
ISO
[S-Nitrosoglutathione binds to CBR1 protein] inhibits the reaction [CBR1 protein results in increased metabolism of Vitamin K 3]; Vitamin K 3 inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]
CTD
PMID:11306090 PMID:19061875 PMID:23295225
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cbr3
carbonyl reductase 3
affects metabolic processing increases expression
ISO
CBR3 protein affects the metabolism of Vitamin K 3 Vitamin K 3 results in increased expression of CBR3 mRNA
CTD
PMID:20007405 PMID:21382384 PMID:25270620
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
G
Ccar2
cell cycle and apoptosis regulator 2
affects expression
ISO
Vitamin K 3 affects the expression of CCAR2 mRNA
CTD
PMID:20044591
NCBI chr15:45,212,797...45,228,001
Ensembl chr15:45,212,803...45,227,636
G
Ccdc12
coiled-coil domain containing 12
affects expression
ISO
Vitamin K 3 affects the expression of CCDC12 mRNA
CTD
PMID:20044591
NCBI chr 8:110,635,276...110,686,417
Ensembl chr 8:110,635,710...110,686,417
G
Ccdc125
coiled-coil domain containing 125
affects expression
ISO
Vitamin K 3 affects the expression of CCDC125 mRNA
CTD
PMID:20044591
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
G
Ccdc136
coiled-coil domain containing 136
decreases expression
ISO
Vitamin K 3 results in decreased expression of CCDC136 mRNA
CTD
PMID:25270620
NCBI chr 4:57,997,825...58,027,598
Ensembl chr 4:57,997,853...58,027,646
G
Ccdc88b
coiled-coil domain containing 88B
affects expression
ISO
Vitamin K 3 affects the expression of CCDC88B mRNA
CTD
PMID:20044591
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
G
Ccdc90b
coiled-coil domain containing 90B
affects expression
ISO
Vitamin K 3 affects the expression of CCDC90B mRNA
CTD
PMID:20044591
NCBI chr 1:146,632,756...146,646,314
Ensembl chr 1:146,633,036...146,647,338
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions increases secretion increases expression
EXP
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL3 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL3 protein]
CTD
PMID:19265712
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions increases secretion increases expression
EXP
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of CCL5 mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of CCL5 protein]
CTD
PMID:19265712
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
increases expression
ISO
Vitamin K 3 results in increased expression of CCN1 mRNA
CTD
PMID:12414654
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
affects expression
ISO
Vitamin K 3 affects the expression of CCN2 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
decreases expression affects expression
ISO
Vitamin K 3 results in decreased expression of CCNA2 mRNA Vitamin K 3 affects the expression of CCNA2 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb2
cyclin B2
affects expression
ISO
Vitamin K 3 affects the expression of CCNB2 mRNA
CTD
PMID:20044591
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of CCND1 mRNA Vitamin K 3 results in decreased expression of CCND1 protein
CTD
PMID:20044591 PMID:31238027
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
affects expression
ISO
Vitamin K 3 affects the expression of CCNE1 mRNA
CTD
PMID:20044591
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccng1
cyclin G1
affects expression
ISO
Vitamin K 3 affects the expression of CCNG1 mRNA
CTD
PMID:20044591
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccni
cyclin I
affects expression
ISO
Vitamin K 3 affects the expression of CCNI mRNA
CTD
PMID:20044591
NCBI chr14:14,879,698...14,902,510
Ensembl chr14:14,879,717...14,902,510
G
Ccnjl
cyclin J-like
affects expression
ISO
Vitamin K 3 affects the expression of CCNJL mRNA
CTD
PMID:20044591
NCBI chr10:27,995,682...28,053,428
Ensembl chr10:27,995,679...28,053,426
G
Ccnq
cyclin Q
affects expression
ISO
Vitamin K 3 affects the expression of CCNQ mRNA
CTD
PMID:20044591
NCBI chr10:63,646,532...63,647,695
Ensembl chr10:63,646,527...63,647,961
G
Cct2
chaperonin containing TCP1 subunit 2
affects expression
ISO
Vitamin K 3 affects the expression of CCT2 mRNA
CTD
PMID:20044591
NCBI chr 7:52,692,725...52,705,478
Ensembl chr 7:52,692,725...52,706,944
G
Cct5
chaperonin containing TCP1 subunit 5
affects expression
ISO
Vitamin K 3 affects the expression of CCT5 mRNA
CTD
PMID:20044591
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
G
Cd1d1
CD1d1 molecule
affects expression
ISO
Vitamin K 3 affects the expression of CD1D mRNA
CTD
PMID:20829426
NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089
G
Cd36
CD36 molecule
affects expression
ISO
Vitamin K 3 affects the expression of CD36 mRNA
CTD
PMID:20829426
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd44
CD44 molecule
affects expression
ISO
Vitamin K 3 affects the expression of CD44 mRNA
CTD
PMID:20829426
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd48
Cd48 molecule
affects expression
ISO
Vitamin K 3 affects the expression of CD48 mRNA
CTD
PMID:20829426
NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142
G
Cd74
CD74 molecule
affects expression
ISO
Vitamin K 3 affects the expression of CD74 mRNA
CTD
PMID:20829426
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd9
CD9 molecule
affects expression
ISO
Vitamin K 3 affects the expression of CD9 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdc14b
cell division cycle 14B
affects expression
ISO
Vitamin K 3 affects the expression of CDC14B mRNA
CTD
PMID:20044591
NCBI chr17:844,686...934,787
Ensembl chr17:844,685...933,235
G
Cdc42ep4
CDC42 effector protein 4
affects expression
ISO
Vitamin K 3 affects the expression of CDC42EP4 mRNA
CTD
PMID:23410634
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdc45
cell division cycle 45
affects expression
ISO
Vitamin K 3 affects the expression of CDC45 mRNA
CTD
PMID:20044591
NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
G
Cdca5
cell division cycle associated 5
affects expression
ISO
Vitamin K 3 affects the expression of CDCA5 mRNA
CTD
PMID:20044591
NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
G
Cdca7
cell division cycle associated 7
affects expression
ISO
Vitamin K 3 affects the expression of CDCA7 mRNA
CTD
PMID:20044591
NCBI chr 3:57,322,718...57,333,353
Ensembl chr 3:57,322,708...57,333,353
G
Cdh1
cadherin 1
increases expression
ISO
Vitamin K 3 results in increased expression of CDH1 protein
CTD
PMID:31238027
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh16
cadherin 16
affects expression
ISO
Vitamin K 3 affects the expression of CDH16 mRNA
CTD
PMID:20044591
NCBI chr19:360,824...371,008
Ensembl chr19:360,824...371,007
G
Cdh2
cadherin 2
decreases expression
ISO
Vitamin K 3 results in decreased expression of CDH2 protein
CTD
PMID:31238027
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Vitamin K 3 results in decreased expression of CDK4 mRNA
CTD
PMID:16010434
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein; EUK-134 affects the reaction [Vitamin K 3 results in increased expression of CDKN1A protein]; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein] Vitamin K 3 results in increased expression of CDKN1A mRNA; Vitamin K 3 results in increased expression of CDKN1A protein
CTD
PMID:12414654 PMID:19082730 PMID:23410634 PMID:25005833
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein]
CTD
PMID:19082730
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
affects expression
ISO
Vitamin K 3 affects the expression of CDKN1C mRNA
CTD
PMID:20044591
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
Vitamin K 3 results in increased expression of CDKN2A mRNA
CTD
PMID:16010434
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdt1
chromatin licensing and DNA replication factor 1
affects expression
ISO
Vitamin K 3 affects the expression of CDT1 mRNA
CTD
PMID:20044591
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Cdx1
caudal type homeo box 1
increases expression
ISO
Vitamin K 3 results in increased expression of CDX1 mRNA
CTD
PMID:25270620
NCBI chr18:54,472,587...54,490,913
Ensembl chr18:54,473,444...54,490,814
G
Cebpa
CCAAT/enhancer binding protein alpha
affects expression
ISO
Vitamin K 3 affects the expression of CEBPA mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cenpa
centromere protein A
decreases expression
ISO
Vitamin K 3 results in decreased expression of CENPA mRNA
CTD
PMID:12414654
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpf
centromere protein F
affects expression
ISO
Vitamin K 3 affects the expression of CENPF mRNA
CTD
PMID:20044591
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
G
Cep95
centrosomal protein 95
affects expression
ISO
Vitamin K 3 affects the expression of CEP95 mRNA
CTD
PMID:20044591
NCBI chr10:91,732,111...91,760,095
Ensembl chr10:91,732,111...91,760,092
G
Cfap20
cilia and flagella associated protein 20
affects expression
ISO
Vitamin K 3 affects the expression of CFAP20 mRNA
CTD
PMID:20044591
NCBI chr19:9,608,867...9,622,558
Ensembl chr19:9,608,859...9,622,558
G
Cgnl1
cingulin-like 1
affects expression
ISO
Vitamin K 3 affects the expression of CGNL1 mRNA
CTD
PMID:20044591
NCBI chr 8:72,273,401...72,424,842
Ensembl chr 8:72,275,645...72,422,917
G
Chek1
checkpoint kinase 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of CHEK1 mRNA
CTD
PMID:12414654
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chka
choline kinase alpha
affects expression
ISO
Vitamin K 3 affects the expression of CHKA mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chpf2
chondroitin polymerizing factor 2
increases expression
ISO
Vitamin K 3 results in increased expression of CHPF2 mRNA
CTD
PMID:25270620
NCBI chr 4:10,578,470...10,585,940
Ensembl chr 4:10,580,462...10,585,916
G
Chst15
carbohydrate sulfotransferase 15
affects expression
ISO
Vitamin K 3 affects the expression of CHST15 mRNA
CTD
PMID:23410634
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707
G
Chst7
carbohydrate sulfotransferase 7
affects expression
ISO
Vitamin K 3 affects the expression of CHST7 mRNA
CTD
PMID:20044591
NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
affects expression
ISO
Vitamin K 3 affects the expression of CITED2 mRNA
CTD
PMID:20044591
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Ckap5
cytoskeleton associated protein 5
affects expression
ISO
Vitamin K 3 affects the expression of CKAP5 mRNA
CTD
PMID:20044591
NCBI chr 3:77,491,195...77,593,300
Ensembl chr 3:77,491,276...77,593,264
G
Ckb
creatine kinase B
affects expression
ISO
Vitamin K 3 affects the expression of CKB mRNA
CTD
PMID:20044591
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
affects expression
ISO
Vitamin K 3 affects the expression of CKS1B mRNA
CTD
PMID:20044591
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
G
Cldn23
claudin 23
affects expression
ISO
Vitamin K 3 affects the expression of CLDN23 mRNA
CTD
PMID:20044591
NCBI chr16:56,413,677...56,415,401
Ensembl chr16:56,413,381...56,415,523
G
Cldn3
claudin 3
affects expression
ISO
Vitamin K 3 affects the expression of CLDN3 mRNA
CTD
PMID:20044591
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Clip1
CAP-GLY domain containing linker protein 1
affects expression
ISO
Vitamin K 3 affects the expression of CLIP1 mRNA
CTD
PMID:20044591
NCBI chr12:32,910,932...33,017,891
Ensembl chr12:32,910,977...33,017,884
G
Clpb
ClpB family mitochondrial disaggregase
affects expression
ISO
Vitamin K 3 affects the expression of CLPB mRNA
CTD
PMID:20044591
NCBI chr 1:156,028,740...156,158,183
Ensembl chr 1:156,028,930...156,168,788
G
Cmbl
carboxymethylenebutenolidase homolog
affects expression
ISO
Vitamin K 3 affects the expression of CMBL mRNA
CTD
PMID:20044591
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmip
c-Maf-inducing protein
affects expression
ISO
Vitamin K 3 affects the expression of CMIP mRNA
CTD
PMID:20044591
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
G
Cmtm3
CKLF-like MARVEL transmembrane domain containing 3
affects expression
ISO
Vitamin K 3 affects the expression of CMTM3 mRNA
CTD
PMID:20044591
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
G
Cntnap2
contactin associated protein 2
affects expression
ISO
Vitamin K 3 affects the expression of CNTNAP2 mRNA
CTD
PMID:20044591
NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027
G
Coa4
cytochrome c oxidase assembly factor 4 homolog
affects expression
ISO
Vitamin K 3 affects the expression of COA4 mRNA
CTD
PMID:20044591
NCBI chr 1:154,882,199...154,885,445
Ensembl chr 1:154,882,155...154,888,174
G
Coa5
cytochrome C oxidase assembly factor 5
affects expression
ISO
Vitamin K 3 affects the expression of COA5 mRNA
CTD
PMID:20044591
NCBI chr 9:39,651,459...39,664,870
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
Vitamin K 3 results in decreased expression of COL1A1 mRNA
CTD
PMID:19675304
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col5a2
collagen type V alpha 2 chain
affects expression
ISO
Vitamin K 3 affects the expression of COL5A2 mRNA
CTD
PMID:20044591
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Coro2a
coronin 2A
affects expression
ISO
Vitamin K 3 affects the expression of CORO2A mRNA
CTD
PMID:20044591
NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
[sodium arsenite co-treated with Vitamin K 3] results in increased phosphorylation of CREB1 protein
CTD
PMID:19082730
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crip1
cysteine rich protein 1
affects expression
ISO
Vitamin K 3 affects the expression of CRIP1 mRNA
CTD
PMID:20044591
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
G
Cryl1
crystallin, lambda 1
affects expression
ISO
Vitamin K 3 affects the expression of CRYL1 mRNA
CTD
PMID:20044591
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
G
Ctbp2
C-terminal binding protein 2
affects expression
ISO
Vitamin K 3 affects the expression of CTBP2 mRNA
CTD
PMID:20044591
NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222
G
Ctf1
cardiotrophin 1
multiple interactions increases expression
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; 2-methoxyestradiol inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; acetovanillone inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; diphenyleneiodonium inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased expression of CTF1 protein] Vitamin K 3 results in increased expression of CTF1 mRNA; Vitamin K 3 results in increased expression of CTF1 protein
CTD
PMID:16507596
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
G
Ctnnb1
catenin beta 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of CTNNB1 protein
CTD
PMID:31238027
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctnnd1
catenin delta 1
affects expression
ISO
Vitamin K 3 affects the expression of CTNND1 mRNA
CTD
PMID:20044591
NCBI chr 3:69,683,328...69,734,550
Ensembl chr 3:69,683,313...69,734,516
G
Ctps1
CTP synthase 1
affects expression
ISO
Vitamin K 3 affects the expression of CTPS1 mRNA
CTD
PMID:20044591
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctr9
CTR9 homolog, Paf1/RNA polymerase II complex component
affects expression
ISO
Vitamin K 3 affects the expression of CTR9 mRNA
CTD
PMID:20044591
NCBI chr 1:165,137,277...165,167,303
Ensembl chr 1:165,137,215...165,167,303
G
Cul4a
cullin 4A
affects expression
ISO
Vitamin K 3 affects the expression of CUL4A mRNA
CTD
PMID:20044591
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
G
Cxxc5
CXXC finger protein 5
affects expression
ISO
Vitamin K 3 affects the expression of CXXC5 mRNA
CTD
PMID:20044591
NCBI chr18:27,427,591...27,458,579
Ensembl chr18:27,427,230...27,458,673
G
Cyb5d2
cytochrome b5 domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of CYB5D2 mRNA
CTD
PMID:23410634
NCBI chr10:57,394,268...57,413,336
Ensembl chr10:57,396,765...57,413,715
G
Cyb5r1
cytochrome b5 reductase 1
affects expression
ISO
Vitamin K 3 affects the expression of CYB5R1 mRNA
CTD
PMID:20044591
NCBI chr13:45,849,017...45,855,458
Ensembl chr13:45,849,091...45,855,458
G
Cyba
cytochrome b-245 alpha chain
increases expression
ISO
Vitamin K 3 results in increased expression of CYBA protein
CTD
PMID:16507596
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases activity increases expression
ISO EXP
Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] Vitamin K 3 results in increased activity of CYP1A1 protein Vitamin K 3 results in increased expression of CYP1A1 mRNA
CTD
PMID:15603920 PMID:18493746
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases expression increases activity
ISO EXP
Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] Vitamin K 3 results in increased expression of CYP1A2 mRNA Vitamin K 3 results in increased activity of CYP1A2 protein
CTD
PMID:15603920 PMID:18493746
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
Vitamin K 3 results in increased expression of CYP1B1 mRNA
CTD
PMID:12414654
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
affects expression
ISO
Vitamin K 3 affects the expression of CYP24A1 mRNA
CTD
PMID:23410634
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression multiple interactions
ISO
Vitamin K 3 results in decreased expression of CYP2E1 mRNA [CYP2E1 protein co-treated with Vitamin K 3 co-treated with Arachidonic Acid] results in increased expression of KLF6 protein; [CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein; Buthionine Sulfoximine promotes the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; CAT protein inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Dicumarol inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; S-ethyl glutathione inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA alternative form]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]
CTD
PMID:22486562 PMID:25270620
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
affects expression
ISO
Vitamin K 3 affects the expression of CYP2J9 mRNA
CTD
PMID:20829426
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
affects expression
ISO
Vitamin K 3 affects the expression of CYP2R1 mRNA
CTD
PMID:20044591
NCBI chr 1:168,749,302...168,798,079
Ensembl chr 1:168,751,038...168,797,759
G
Dbi
diazepam binding inhibitor
affects expression
ISO
Vitamin K 3 affects the expression of DBI mRNA
CTD
PMID:20044591
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
G
Dcp1b
decapping mRNA 1B
affects expression
ISO
Vitamin K 3 affects the expression of DCP1B mRNA
CTD
PMID:20044591
NCBI chr 4:152,358,267...152,395,747
Ensembl chr 4:152,358,241...152,397,145
G
Dcxr
dicarbonyl and L-xylulose reductase
multiple interactions increases metabolic processing decreases activity
ISO
[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Hydrogen Peroxide; [DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Superoxides; [Vitamin K 3 co-treated with NADP] binds to DCXR protein; CAT protein inhibits the reaction [[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Hydrogen Peroxide]; Diacetyl inhibits the reaction [[DCXR protein results in increased metabolism of Vitamin K 3] which results in increased chemical synthesis of Superoxides]; Vitamin K 3 inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of Diacetyl] which results in increased chemical synthesis of Acetoin] Vitamin K 3 results in decreased activity of DCXR protein
CTD
PMID:25526675 PMID:28595002
NCBI chr10:106,006,404...106,008,293
G
Ddc
dopa decarboxylase
affects expression
ISO
Vitamin K 3 affects the expression of DDC mRNA
CTD
PMID:20044591
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO
Vitamin K 3 results in increased expression of DDIT3 mRNA; Vitamin K 3 results in increased expression of DDIT3 protein Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of DDIT3 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of DDIT3 protein]
CTD
PMID:12414654 PMID:19819344
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
affects expression
ISO
Vitamin K 3 affects the expression of DDIT4 mRNA
CTD
PMID:23410634
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddit4l
DNA-damage-inducible transcript 4-like
increases expression
ISO
Vitamin K 3 results in increased expression of DDIT4L mRNA
CTD
PMID:25270620
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
G
Ddx1
DEAD-box helicase 1
affects expression
ISO
Vitamin K 3 affects the expression of DDX1 mRNA
CTD
PMID:20044591
NCBI chr 6:35,996,469...36,027,340
Ensembl chr 6:35,996,469...36,027,365
G
Ddx23
DEAD-box helicase 23
affects expression
ISO
Vitamin K 3 affects the expression of DDX23 mRNA
CTD
PMID:20044591
NCBI chr 7:129,797,620...129,814,909
Ensembl chr 7:129,797,614...129,814,949
G
Ddx42
DEAD-box helicase 42
increases expression
ISO
Vitamin K 3 results in increased expression of DDX42 mRNA
CTD
PMID:12414654
NCBI chr10:91,148,926...91,180,940
Ensembl chr10:91,148,254...91,180,939
G
Ddx47
DEAD-box helicase 47
affects expression
ISO
Vitamin K 3 affects the expression of DDX47 mRNA
CTD
PMID:20044591
NCBI chr 4:167,845,652...167,858,115
Ensembl chr 4:167,845,640...167,859,115
G
Defb1
defensin beta 1
affects expression
ISO
Vitamin K 3 affects the expression of DEFB1 mRNA
CTD
PMID:20044591
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
G
Depdc7
DEP domain containing 7
affects expression
ISO
Vitamin K 3 affects the expression of DEPDC7 mRNA
CTD
PMID:20044591
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
G
Deptor
DEP domain containing MTOR-interacting protein
affects expression
ISO
Vitamin K 3 affects the expression of DEPTOR mRNA
CTD
PMID:20044591
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Desi2
desumoylating isopeptidase 2
affects expression
ISO
Vitamin K 3 affects the expression of DESI2 mRNA
CTD
PMID:20044591
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
G
Dgat1
diacylglycerol O-acyltransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of DGAT1 mRNA
CTD
PMID:20044591
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dgat2
diacylglycerol O-acyltransferase 2
affects expression
ISO
Vitamin K 3 affects the expression of DGAT2 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dgkd
diacylglycerol kinase, delta
affects expression
ISO
Vitamin K 3 affects the expression of DGKD mRNA
CTD
PMID:20044591
NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
G
Dhrs11
dehydrogenase/reductase 11
increases reduction
ISO
DHRS11 protein results in increased reduction of Vitamin K 3
CTD
PMID:30926317
NCBI chr10:69,698,214...69,708,294
Ensembl chr10:69,698,214...69,708,295
G
Dhx35
DEAH-box helicase 35
affects expression
ISO
Vitamin K 3 affects the expression of DHX35 mRNA
CTD
PMID:20044591
NCBI chr 3:147,450,178...147,507,473
Ensembl chr 3:147,450,163...147,507,451
G
Dhx9
DExH-box helicase 9
affects expression
ISO
Vitamin K 3 affects the expression of DHX9 mRNA
CTD
PMID:20044591
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dipk1b
divergent protein kinase domain 1B
affects expression
ISO
Vitamin K 3 affects the expression of DIPK1B mRNA
CTD
PMID:20044591
NCBI chr 3:9,455,914...9,464,169
Ensembl chr 3:9,456,409...9,464,161
G
Dkc1
dyskerin pseudouridine synthase 1
affects expression
ISO
Vitamin K 3 affects the expression of DKC1 mRNA
CTD
PMID:20044591
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
affects expression increases expression
ISO
Vitamin K 3 affects the expression of DKK1 mRNA Vitamin K 3 results in increased expression of DKK1 mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Dlgap5
DLG associated protein 5
affects expression
ISO
Vitamin K 3 affects the expression of DLGAP5 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dmd
dystrophin
increases response to substance
ISO
DMD gene mutant form results in increased susceptibility to Vitamin K 3
CTD
PMID:10797403
NCBI chr X:47,272,324...49,504,219
Ensembl chr X:47,272,331...49,504,207
G
Dmrt1
doublesex and mab-3 related transcription factor 1
increases expression
ISO
Vitamin K 3 results in increased expression of DMRT1 mRNA
CTD
PMID:25270620
NCBI chr 1:223,142,859...223,241,333
Ensembl chr 1:223,142,859...223,241,333
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
affects expression
ISO
Vitamin K 3 affects the expression of DNAJB1 mRNA
CTD
PMID:20044591
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajc14
DnaJ heat shock protein family (Hsp40) member C14
affects expression
ISO
Vitamin K 3 affects the expression of DNAJC14 mRNA
CTD
PMID:20044591
NCBI chr 7:1,233,856...1,247,349
Ensembl chr 7:1,235,162...1,248,645
G
Dnm1l
dynamin 1-like
affects expression
ISO
Vitamin K 3 affects the expression of DNM1L mRNA
CTD
PMID:20829426
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
G
Dnmt3b
DNA methyltransferase 3 beta
affects expression
ISO
Vitamin K 3 affects the expression of DNMT3B mRNA
CTD
PMID:20044591
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dnmt3l
DNA methyltransferase 3 like
decreases expression
ISO
Vitamin K 3 results in decreased expression of DNMT3L mRNA
CTD
PMID:25270620
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
G
Dph1
diphthamide biosynthesis 1
affects expression
ISO
Vitamin K 3 affects the expression of DPH1 mRNA
CTD
PMID:20044591
NCBI chr10:60,028,081...60,039,764
Ensembl chr10:60,026,048...60,039,850
G
Dph3
diphthamide biosynthesis 3
affects expression
ISO
Vitamin K 3 affects the expression of DPH3 mRNA
CTD
PMID:20044591
NCBI chr16:7,288,295...7,293,734
Ensembl chr16:7,282,705...7,291,265
G
Dpm3
dolichyl-phosphate mannosyltransferase subunit 3, regulatory
affects expression
ISO
Vitamin K 3 affects the expression of DPM3 mRNA
CTD
PMID:20044591
NCBI chr 2:174,676,532...174,677,047
Ensembl chr 2:174,676,363...174,677,668 Ensembl chr15:174,676,363...174,677,668
G
Dpyd
dihydropyrimidine dehydrogenase
affects expression
ISO
Vitamin K 3 affects the expression of DPYD mRNA
CTD
PMID:20829426
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dusp1
dual specificity phosphatase 1
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of DUSP1 mRNA Vitamin K 3 results in decreased expression of DUSP1 mRNA
CTD
PMID:23410634 PMID:25270620
NCBI chr10:16,680,478...16,683,275
G
Dusp2
dual specificity phosphatase 2
affects expression
ISO
Vitamin K 3 affects the expression of DUSP2 mRNA
CTD
PMID:20044591
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Dusp3
dual specificity phosphatase 3
affects expression
ISO
Vitamin K 3 affects the expression of DUSP3 mRNA
CTD
PMID:20044591
NCBI chr10:86,920,014...86,933,739
Ensembl chr10:86,920,014...86,933,962
G
Dusp6
dual specificity phosphatase 6
affects expression
ISO
Vitamin K 3 affects the expression of DUSP6 mRNA
CTD
PMID:20044591
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp9
dual specificity phosphatase 9
affects expression
ISO
Vitamin K 3 affects the expression of DUSP9 mRNA
CTD
PMID:23410634
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
Dync1h1
dynein cytoplasmic 1 heavy chain 1
affects expression
ISO
Vitamin K 3 affects the expression of DYNC1H1 mRNA
CTD
PMID:20044591
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
G
Dync1li2
dynein, cytoplasmic 1 light intermediate chain 2
affects expression
ISO
Vitamin K 3 affects the expression of DYNC1LI2 mRNA
CTD
PMID:20044591
NCBI chr19:531,783...554,670
Ensembl chr19:531,812...554,670
G
Dyrk2
dual specificity tyrosine phosphorylation regulated kinase 2
affects expression
ISO
Vitamin K 3 affects the expression of DYRK2 mRNA
CTD
PMID:20044591
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
G
E2f1
E2F transcription factor 1
affects expression
ISO
Vitamin K 3 affects the expression of E2F1 mRNA
CTD
PMID:20044591
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
E2f3
E2F transcription factor 3
affects expression
ISO
Vitamin K 3 affects the expression of E2F3 mRNA
CTD
PMID:20044591
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
G
Ebna1bp2
EBNA1 binding protein 2
affects expression
ISO
Vitamin K 3 affects the expression of EBNA1BP2 mRNA
CTD
PMID:20044591
NCBI chr 5:132,148,164...132,152,730
Ensembl chr 5:132,148,143...132,153,267
G
Ecpas
Ecm29 proteasome adaptor and scaffold
affects expression
ISO
Vitamin K 3 affects the expression of ECPAS mRNA
CTD
PMID:20044591
NCBI chr 5:73,601,745...73,714,026
Ensembl chr 5:73,604,533...73,713,860
G
Edc3
enhancer of mRNA decapping 3
affects expression
ISO
Vitamin K 3 affects the expression of EDC3 mRNA
CTD
PMID:20044591
NCBI chr 8:58,106,147...58,151,685
Ensembl chr 8:58,106,175...58,151,671
G
Edn1
endothelin 1
increases expression affects expression
ISO
Vitamin K 3 results in increased expression of EDN1 mRNA Vitamin K 3 affects the expression of EDN1 mRNA
CTD
PMID:12414654 PMID:20044591 PMID:23410634
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Efnb2
ephrin B2
decreases expression
ISO
Vitamin K 3 results in decreased expression of EFNB2 mRNA
CTD
PMID:25270620
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
G
Egfr
epidermal growth factor receptor
increases phosphorylation
EXP
Vitamin K 3 results in increased phosphorylation of EGFR protein
CTD
PMID:15843167
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egln3
egl-9 family hypoxia-inducible factor 3
decreases expression
ISO
Vitamin K 3 results in decreased expression of EGLN3 mRNA
CTD
PMID:25270620
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
G
Egr1
early growth response 1
increases expression affects expression
ISO
Vitamin K 3 results in increased expression of EGR1 mRNA Vitamin K 3 affects the expression of EGR1 mRNA
CTD
PMID:12414654 PMID:20044591 PMID:23410634
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Ehmt1
euchromatic histone lysine methyltransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of EHMT1 mRNA
CTD
PMID:20044591
NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007
G
Eif3c
eukaryotic translation initiation factor 3, subunit C
affects expression
ISO
Vitamin K 3 affects the expression of EIF3C mRNA
CTD
PMID:20044591
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
G
Eif3j
eukaryotic translation initiation factor 3, subunit J
affects expression
ISO
Vitamin K 3 affects the expression of EIF3J mRNA
CTD
PMID:20044591
NCBI chr 3:108,985,103...109,007,341
Ensembl chr 3:108,985,118...109,007,953
G
Eif4a1
eukaryotic translation initiation factor 4A1
affects expression
ISO
Vitamin K 3 affects the expression of EIF4A1 mRNA
CTD
PMID:20044591
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Eif4b
eukaryotic translation initiation factor 4B
affects expression
ISO
Vitamin K 3 affects the expression of EIF4B mRNA
CTD
PMID:20044591
NCBI chr 7:133,206,637...133,228,436
G
Eif4enif1
eukaryotic translation initiation factor 4E nuclear import factor 1
affects expression
ISO
Vitamin K 3 affects the expression of EIF4ENIF1 mRNA
CTD
PMID:20044591
NCBI chr14:78,056,115...78,099,846
Ensembl chr14:78,056,297...78,098,793
G
Eif4g2
eukaryotic translation initiation factor 4, gamma 2
affects expression
ISO
Vitamin K 3 affects the expression of EIF4G2 mRNA
CTD
PMID:20044591
NCBI chr 1:165,181,433...165,193,583
Ensembl chr 1:165,181,434...165,193,588
G
Elavl1
ELAV like RNA binding protein 1
multiple interactions increases phosphorylation
ISO
[[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]; [[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]; [Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein; JAK3 protein promotes the reaction [Vitamin K 3 results in increased phosphorylation of ELAVL1 protein]; Janus Kinase Inhibitors inhibits the reaction [Vitamin K 3 results in increased phosphorylation of ELAVL1 protein]; Vitamin K 3 inhibits the reaction [sodium arsenite promotes the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]]; Vitamin K 3 inhibits the reaction [sodium arsenite promotes the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]]
CTD
PMID:24106086
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
G
Elavl2
ELAV like RNA binding protein 2
affects expression
ISO
Vitamin K 3 affects the expression of ELAVL2 mRNA
CTD
PMID:20829426
NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097
G
Elof1
elongation factor 1
affects expression
ISO
Vitamin K 3 affects the expression of ELOF1 mRNA
CTD
PMID:20044591
NCBI chr 8:20,645,336...20,650,888
Ensembl chr 8:20,645,336...20,650,579
G
Emg1
EMG1 N1-specific pseudouridine methyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of EMG1 mRNA
CTD
PMID:20044591
NCBI chr 4:157,509,258...157,517,540
Ensembl chr 4:157,509,277...157,517,540
G
Emilin1
elastin microfibril interfacer 1
affects expression
ISO
Vitamin K 3 affects the expression of EMILIN1 mRNA
CTD
PMID:23410634
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
G
Emp2
epithelial membrane protein 2
affects expression
ISO
Vitamin K 3 affects the expression of EMP2 mRNA
CTD
PMID:20044591
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
G
Enc1
ectodermal-neural cortex 1
affects expression
ISO
Vitamin K 3 affects the expression of ENC1 mRNA
CTD
PMID:20044591
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Enosf1
enolase superfamily member 1
affects expression
ISO
Vitamin K 3 affects the expression of ENOSF1 mRNA
CTD
PMID:20044591
NCBI chr 9:113,275,267...113,314,842
G
Enpp3
ectonucleotide pyrophosphatase/phosphodiesterase 3
decreases expression
ISO
Vitamin K 3 results in decreased expression of ENPP3 mRNA
CTD
PMID:25270620
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
G
Ep300
E1A binding protein p300
decreases expression
ISO
Vitamin K 3 results in decreased expression of EP300 protein
CTD
PMID:31238027
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epas1
endothelial PAS domain protein 1
affects expression
ISO
Vitamin K 3 affects the expression of EPAS1 mRNA
CTD
PMID:20044591
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
Vitamin K 3 results in increased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epn2
epsin 2
affects expression
ISO
Vitamin K 3 affects the expression of EPN2 mRNA
CTD
PMID:20044591
NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642
G
Epn3
epsin 3
affects expression
ISO
Vitamin K 3 affects the expression of EPN3 mRNA
CTD
PMID:20044591
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
G
Epo
erythropoietin
multiple interactions
ISO
[Vitamin K 3 results in increased abundance of Hydrogen Peroxide] which results in decreased expression of EPO protein
CTD
PMID:7980410
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Eprs1
glutamyl-prolyl-tRNA synthetase 1
affects expression
ISO
Vitamin K 3 affects the expression of EPRS1 mRNA
CTD
PMID:20044591
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
G
Eps8l2
EPS8-like 2
affects expression
ISO
Vitamin K 3 affects the expression of EPS8L2 mRNA
CTD
PMID:20044591
NCBI chr 1:196,446,260...196,471,544
Ensembl chr 1:196,446,287...196,471,541
G
Erbb3
erb-b2 receptor tyrosine kinase 3
affects expression
ISO
Vitamin K 3 affects the expression of ERBB3 mRNA
CTD
PMID:20044591
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
G
Erbin
erbb2 interacting protein
affects expression
ISO
Vitamin K 3 affects the expression of ERBIN mRNA
CTD
PMID:20044591
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
G
Esr1
estrogen receptor 1
affects binding multiple interactions
ISO
Vitamin K 3 binds to ESR1 protein Vitamin K 3 inhibits the reaction [Estradiol binds to ESR1 protein]
CTD
PMID:15081572
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esrp1
epithelial splicing regulatory protein 1
affects expression
ISO
Vitamin K 3 affects the expression of ESRP1 mRNA
CTD
PMID:20044591
NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
G
Esrp2
epithelial splicing regulatory protein 2
affects expression
ISO
Vitamin K 3 affects the expression of ESRP2 mRNA
CTD
PMID:20044591
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
G
Esyt2
extended synaptotagmin 2
affects expression
ISO
Vitamin K 3 affects the expression of ESYT2 mRNA
CTD
PMID:20044591
NCBI chr 6:137,219,653...137,312,590
Ensembl chr 6:137,219,707...137,312,590
G
Ets2
ETS proto-oncogene 2, transcription factor
affects expression
ISO
Vitamin K 3 affects the expression of ETS2 mRNA
CTD
PMID:20044591
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Exosc10
exosome component 10
affects expression
ISO
Vitamin K 3 affects the expression of EXOSC10 mRNA
CTD
PMID:20044591
NCBI chr 5:158,995,313...159,018,940
Ensembl chr 5:158,995,313...159,018,940
G
Exosc8
exosome component 8
affects expression
ISO
Vitamin K 3 affects the expression of EXOSC8 mRNA
CTD
PMID:20044591
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
affects expression
ISO
Vitamin K 3 affects the expression of EZH2 mRNA
CTD
PMID:20044591
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Ezr
ezrin
affects expression
ISO
Vitamin K 3 affects the expression of EZR mRNA
CTD
PMID:20044591
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F10
coagulation factor X
multiple interactions
EXP
Vitamin K 3 inhibits the reaction [Ethyl Biscoumacetate results in decreased expression of F10 protein]
CTD
PMID:6768192
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F2rl1
F2R like trypsin receptor 1
affects expression
ISO
Vitamin K 3 affects the expression of F2RL1 mRNA
CTD
PMID:23410634
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
F8a1
coagulation factor VIII-associated 1
affects expression
ISO
Vitamin K 3 affects the expression of F8A1 mRNA
CTD
PMID:20044591
NCBI chr X:150,957,357...150,958,871
Ensembl chr X:150,916,679...150,960,168
G
Fabp1
fatty acid binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of FABP1 mRNA
CTD
PMID:20044591
NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788
G
Faf1
Fas associated factor 1
affects expression
ISO
Vitamin K 3 affects the expression of FAF1 mRNA
CTD
PMID:20044591
NCBI chr 5:124,426,032...124,790,014
Ensembl chr 5:124,426,062...124,789,977
G
Fam107b
family with sequence similarity 107, member B
affects expression
ISO
Vitamin K 3 affects the expression of FAM107B mRNA
CTD
PMID:20044591
NCBI chr17:74,478,608...74,685,027
Ensembl chr17:74,478,608...74,684,989
G
Fam111a
FAM111 trypsin like peptidase A
affects expression
ISO
Vitamin K 3 affects the expression of FAM111A mRNA
CTD
PMID:20044591
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fam174b
family with sequence similarity 174, member B
affects expression
ISO
Vitamin K 3 affects the expression of FAM174B mRNA
CTD
PMID:20044591
NCBI chr 1:127,515,393...127,618,591
Ensembl chr 1:127,514,041...127,596,128 Ensembl chr 1:127,514,041...127,596,128
G
Fam20c
FAM20C, golgi associated secretory pathway kinase
affects expression
ISO
Vitamin K 3 affects the expression of FAM20C mRNA
CTD
PMID:20044591
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
G
Fam217b
family with sequence similarity 217, member B
affects expression
ISO
Vitamin K 3 affects the expression of FAM217B mRNA
CTD
PMID:20044591
NCBI chr 3:165,505,574...165,515,273
Ensembl chr 3:165,501,532...165,513,377
G
Fam222b
family with sequence similarity 222, member B
affects expression
ISO
Vitamin K 3 affects the expression of FAM222B mRNA
CTD
PMID:20044591
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
G
Fam241b
family with sequence similarity 241 member B
affects expression
ISO
Vitamin K 3 affects the expression of FAM241B mRNA
CTD
PMID:20044591
NCBI chr20:30,052,315...30,055,247
Ensembl chr20:30,052,324...30,055,084
G
Fam89b
family with sequence similarity 89, member B
affects expression
ISO
Vitamin K 3 affects the expression of FAM89B mRNA
CTD
PMID:20044591
NCBI chr 1:203,015,772...203,017,890
Ensembl chr 1:203,015,773...203,017,367
G
Fanca
FA complementation group A
affects expression
ISO
Vitamin K 3 affects the expression of FANCA mRNA
CTD
PMID:20044591
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
G
Fancf
FA complementation group F
affects expression
ISO
Vitamin K 3 affects the expression of FANCF mRNA
CTD
PMID:20044591
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
G
Farp1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
affects expression
ISO
Vitamin K 3 affects the expression of FARP1 mRNA
CTD
PMID:20044591
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
G
Farsb
phenylalanyl-tRNA synthetase subunit beta
affects expression
ISO
Vitamin K 3 affects the expression of FARSB mRNA
CTD
PMID:20044591
NCBI chr 9:79,887,852...79,947,082
Ensembl chr 9:79,887,842...79,947,045
G
Fas
Fas cell surface death receptor
increases expression
ISO
Vitamin K 3 results in increased expression of FAS mRNA
CTD
PMID:12414654
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faxdc2
fatty acid hydroxylase domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of FAXDC2 mRNA
CTD
PMID:20044591
NCBI chr10:42,245,808...42,271,679
Ensembl chr10:42,246,868...42,271,871
G
Fbln1
fibulin 1
affects expression
ISO
Vitamin K 3 affects the expression of FBLN1 mRNA
CTD
PMID:20044591
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbxl15
F-box and leucine-rich repeat protein 15
affects expression
ISO
Vitamin K 3 affects the expression of FBXL15 mRNA
CTD
PMID:20044591
NCBI chr 1:245,189,732...245,191,973
Ensembl chr 1:245,189,736...245,192,007
G
Fbxl16
F-box and leucine-rich repeat protein 16
affects expression
ISO
Vitamin K 3 affects the expression of FBXL16 mRNA
CTD
PMID:20044591
NCBI chr10:14,829,453...14,841,739
Ensembl chr10:14,829,449...14,840,986
G
Fbxo11
F-box protein 11
affects expression
ISO
Vitamin K 3 affects the expression of FBXO11 mRNA
CTD
PMID:20044591
NCBI chr 6:6,486,761...6,562,664
Ensembl chr 6:6,486,015...6,562,662
G
Fbxo21
F-box protein 21
affects expression
ISO
Vitamin K 3 affects the expression of FBXO21 mRNA
CTD
PMID:20044591
NCBI chr12:38,570,878...38,605,133
Ensembl chr12:38,571,023...38,605,133
G
Fbxo30
F-box protein 30
increases expression
ISO
Vitamin K 3 results in increased expression of FBXO30 mRNA
CTD
PMID:23410634
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
G
Fcgr2b
Fc gamma receptor 2B
affects expression
ISO
Vitamin K 3 affects the expression of FCGR2B mRNA
CTD
PMID:20829426
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fcsk
fucose kinase
affects expression
ISO
Vitamin K 3 affects the expression of FCSK mRNA
CTD
PMID:20044591
NCBI chr19:38,849,130...38,874,497
Ensembl chr19:38,854,762...38,874,418
G
Fdxr
ferredoxin reductase
affects expression increases expression
ISO
Vitamin K 3 affects the expression of FDXR mRNA Vitamin K 3 results in increased expression of FDXR mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of FEN1 mRNA
CTD
PMID:12414654
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fermt1
FERM domain containing kindlin 1
affects expression
ISO
Vitamin K 3 affects the expression of FERMT1 mRNA
CTD
PMID:20044591
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
G
Fgfr2
fibroblast growth factor receptor 2
affects expression
ISO
Vitamin K 3 affects the expression of FGFR2 mRNA
CTD
PMID:20044591
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fgg
fibrinogen gamma chain
increases expression affects expression
ISO
Vitamin K 3 results in increased expression of FGG mRNA Vitamin K 3 affects the expression of FGG mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fhit
fragile histidine triad diadenosine triphosphatase
increases response to substance
ISO
FHIT protein results in increased susceptibility to Vitamin K 3
CTD
PMID:19622739
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
G
Fhl2
four and a half LIM domains 2
affects expression
ISO
Vitamin K 3 affects the expression of FHL2 mRNA
CTD
PMID:20044591
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Fibp
FGF1 intracellular binding protein
affects expression
ISO
Vitamin K 3 affects the expression of FIBP mRNA
CTD
PMID:20044591
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
G
Fip1l1
factor interacting with PAPOLA and CPSF1
affects expression
ISO
Vitamin K 3 affects the expression of FIP1L1 mRNA
CTD
PMID:20044591
NCBI chr14:33,615,210...33,675,742
Ensembl chr14:33,617,720...33,675,708
G
Fkbp9
FKBP prolyl isomerase 9
affects expression
ISO
Vitamin K 3 affects the expression of FKBP9 mRNA
CTD
PMID:20044591
NCBI chr 4:86,106,256...86,156,723
Ensembl chr 4:86,106,282...86,156,721
G
Flcn
folliculin
affects expression
ISO
Vitamin K 3 affects the expression of FLCN mRNA
CTD
PMID:20044591
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
G
Flnb
filamin B
decreases expression
ISO
Vitamin K 3 results in decreased expression of FLNB mRNA
CTD
PMID:25270620
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
G
Flrt3
fibronectin leucine rich transmembrane protein 3
affects expression
ISO
Vitamin K 3 affects the expression of FLRT3 mRNA
CTD
PMID:20044591
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
G
Flvcr1
FLVCR choline and heme transporter 1
affects expression
ISO
Vitamin K 3 affects the expression of FLVCR1 mRNA
CTD
PMID:20044591
NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661
G
Fmr1
fragile X messenger ribonucleoprotein 1
affects expression
ISO
Vitamin K 3 affects the expression of FMR1 mRNA
CTD
PMID:20829426
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
G
Fn3krp
fructosamine-3-kinase-related protein
affects expression
ISO
Vitamin K 3 affects the expression of FN3KRP mRNA
CTD
PMID:20044591
NCBI chr10:106,688,413...106,697,137
Ensembl chr10:106,688,439...106,697,134
G
Fndc3a
fibronectin type III domain containing 3a
affects expression
ISO
Vitamin K 3 affects the expression of FNDC3A mRNA
CTD
PMID:20044591
NCBI chr15:47,689,909...47,867,354
Ensembl chr15:47,689,919...47,866,784
G
Focad
focadhesin
affects expression
ISO
Vitamin K 3 affects the expression of FOCAD mRNA
CTD
PMID:20044591
NCBI chr 5:102,564,560...102,886,587
Ensembl chr 5:102,564,598...102,886,582
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Vitamin K 3 analog results in increased expression of FOS mRNA; Vitamin K 3 results in increased expression of FOS mRNA
CTD
PMID:19273458
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxa1
forkhead box A1
affects expression
ISO
Vitamin K 3 affects the expression of FOXA1 mRNA
CTD
PMID:20044591
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
G
Foxa3
forkhead box A3
affects expression
ISO
Vitamin K 3 affects the expression of FOXA3 mRNA
CTD
PMID:20044591
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
G
Foxc1
forkhead box C1
affects expression
ISO
Vitamin K 3 affects the expression of FOXC1 mRNA
CTD
PMID:20044591
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
G
Foxd2
forkhead box D2
affects expression
ISO
Vitamin K 3 affects the expression of FOXD2 mRNA
CTD
PMID:20044591
NCBI chr 5:128,427,986...128,430,709
Ensembl chr 5:128,429,020...128,430,504
G
Foxj3
forkhead box J3
affects expression
ISO
Vitamin K 3 affects the expression of FOXJ3 mRNA
CTD
PMID:20044591
NCBI chr 5:133,140,344...133,228,489
Ensembl chr 5:133,140,884...133,228,489
G
Foxm1
forkhead box M1
decreases expression
ISO
Vitamin K 3 results in decreased expression of FOXM1 mRNA
CTD
PMID:12414654
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Foxp1
forkhead box P1
affects expression
ISO
Vitamin K 3 affects the expression of FOXP1 mRNA
CTD
PMID:20044591
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Frmd4a
FERM domain containing 4A
affects expression
ISO
Vitamin K 3 affects the expression of FRMD4A mRNA
CTD
PMID:20044591
NCBI chr17:73,667,787...74,258,487
Ensembl chr17:73,667,789...74,258,687
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
Vitamin K 3 results in decreased expression of and results in decreased secretion of FSHB protein
CTD
PMID:30536483
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Ftl1
ferritin light chain 1
affects expression increases expression multiple interactions
ISO
Vitamin K 3 affects the expression of FTL mRNA Vitamin K 3 results in increased expression of FTL mRNA Vitamin K 3 promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]
CTD
PMID:12414654 PMID:12644586 PMID:20044591
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Ftmt
ferritin mitochondrial
multiple interactions
ISO
Vitamin K 3 promotes the reaction [Iron binds to [FTL protein binds to FTMT protein]]
CTD
PMID:12644586
NCBI chr18:45,758,874...45,760,123
Ensembl chr18:45,758,874...45,760,123
G
Fuom
fucose mutarotase
affects expression
ISO
Vitamin K 3 affects the expression of FUOM mRNA
CTD
PMID:20044591
NCBI chr 1:194,888,535...194,893,046
Ensembl chr 1:194,886,709...194,893,046
G
Fut1
fucosyltransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of FUT1 mRNA
CTD
PMID:20044591
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
G
Fut8
fucosyltransferase 8
affects expression
ISO
Vitamin K 3 affects the expression of FUT8 mRNA
CTD
PMID:20044591
NCBI chr 6:95,949,246...96,176,677
Ensembl chr 6:95,949,991...96,176,677
G
Fzd4
frizzled class receptor 4
affects expression
ISO
Vitamin K 3 affects the expression of FZD4 mRNA
CTD
PMID:20044591
NCBI chr 1:143,279,934...143,288,799
Ensembl chr 1:143,280,065...143,285,724
G
Fzd7
frizzled class receptor 7
affects expression
ISO
Vitamin K 3 affects the expression of FZD7 mRNA
CTD
PMID:20044591
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
G0s2
G0/G1switch 2
affects expression
ISO
Vitamin K 3 affects the expression of G0S2 mRNA
CTD
PMID:20044591
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G2e3
G2/M-phase specific E3 ubiquitin protein ligase
decreases expression
ISO
Vitamin K 3 results in decreased expression of G2E3 mRNA
CTD
PMID:25270620
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
G
Gaa
alpha glucosidase
affects expression
ISO
Vitamin K 3 affects the expression of GAA mRNA
CTD
PMID:20044591
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
affects expression
ISO
Vitamin K 3 affects the expression of GADD45B mRNA
CTD
PMID:23410634
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gal
galanin and GMAP prepropeptide
affects expression
ISO
Vitamin K 3 affects the expression of GAL mRNA
CTD
PMID:20044591
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
G
Gal3st1
galactose-3-O-sulfotransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of GAL3ST1 mRNA
CTD
PMID:20044591
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
G
Galm
galactose mutarotase
affects expression
ISO
Vitamin K 3 affects the expression of GALM mRNA
CTD
PMID:20044591
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
G
Galnt11
polypeptide N-acetylgalactosaminyltransferase 11
affects expression
ISO
Vitamin K 3 affects the expression of GALNT11 mRNA
CTD
PMID:20044591
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
G
Gap43
growth associated protein 43
increases expression
ISO
Vitamin K 3 analog results in increased expression of GAP43 mRNA
CTD
PMID:19273458
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
affects expression
ISO
Vitamin K 3 affects the expression of GART mRNA
CTD
PMID:20044591
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gata6
GATA binding protein 6
affects expression
ISO
Vitamin K 3 affects the expression of GATA6 mRNA
CTD
PMID:20044591
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases activity increases expression multiple interactions
ISO
Vitamin K 3 results in increased activity of GCLC protein Vitamin K 3 results in increased expression of GCLC mRNA Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA]
CTD
PMID:11972604 PMID:23410634 PMID:25270620
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Vitamin K 3 results in increased expression of GCLM mRNA
CTD
PMID:12414654 PMID:23410634 PMID:25270620
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
Vitamin K 3 results in increased expression of GCNT3 mRNA
CTD
PMID:23410634
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdf15
growth differentiation factor 15
affects expression increases expression
ISO
Vitamin K 3 affects the expression of GDF15 mRNA Vitamin K 3 results in increased expression of GDF15 mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdi1
GDP dissociation inhibitor 1
affects expression
ISO
Vitamin K 3 affects the expression of GDI1 mRNA
CTD
PMID:20044591
NCBI chr X:152,087,611...152,094,274
Ensembl chr X:152,087,444...152,094,272
G
Gdi2
GDP dissociation inhibitor 2
affects expression
ISO
Vitamin K 3 affects the expression of GDI2 mRNA
CTD
PMID:20044591
NCBI chr17:66,649,616...66,676,299
Ensembl chr17:66,649,619...66,676,366
G
Gdpd5
glycerophosphodiester phosphodiesterase domain containing 5
affects expression
ISO
Vitamin K 3 affects the expression of GDPD5 mRNA
CTD
PMID:23410634
NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446
G
Gemin6
gem (nuclear organelle) associated protein 6
affects expression
ISO
Vitamin K 3 affects the expression of GEMIN6 mRNA
CTD
PMID:20044591
NCBI chr 6:14,786,090...14,790,617
Ensembl chr 6:14,786,070...14,790,612
G
Ggt1
gamma-glutamyltransferase 1
decreases expression multiple interactions
EXP
Vitamin K 3 results in decreased expression of GGT1 mRNA alternative form Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of GGT1 protein]; Vitamin K 3 results in increased expression of and results in increased activity of GGT1 protein
CTD
PMID:12030384
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Ghr
growth hormone receptor
affects expression
ISO
Vitamin K 3 affects the expression of GHR mRNA
CTD
PMID:20829426
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gigyf2
GRB10 interacting GYF protein 2
affects expression
ISO
Vitamin K 3 affects the expression of GIGYF2 mRNA
CTD
PMID:20044591
NCBI chr 9:88,001,212...88,127,040
Ensembl chr 9:88,001,301...88,125,715
G
Gipc2
GIPC PDZ domain containing family, member 2
increases expression
ISO
Vitamin K 3 results in increased expression of GIPC2 mRNA
CTD
PMID:25270620
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
G
Gja1
gap junction protein, alpha 1
affects expression
ISO
Vitamin K 3 affects the expression of GJA1 mRNA
CTD
PMID:20829426
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Glcci1
glucocorticoid induced 1
affects expression
ISO
Vitamin K 3 affects the expression of GLCCI1 mRNA
CTD
PMID:20044591
NCBI chr 4:36,307,956...36,635,614
Ensembl chr 4:36,307,903...36,635,612
G
Gldc
glycine decarboxylase
affects expression
ISO
Vitamin K 3 affects the expression of GLDC mRNA
CTD
PMID:20044591
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Glg1
golgi glycoprotein 1
affects expression
ISO
Vitamin K 3 affects the expression of GLG1 mRNA
CTD
PMID:20044591
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
G
Glrx
glutaredoxin
increases expression
ISO
Vitamin K 3 results in increased expression of GLRX mRNA
CTD
PMID:12414654
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Gls
glutaminase
affects expression
ISO
Vitamin K 3 affects the expression of GLS mRNA
CTD
PMID:20044591
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Glt8d1
glycosyltransferase 8 domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of GLT8D1 mRNA
CTD
PMID:20044591
NCBI chr16:6,192,269...6,207,227
Ensembl chr16:6,192,300...6,207,229
G
Glyctk
glycerate kinase
affects expression
ISO
Vitamin K 3 affects the expression of GLYCTK mRNA
CTD
PMID:20044591
NCBI chr 8:106,795,461...106,802,675
Ensembl chr 8:106,797,343...106,802,397
G
Gnai1
G protein subunit alpha i1
affects expression
ISO
Vitamin K 3 affects the expression of GNAI1 mRNA
CTD
PMID:23410634
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnaz
G protein subunit alpha z
affects expression
ISO
Vitamin K 3 affects the expression of GNAZ mRNA
CTD
PMID:20044591
NCBI chr20:13,643,473...13,694,240
Ensembl chr20:13,644,640...13,669,907
G
Gnpat
glyceronephosphate O-acyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of GNPAT mRNA
CTD
PMID:20044591
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
G
Golga3
golgin A3
affects expression
ISO
Vitamin K 3 affects the expression of GOLGA3 mRNA
CTD
PMID:20044591
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509
G
Gon4l
gon-4 like
affects expression
ISO
Vitamin K 3 affects the expression of GON4L mRNA
CTD
PMID:20044591
NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634
G
Gopc
golgi associated PDZ and coiled-coil motif containing
affects expression
ISO
Vitamin K 3 affects the expression of GOPC mRNA
CTD
PMID:20044591
NCBI chr20:31,727,617...31,776,904
Ensembl chr20:31,727,620...31,776,903
G
Gpank1
G patch domain and ankyrin repeats 1
affects expression
ISO
Vitamin K 3 affects the expression of GPANK1 mRNA
CTD
PMID:20044591
NCBI chr20:3,697,641...3,700,814
Ensembl chr20:3,697,641...3,700,858
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
Vitamin K 3 results in increased expression of GPAT3 mRNA
CTD
PMID:23410634
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpbp1
GC-rich promoter binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of GPBP1 mRNA
CTD
PMID:20829426
NCBI chr 2:43,023,504...43,091,146
Ensembl chr 2:43,023,504...43,090,907
G
Gpr160
G protein-coupled receptor 160
affects expression
ISO
Vitamin K 3 affects the expression of GPR160 mRNA
CTD
PMID:20044591
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
G
Gprc5a
G protein-coupled receptor, class C, group 5, member A
affects expression
ISO
Vitamin K 3 affects the expression of GPRC5A mRNA
CTD
PMID:20044591
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
affects expression
ISO
Vitamin K 3 affects the expression of GPRC5B mRNA
CTD
PMID:20044591
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
G
Gprc5c
G protein-coupled receptor, class C, group 5, member C
affects expression
ISO
Vitamin K 3 affects the expression of GPRC5C mRNA
CTD
PMID:20044591
NCBI chr10:99,886,900...99,908,928
Ensembl chr10:99,887,077...99,908,926
G
Gpt2
glutamic--pyruvic transaminase 2
affects expression
ISO
Vitamin K 3 affects the expression of GPT2 mRNA
CTD
PMID:20044591
NCBI chr19:21,526,800...21,561,314
Ensembl chr19:21,517,621...21,560,610
G
Gpx1
glutathione peroxidase 1
decreases response to substance
ISO
GPX1 protein results in decreased susceptibility to Vitamin K 3
CTD
PMID:1939125
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
Vitamin K 3 results in increased expression of GPX2 mRNA
CTD
PMID:12414654
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Grid1
glutamate ionotropic receptor delta type subunit 1
affects expression
ISO
Vitamin K 3 affects the expression of GRID1 mRNA
CTD
PMID:20044591
NCBI chr16:10,138,564...10,885,803
Ensembl chr16:10,138,925...10,885,808
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
ISO
Vitamin K 3 results in increased expression of GRIN2C mRNA
CTD
PMID:12414654
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grk5
G protein-coupled receptor kinase 5
affects expression
ISO
Vitamin K 3 affects the expression of GRK5 mRNA
CTD
PMID:20044591
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
G
Grn
granulin precursor
affects expression
ISO
Vitamin K 3 affects the expression of GRN mRNA
CTD
PMID:20044591
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Grwd1
glutamate-rich WD repeat containing 1
affects expression
ISO
Vitamin K 3 affects the expression of GRWD1 mRNA
CTD
PMID:20044591
NCBI chr 1:96,301,260...96,306,962
Ensembl chr 1:96,301,261...96,307,201
G
Gsdme
gasdermin E
affects expression
ISO
Vitamin K 3 affects the expression of GSDME mRNA
CTD
PMID:20044591
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
G
Gsk3b
glycogen synthase kinase 3 beta
increases expression
ISO
Vitamin K 3 results in increased expression of GSK3B protein
CTD
PMID:31238027
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
affects response to substance
ISO
GSN mRNA affects the susceptibility to Vitamin K 3
CTD
PMID:14652020 PMID:15033777
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
Vitamin K 3 results in increased expression of GSR mRNA
CTD
PMID:23410634
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta1
glutathione S-transferase alpha 1
affects expression
ISO
Vitamin K 3 affects the expression of GSTA1 mRNA
CTD
PMID:20044591
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta2
glutathione S-transferase alpha 2
affects expression
ISO
Vitamin K 3 affects the expression of GSTA2 mRNA
CTD
PMID:20044591
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta4
glutathione S-transferase alpha 4
affects expression
ISO
Vitamin K 3 affects the expression of GSTA4 mRNA
CTD
PMID:20044591
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gsta5
glutathione S-transferase alpha 5
affects expression
ISO
Vitamin K 3 affects the expression of GSTA5 mRNA
CTD
PMID:20044591 PMID:20829426
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
increases expression
ISO
Vitamin K 3 results in increased expression of GSTM1 mRNA
CTD
PMID:14610226
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gsto1
glutathione S-transferase omega 1
affects expression
ISO
Vitamin K 3 affects the expression of GSTO1 mRNA
CTD
PMID:20044591
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
G
Gtf2i
general transcription factor II I
affects expression
ISO
Vitamin K 3 affects the expression of GTF2I mRNA
CTD
PMID:20044591
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
G
Gtf3c2
general transcription factor IIIC subunit 2
affects expression
ISO
Vitamin K 3 affects the expression of GTF3C2 mRNA
CTD
PMID:20044591
NCBI chr 6:25,196,439...25,221,338
Ensembl chr 6:25,197,268...25,220,490
G
Gtpbp3
GTP binding protein 3
affects expression
ISO
Vitamin K 3 affects the expression of GTPBP3 mRNA
CTD
PMID:20044591
NCBI chr16:18,175,766...18,180,857
Ensembl chr16:18,175,766...18,180,857
G
Gtpbp4
GTP binding protein 4
affects expression
ISO
Vitamin K 3 affects the expression of GTPBP4 mRNA
CTD
PMID:20044591
NCBI chr17:61,308,033...61,328,184
Ensembl chr17:61,308,014...61,418,009
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
decreases expression
EXP
Vitamin K 3 results in decreased expression of GUCY1A1 protein
CTD
PMID:17339839
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
G
Gucy1b1
guanylate cyclase 1 soluble subunit beta 1
decreases expression
EXP
Vitamin K 3 results in decreased expression of GUCY1B1 protein
CTD
PMID:17339839
NCBI chr 2:167,348,824...167,398,983
Ensembl chr 2:167,348,825...167,398,916
G
Gucy2c
guanylate cyclase 2C
affects expression
ISO
Vitamin K 3 affects the expression of GUCY2C mRNA
CTD
PMID:20044591
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
G
Gusb
glucuronidase, beta
affects expression
ISO
Vitamin K 3 affects the expression of GUSB mRNA
CTD
PMID:20044591
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
H1f4
H1.4 linker histone, cluster member
affects expression
ISO
Vitamin K 3 affects the expression of H1-4 mRNA
CTD
PMID:20044591
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
G
H1f5
H1.5 linker histone, cluster member
affects expression
ISO
Vitamin K 3 affects the expression of H1-5 mRNA
CTD
PMID:20044591
NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160
G
H2ac18
H2A clustered histone 18
affects expression
ISO
Vitamin K 3 affects the expression of H2AC18 mRNA
CTD
PMID:20044591
NCBI chr 2:183,808,398...183,808,992
G
H2ac20
H2A clustered histone 20
affects expression
ISO
Vitamin K 3 affects the expression of H2AC20 mRNA
CTD
PMID:20044591
NCBI chr 2:183,779,879...183,780,357
G
H2ac25
H2A clustered histone 25
affects expression
ISO
Vitamin K 3 affects the expression of H2AC25 mRNA
CTD
PMID:20044591
NCBI chr10:43,733,702...43,735,254
Ensembl chr10:43,733,668...43,744,874
G
H2aj
H2A.J histone
affects expression
ISO
Vitamin K 3 affects the expression of H2AJ mRNA
CTD
PMID:20044591
NCBI chr 4:169,675,718...169,676,202
Ensembl chr 4:169,675,752...169,677,006
G
H2ax
H2A.X variant histone
multiple interactions
ISO
[Ascorbic Acid results in increased reduction of Vitamin K 3] which results in increased phosphorylation of H2AX protein
CTD
PMID:19482829
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2bc3
H2B clustered histone 3
affects expression
ISO
Vitamin K 3 affects the expression of H2BC3 mRNA
CTD
PMID:20044591
NCBI chr17:41,380,056...41,380,686
G
H2bc6
H2B clustered histone 6
affects expression
ISO
Vitamin K 3 affects the expression of H2BC6 mRNA
CTD
PMID:20044591
NCBI chr17:41,520,775...41,521,238
G
H2bc9
H2B clustered histone 9
affects expression
ISO
Vitamin K 3 affects the expression of H2BC9 mRNA
CTD
PMID:20044591
NCBI chr17:42,470,593...42,478,590
G
H2bu1
H2B.U histone 1
affects expression
ISO
Vitamin K 3 affects the expression of H2BC26 mRNA
CTD
PMID:20044591
NCBI chr10:43,732,737...43,733,484
Ensembl chr10:43,732,864...43,736,277
G
Hadh
hydroxyacyl-CoA dehydrogenase
affects expression
ISO
Vitamin K 3 affects the expression of HADH mRNA
CTD
PMID:20044591
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hamp
hepcidin antimicrobial peptide
affects expression
ISO
Vitamin K 3 affects the expression of HAMP mRNA
CTD
PMID:23410634
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hars2
histidyl-tRNA synthetase 2, mitochondrial
affects expression
ISO
Vitamin K 3 affects the expression of HARS2 mRNA
CTD
PMID:20044591
NCBI chr18:28,398,790...28,408,075
Ensembl chr18:28,398,795...28,414,747
G
Havcr1
hepatitis A virus cellular receptor 1
affects expression
ISO
Vitamin K 3 affects the expression of HAVCR1 mRNA
CTD
PMID:20044591
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hba-a3
hemoglobin alpha, adult chain 3
affects expression
ISO
Vitamin K 3 affects the expression of HBA2 mRNA
CTD
PMID:20044591
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
G
Hbp1
HMG-box transcription factor 1
affects expression
ISO
Vitamin K 3 affects the expression of HBP1 mRNA
CTD
PMID:20044591
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hcar1
hydroxycarboxylic acid receptor 1
affects expression
ISO
Vitamin K 3 affects the expression of HCAR1 mRNA
CTD
PMID:20044591
NCBI chr12:32,710,680...32,713,934
Ensembl chr12:32,711,027...32,712,082
G
Hccs
holocytochrome c synthase
affects expression
ISO
Vitamin K 3 affects the expression of HCCS mRNA
CTD
PMID:20044591
NCBI chr X:24,932,943...24,942,376
Ensembl chr X:24,933,002...24,942,366
G
Hcfc1r1
host cell factor C1 regulator 1
affects expression
ISO
Vitamin K 3 affects the expression of HCFC1R1 mRNA
CTD
PMID:20044591
NCBI chr10:12,705,139...12,706,852
Ensembl chr10:12,705,077...12,706,850
G
Hdac11
histone deacetylase 11
affects expression
ISO
Vitamin K 3 affects the expression of HDAC11 mRNA
CTD
PMID:23410634
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
G
Hdac2
histone deacetylase 2
affects expression
ISO
Vitamin K 3 affects the expression of HDAC2 mRNA
CTD
PMID:20044591
NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
G
Heatr1
HEAT repeat containing 1
affects expression
ISO
Vitamin K 3 affects the expression of HEATR1 mRNA
CTD
PMID:20044591
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
G
Heca
hdc homolog, cell cycle regulator
affects expression
ISO
Vitamin K 3 affects the expression of HECA mRNA
CTD
PMID:20044591
NCBI chr 1:12,525,445...12,575,358
Ensembl chr 1:12,525,135...12,576,427
G
Heph
hephaestin
affects expression
ISO
Vitamin K 3 affects the expression of HEPH mRNA
CTD
PMID:20044591
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Herc2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
affects expression
ISO
Vitamin K 3 affects the expression of HERC2 mRNA
CTD
PMID:20044591
NCBI chr 1:106,904,789...107,110,997
Ensembl chr 1:106,880,084...107,108,134
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
affects expression
ISO
Vitamin K 3 affects the expression of HERPUD1 mRNA
CTD
PMID:20044591
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hes1
hes family bHLH transcription factor 1
affects expression increases expression multiple interactions
ISO
Vitamin K 3 affects the expression of HES1 mRNA Vitamin K 3 results in increased expression of HES1 protein EUK-134 inhibits the reaction [Vitamin K 3 results in increased expression of HES1 protein]
CTD
PMID:20044591 PMID:25005833
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hes6
hes family bHLH transcription factor 6
affects expression
ISO
Vitamin K 3 affects the expression of HES6 mRNA
CTD
PMID:23410634
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hgsnat
heparan-alpha-glucosaminide N-acetyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of HGSNAT mRNA
CTD
PMID:20044591
NCBI chr16:66,105,233...66,137,444
Ensembl chr16:66,105,181...66,136,138
G
Hibadh
3-hydroxyisobutyrate dehydrogenase
affects expression
ISO
Vitamin K 3 affects the expression of HIBADH mRNA
CTD
PMID:20044591
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression multiple interactions
ISO EXP
Vitamin K 3 results in increased expression of HIF1A mRNA; Vitamin K 3 results in increased expression of HIF1A protein Vitamin K 3 inhibits the reaction [carbobenzoxy-leucyl-leucyl-leucine results in increased expression of HIF1A protein]; Vitamin K 3 inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Vitamin K 3 inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]
CTD
PMID:12595275 PMID:16507596
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hif3a
hypoxia inducible factor 3 subunit alpha
affects expression
ISO
Vitamin K 3 affects the expression of HIF3A mRNA
CTD
PMID:20044591
NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758
G
Hipk2
homeodomain interacting protein kinase 2
affects expression
ISO
Vitamin K 3 affects the expression of HIPK2 mRNA
CTD
PMID:20044591
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
G
Hist1h2af
histone cluster 1 H2A family member F
affects expression
ISO
Vitamin K 3 affects the expression of H2AC8 mRNA
CTD
PMID:20044591
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
G
Hist1h2bq
histone cluster 1 H2B family member Q
affects expression
ISO
Vitamin K 3 affects the expression of H2BC7 mRNA
CTD
PMID:20044591
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
G
Hist1h4m
histone cluster 1, H4m
affects expression
ISO
Vitamin K 3 affects the expression of H4C1 mRNA
CTD
PMID:20044591
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
G
Hlcs
holocarboxylase synthetase
affects expression
ISO
Vitamin K 3 affects the expression of HLCS mRNA
CTD
PMID:20044591
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
G
Hmbox1
homeobox containing 1
affects expression
ISO
Vitamin K 3 affects the expression of HMBOX1 mRNA
CTD
PMID:20044591
NCBI chr15:39,067,805...39,200,633
Ensembl chr15:39,067,804...39,200,323
G
Hmgb3
high mobility group box 3
affects expression
ISO
Vitamin K 3 affects the expression of HMGB3 mRNA
CTD
PMID:20044591
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression multiple interactions decreases activity
ISO
Vitamin K 3 results in increased expression of HMGCR mRNA manganese protoporphyrin inhibits the reaction [Vitamin K 3 results in decreased activity of HMGCR protein]; tempol inhibits the reaction [Vitamin K 3 results in decreased activity of HMGCR protein]
CTD
PMID:12414654 PMID:21257924
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
affects expression
ISO
Vitamin K 3 affects the expression of HMGCS2 mRNA
CTD
PMID:20044591
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hmox1
heme oxygenase 1
increases expression
EXP ISO
Vitamin K 3 results in increased expression of HMOX1 mRNA
CTD
PMID:12414654 PMID:19386027 PMID:23410634
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnmt
histamine N-methyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of HNMT mRNA
CTD
PMID:20044591
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Hoxd1
homeo box D1
affects expression
ISO
Vitamin K 3 affects the expression of HOXD1 mRNA
CTD
PMID:23410634
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hp
haptoglobin
affects expression
ISO
Vitamin K 3 affects the expression of HP mRNA
CTD
PMID:20044591
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hsbp1
heat shock factor binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of HSBP1 mRNA
CTD
PMID:20044591
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
affects expression
ISO
Vitamin K 3 affects the expression of HSD11B2 mRNA
CTD
PMID:23410634
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b11
hydroxysteroid (17-beta) dehydrogenase 11
affects expression
ISO
Vitamin K 3 affects the expression of HSD17B11 mRNA
CTD
PMID:20044591
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
affects expression
ISO
Vitamin K 3 affects the expression of HSD17B4 mRNA
CTD
PMID:20044591
NCBI chr18:43,328,903...43,417,950
Ensembl chr18:43,328,824...43,417,952
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
affects expression multiple interactions
ISO
Vitamin K 3 affects the expression of HSD3B1 mRNA [Vitamin K 3 co-treated with NADP] binds to HSD3B1 protein
CTD
PMID:20044591 PMID:25526675
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
Vitamin K 3 results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Hsp90b1
heat shock protein 90 beta family member 1
affects expression
ISO
Vitamin K 3 affects the expression of HSP90B1 mRNA
CTD
PMID:20829426
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
affects expression increases expression
ISO
Vitamin K 3 affects the expression of HSPA1A mRNA Vitamin K 3 results in increased expression of HSPA1A mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
Vitamin K 3 results in increased expression of HSPA1B mRNA
CTD
PMID:12414654
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression
ISO
Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of HSPA5 protein]
CTD
PMID:19819344
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Vitamin K 3 results in increased expression of HSPA6 mRNA
CTD
PMID:12414654
NCBI chr13:83,273,176...83,274,317
G
Hspb1
heat shock protein family B (small) member 1
affects expression
ISO
Vitamin K 3 affects the expression of HSPB1 mRNA
CTD
PMID:20044591
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
ISO
Vitamin K 3 results in increased expression of HTATIP2 mRNA
CTD
PMID:25270620
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Iars1
isoleucyl-tRNA synthetase 1
affects expression
ISO
Vitamin K 3 affects the expression of IARS1 mRNA
CTD
PMID:20044591
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
G
Ica1
islet cell autoantigen 1
affects expression
ISO
Vitamin K 3 affects the expression of ICA1 mRNA
CTD
PMID:20044591
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
G
Icoslg
inducible T-cell co-stimulator ligand
decreases expression
ISO
Vitamin K 3 results in decreased expression of ICOSL mRNA
CTD
PMID:25270620
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
G
Id1
inhibitor of DNA binding 1
affects expression
ISO
Vitamin K 3 affects the expression of ID1 mRNA
CTD
PMID:20044591
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Ier5
immediate early response 5
affects expression
ISO
Vitamin K 3 affects the expression of IER5 mRNA
CTD
PMID:20044591
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
G
Ifi30
IFI30, lysosomal thiol reductase
affects expression
ISO
Vitamin K 3 affects the expression of IFI30 mRNA
CTD
PMID:20044591
NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
affects expression
ISO
Vitamin K 3 affects the expression of IFIT3 mRNA
CTD
PMID:20829426
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ift22
intraflagellar transport 22
affects expression
ISO
Vitamin K 3 affects the expression of IFT22 mRNA
CTD
PMID:20044591
NCBI chr12:19,759,072...19,768,859
Ensembl chr12:19,761,790...19,768,809
G
Igf1r
insulin-like growth factor 1 receptor
affects expression
ISO
Vitamin K 3 affects the expression of IGF1R mRNA
CTD
PMID:20044591
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2r
insulin-like growth factor 2 receptor
affects expression
ISO
Vitamin K 3 affects the expression of IGF2R mRNA
CTD
PMID:20044591
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
Vitamin K 3 results in decreased expression of IGFBP2 mRNA
CTD
PMID:25270620
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
Vitamin K 3 results in increased expression of IGFBP5 mRNA
CTD
PMID:12414654
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Il11
interleukin 11
affects expression
ISO
Vitamin K 3 affects the expression of IL11 mRNA
CTD
PMID:23410634
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il1a
interleukin 1 alpha
multiple interactions increases secretion increases expression
EXP ISO
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of IL1A mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of IL1A protein] [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Vitamin K 3
CTD
PMID:19265712 PMID:19362101
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions increases expression increases secretion
EXP
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of IL1B mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of IL1B protein]
CTD
PMID:19265712
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Vitamin K 3
CTD
PMID:19362101
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ilf2
interleukin enhancer binding factor 2
affects expression
ISO
Vitamin K 3 affects the expression of ILF2 mRNA
CTD
PMID:20044591
NCBI chr 2:175,952,174...175,971,191
Ensembl chr 2:175,952,186...175,971,337
G
Inhbb
inhibin subunit beta B
affects expression increases expression
ISO
Vitamin K 3 affects the expression of INHBB mRNA Vitamin K 3 results in increased expression of INHBB mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Insig2
insulin induced gene 2
affects expression
ISO
Vitamin K 3 affects the expression of INSIG2 mRNA
CTD
PMID:20044591
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Ints10
integrator complex subunit 10
affects expression
ISO
Vitamin K 3 affects the expression of INTS10 mRNA
CTD
PMID:20044591
NCBI chr16:20,915,223...20,947,146
Ensembl chr16:20,916,082...20,967,610
G
Ipo7
importin 7
affects expression
ISO
Vitamin K 3 affects the expression of IPO7 mRNA
CTD
PMID:20044591
NCBI chr 1:164,062,702...164,102,938
Ensembl chr 1:164,062,702...164,102,938
G
Irf2bp2
interferon regulatory factor 2 binding protein 2
affects expression
ISO
Vitamin K 3 affects the expression of IRF2BP2 mRNA
CTD
PMID:20044591
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
G
Irf5
interferon regulatory factor 5
affects expression
ISO
Vitamin K 3 affects the expression of IRF5 mRNA
CTD
PMID:20044591
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Irx5
iroquois homeobox 5
affects expression
ISO
Vitamin K 3 affects the expression of IRX5 mRNA
CTD
PMID:20044591
NCBI chr19:14,639,052...14,643,911
Ensembl chr19:14,624,225...14,642,318
G
Isg20
interferon stimulated exonuclease gene 20
affects expression
ISO
Vitamin K 3 affects the expression of ISG20 mRNA
CTD
PMID:20044591
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Isg20l2
interferon stimulated exonuclease gene 20-like 2
affects expression
ISO
Vitamin K 3 affects the expression of ISG20L2 mRNA
CTD
PMID:20044591
NCBI chr 2:173,396,780...173,407,102
Ensembl chr 2:173,396,780...173,406,614
G
Itga4
integrin subunit alpha 4
affects expression
ISO
Vitamin K 3 affects the expression of ITGA4 mRNA
CTD
PMID:20829426
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
affects expression
ISO
Vitamin K 3 affects the expression of ITPR3 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Itprid2
ITPR interacting domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of ITPRID2 mRNA
CTD
PMID:20044591
NCBI chr 3:64,536,707...64,573,978
Ensembl chr 3:64,536,707...64,573,978
G
Jag1
jagged canonical Notch ligand 1
affects expression
ISO
Vitamin K 3 affects the expression of JAG1 mRNA
CTD
PMID:20044591
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Jak1
Janus kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of JAK1 mRNA
CTD
PMID:20829426
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
G
Jak3
Janus kinase 3
multiple interactions increases phosphorylation
ISO
[[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]; [[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]; [Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein; JAK3 protein promotes the reaction [Vitamin K 3 results in increased phosphorylation of ELAVL1 protein]
CTD
PMID:24106086
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Jaml
junction adhesion molecule like
affects expression
ISO
Vitamin K 3 affects the expression of JAML mRNA
CTD
PMID:20044591
NCBI chr 8:45,384,836...45,415,459
Ensembl chr 8:45,383,495...45,416,565
G
Jarid2
jumonji and AT-rich interaction domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of JARID2 mRNA
CTD
PMID:20044591
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Vitamin K 3 results in increased expression of JUN mRNA
CTD
PMID:12414654
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kank1
KN motif and ankyrin repeat domains 1
affects expression
ISO
Vitamin K 3 affects the expression of KANK1 mRNA
CTD
PMID:20044591
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
G
Kat2a
lysine acetyltransferase 2A
affects expression
ISO
Vitamin K 3 affects the expression of KAT2A mRNA
CTD
PMID:23410634
NCBI chr10:85,632,216...85,640,561
Ensembl chr10:85,632,216...85,640,166
G
Kazald1
Kazal-type serine peptidase inhibitor domain 1
affects expression
ISO
Vitamin K 3 affects the expression of KAZALD1 mRNA
CTD
PMID:20044591
NCBI chr 1:243,939,596...243,943,060
Ensembl chr 1:243,939,647...243,943,059
G
Kbtbd11
kelch repeat and BTB domain containing 11
affects expression
ISO
Vitamin K 3 affects the expression of KBTBD11 mRNA
CTD
PMID:20044591
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kcnj14
potassium inwardly-rectifying channel, subfamily J, member 14
affects expression
ISO
Vitamin K 3 affects the expression of KCNJ14 mRNA
CTD
PMID:20044591
NCBI chr 1:96,293,159...96,300,810
Ensembl chr 1:96,293,435...96,495,459
G
Kcnj16
potassium inwardly-rectifying channel, subfamily J, member 16
affects expression
ISO
Vitamin K 3 affects the expression of KCNJ16 mRNA
CTD
PMID:20044591
NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
affects expression
ISO
Vitamin K 3 affects the expression of KCNN4 mRNA
CTD
PMID:20044591
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Kctd10
potassium channel tetramerization domain containing 10
affects expression
ISO
Vitamin K 3 affects the expression of KCTD10 mRNA
CTD
PMID:20044591
NCBI chr12:42,230,159...42,248,792
Ensembl chr12:42,230,269...42,248,783
G
Kctd21
potassium channel tetramerization domain containing 21
affects expression
ISO
Vitamin K 3 affects the expression of KCTD21 mRNA
CTD
PMID:23410634
NCBI chr 1:151,650,074...151,669,775
Ensembl chr 1:151,650,104...151,667,645
G
Kdm2b
lysine demethylase 2B
affects expression
ISO
Vitamin K 3 affects the expression of KDM2B mRNA
CTD
PMID:20044591
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
G
Kdm3a
lysine demethylase 3A
affects expression
ISO
Vitamin K 3 affects the expression of KDM3A mRNA
CTD
PMID:23410634
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
G
Kdm3b
lysine demethylase 3B
affects expression
ISO
Vitamin K 3 affects the expression of KDM3B mRNA
CTD
PMID:20044591
NCBI chr18:26,380,859...26,436,701
Ensembl chr18:26,380,964...26,436,628
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions decreases expression
ISO
[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 Vitamin K 3 results in decreased expression of KEAP1 mRNA
CTD
PMID:19608619 PMID:23410634
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Khdrbs1
KH RNA binding domain containing, signal transduction associated 1
affects expression
ISO
Vitamin K 3 affects the expression of KHDRBS1 mRNA
CTD
PMID:20044591
NCBI chr 5:142,051,844...142,089,175
Ensembl chr 5:142,063,570...142,089,180
G
Kiaa1549
KIAA1549 homolog
affects expression
ISO
Vitamin K 3 affects the expression of KIAA1549 mRNA
CTD
PMID:20044591
NCBI chr 4:66,840,674...66,968,407
Ensembl chr 4:66,760,162...66,968,436
G
Kif13b
kinesin family member 13B
affects expression
ISO
Vitamin K 3 affects the expression of KIF13B mRNA
CTD
PMID:20044591
NCBI chr15:38,908,257...39,066,021
Ensembl chr15:38,924,624...39,084,879
G
Kif15
kinesin family member 15
affects expression
ISO
Vitamin K 3 affects the expression of KIF15 mRNA
CTD
PMID:23410634
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif1b
kinesin family member 1B
affects expression
ISO
Vitamin K 3 affects the expression of KIF1B mRNA
CTD
PMID:20044591
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
G
Kif23
kinesin family member 23
affects expression
ISO
Vitamin K 3 affects the expression of KIF23 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif2c
kinesin family member 2C
affects expression
ISO
Vitamin K 3 affects the expression of KIF2C mRNA
CTD
PMID:20044591
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kiss1r
KISS1 receptor
affects expression
ISO
Vitamin K 3 affects the expression of KISS1R mRNA
CTD
PMID:23410634
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Klf10
KLF transcription factor 10
affects expression
ISO
Vitamin K 3 affects the expression of KLF10 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
G
Klf11
KLF transcription factor 11
affects expression
ISO
Vitamin K 3 affects the expression of KLF11 mRNA
CTD
PMID:20044591
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
G
Klf6
KLF transcription factor 6
affects expression increases expression multiple interactions
ISO
Vitamin K 3 affects the expression of KLF6 mRNA Vitamin K 3 results in increased expression of KLF6 mRNA; Vitamin K 3 results in increased expression of KLF6 mRNA alternative form; Vitamin K 3 results in increased expression of KLF6 protein [Arachidonic Acid co-treated with Vitamin K 3] results in increased expression of KLF6 protein; [CYP2E1 protein co-treated with Vitamin K 3 co-treated with Arachidonic Acid] results in increased expression of KLF6 protein; [CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein; Buthionine Sulfoximine promotes the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; CAT protein inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Dicumarol inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; S-ethyl glutathione inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA alternative form]; Vitamin K 3 promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]
CTD
PMID:20044591 PMID:22486562
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Kng1
kininogen 1
affects expression
ISO
Vitamin K 3 affects the expression of KNG1 mRNA
CTD
PMID:20044591
NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
G
Kpnb1
karyopherin subunit beta 1
affects expression
ISO
Vitamin K 3 affects the expression of KPNB1 mRNA
CTD
PMID:20044591
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Kri1
KRI1 homolog
affects expression
ISO
Vitamin K 3 affects the expression of KRI1 mRNA
CTD
PMID:20044591
NCBI chr 8:19,817,005...19,831,516
Ensembl chr 8:19,817,017...19,831,392
G
Krt10
keratin 10
affects expression
ISO
Vitamin K 3 affects the expression of KRT10 mRNA
CTD
PMID:20044591
NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
G
Krt23
keratin 23
affects expression
ISO
Vitamin K 3 affects the expression of KRT23 mRNA
CTD
PMID:20044591
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
G
Krt8
keratin 8
multiple interactions increases phosphorylation
ISO
Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased phosphorylation of KRT8 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased phosphorylation of KRT8 protein]
CTD
PMID:15939799
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Kynu
kynureninase
affects expression
ISO
Vitamin K 3 affects the expression of KYNU mRNA
CTD
PMID:20044591
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lama5
laminin subunit alpha 5
affects expression
ISO
Vitamin K 3 affects the expression of LAMA5 mRNA
CTD
PMID:20044591
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
G
Lamb2
laminin subunit beta 2
affects expression
ISO
Vitamin K 3 affects the expression of LAMB2 mRNA
CTD
PMID:20044591
NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
G
Lamc1
laminin subunit gamma 1
affects expression
ISO
Vitamin K 3 affects the expression of LAMC1 mRNA
CTD
PMID:20044591
NCBI chr13:65,374,372...65,501,492
Ensembl chr13:65,374,372...65,501,492
G
Lamtor2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 2
affects expression
ISO
Vitamin K 3 affects the expression of LAMTOR2 mRNA
CTD
PMID:20044591
NCBI chr 2:174,008,556...174,011,950
Ensembl chr 2:174,008,548...174,013,013
G
Large1
LARGE xylosyl- and glucuronyltransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of LARGE1 mRNA
CTD
PMID:20044591
NCBI chr19:11,603,129...12,048,930
Ensembl chr19:11,603,129...12,048,930
G
Larp1b
La ribonucleoprotein 1B
affects expression
ISO
Vitamin K 3 affects the expression of LARP1B mRNA
CTD
PMID:20044591
NCBI chr 2:123,936,057...123,969,254
Ensembl chr 2:123,935,983...123,968,896
G
Larp6
La ribonucleoprotein 6, translational regulator
affects expression
ISO
Vitamin K 3 affects the expression of LARP6 mRNA
CTD
PMID:20044591
NCBI chr 8:61,183,744...61,205,548
Ensembl chr 8:61,184,116...61,205,535
G
Las1l
LAS1-like, ribosome biogenesis factor
affects expression
ISO
Vitamin K 3 affects the expression of LAS1L mRNA
CTD
PMID:20044591
NCBI chr X:60,851,969...60,873,717
Ensembl chr X:60,851,962...60,873,687
G
Lats2
large tumor suppressor kinase 2
affects expression
ISO
Vitamin K 3 affects the expression of LATS2 mRNA
CTD
PMID:20044591
NCBI chr15:31,825,068...31,877,193
Ensembl chr15:31,825,092...31,877,220
G
Lbp
lipopolysaccharide binding protein
affects expression
ISO
Vitamin K 3 affects the expression of LBP mRNA
CTD
PMID:20829426
NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:146,954,015...146,981,586
G
Lbr
lamin B receptor
decreases expression
ISO
Vitamin K 3 results in decreased expression of LBR mRNA
CTD
PMID:12414654
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Ldha
lactate dehydrogenase A
affects expression
ISO
Vitamin K 3 affects the expression of LDHA mRNA
CTD
PMID:20044591
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Ldhd
lactate dehydrogenase D
affects expression
ISO
Vitamin K 3 affects the expression of LDHD mRNA
CTD
PMID:20044591
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
Vitamin K 3 results in increased expression of LDLR mRNA
CTD
PMID:12414654
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lef1
lymphoid enhancer binding factor 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of LEF1 mRNA
CTD
PMID:25270620
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
G
Leo1
LEO1 homolog, Paf1/RNA polymerase II complex component
affects expression
ISO
Vitamin K 3 affects the expression of LEO1 mRNA
CTD
PMID:20044591
NCBI chr 8:76,199,547...76,223,983
Ensembl chr 8:76,199,099...76,223,983
G
Lep
leptin
multiple interactions increases expression
ISO
1,2-linoleoylphosphatidylcholine inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]; S-Adenosylmethionine inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]; SB 203580 inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA]
CTD
PMID:16996477
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Leprot
leptin receptor overlapping transcript
affects expression
ISO
Vitamin K 3 affects the expression of LEPROT mRNA
CTD
PMID:20044591
NCBI chr 5:116,289,843...116,301,951
Ensembl chr 5:116,289,822...116,301,988
G
Lgals8
galectin 8
affects expression
ISO
Vitamin K 3 affects the expression of LGALS8 mRNA
CTD
PMID:20044591
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
affects expression
ISO
Vitamin K 3 affects the expression of LGR5 mRNA
CTD
PMID:23410634
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
G
Lgsn
lengsin, lens protein with glutamine synthetase domain
affects expression
ISO
Vitamin K 3 affects the expression of LGSN mRNA
CTD
PMID:20044591
NCBI chr 9:33,416,362...33,447,919
Ensembl chr 9:33,420,484...33,447,907
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
Vitamin K 3 results in decreased expression of and results in decreased secretion of LHB protein
CTD
PMID:30536483
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhx6
LIM homeobox 6
affects expression
ISO
Vitamin K 3 affects the expression of LHX6 mRNA
CTD
PMID:20044591
NCBI chr 3:19,432,439...19,456,268
Ensembl chr 3:19,433,494...19,456,061
G
Lif
LIF, interleukin 6 family cytokine
increases expression
ISO
Vitamin K 3 results in increased expression of LIF mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lmbr1
limb development membrane protein 1
affects expression
ISO
Vitamin K 3 affects the expression of LMBR1 mRNA
CTD
PMID:23410634
NCBI chr 4:5,974,687...6,146,348
Ensembl chr 4:5,974,750...6,146,368
G
Lmcd1
LIM and cysteine-rich domains 1
affects expression
ISO
Vitamin K 3 affects the expression of LMCD1 mRNA
CTD
PMID:20044591
NCBI chr 4:145,393,153...145,452,049
Ensembl chr 4:145,393,145...145,452,046
G
Lmnb1
lamin B1
affects expression
ISO
Vitamin K 3 affects the expression of LMNB1 mRNA
CTD
PMID:20044591
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lonp1
lon peptidase 1, mitochondrial
affects expression
ISO
Vitamin K 3 affects the expression of LONP1 mRNA
CTD
PMID:20044591
NCBI chr 9:1,447,444...1,459,771
Ensembl chr 9:1,447,447...1,459,771
G
Lox
lysyl oxidase
affects expression
ISO
Vitamin K 3 affects the expression of LOX mRNA
CTD
PMID:23410634
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Lrfn3
leucine rich repeat and fibronectin type III domain containing 3
affects expression
ISO
Vitamin K 3 affects the expression of LRFN3 mRNA
CTD
PMID:20044591
NCBI chr 1:85,616,862...85,623,725
Ensembl chr 1:85,616,868...85,623,725
G
Lrig1
leucine-rich repeats and immunoglobulin-like domains 1
affects expression
ISO
Vitamin K 3 affects the expression of LRIG1 mRNA
CTD
PMID:20044591
NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:127,130,898...127,231,513
G
Lrp1
LDL receptor related protein 1
affects expression
ISO
Vitamin K 3 affects the expression of LRP1 mRNA
CTD
PMID:23410634
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Lrp6
LDL receptor related protein 6
increases expression
ISO
Vitamin K 3 results in increased expression of LRP6 mRNA
CTD
PMID:12414654
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
G
Lrrc8e
leucine rich repeat containing 8 VRAC subunit E
affects expression
ISO
Vitamin K 3 affects the expression of LRRC8E mRNA
CTD
PMID:20044591
NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412
G
Lrwd1
leucine-rich repeats and WD repeat domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of LRWD1 mRNA
CTD
PMID:20044591
NCBI chr12:20,530,035...20,543,078
Ensembl chr12:20,530,012...20,549,536
G
Lsm14a
LSM14A mRNA processing body assembly factor
affects expression
ISO
Vitamin K 3 affects the expression of LSM14A mRNA
CTD
PMID:20044591
NCBI chr 1:86,964,800...87,009,325
Ensembl chr 1:86,964,828...87,009,276
G
Lta4h
leukotriene A4 hydrolase
affects expression
ISO
Vitamin K 3 affects the expression of LTA4H mRNA
CTD
PMID:20044591
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
G
Ltv1
LTV1 ribosome biogenesis factor
affects expression
ISO
Vitamin K 3 affects the expression of LTV1 mRNA
CTD
PMID:20044591
NCBI chr 1:7,565,673...7,578,398
Ensembl chr 1:7,565,669...7,578,563
G
Lyar
Ly1 antibody reactive
affects expression
ISO
Vitamin K 3 affects the expression of LYAR mRNA
CTD
PMID:20044591
NCBI chr14:72,576,878...72,590,854
Ensembl chr14:72,576,879...72,590,612
G
Mab21l4
mab-21 like 4
affects expression
ISO
Vitamin K 3 affects the expression of MAB21L4 mRNA
CTD
PMID:20044591
NCBI chr 9:93,690,455...93,701,267
Ensembl chr 9:93,690,999...93,700,506
G
Maf
MAF bZIP transcription factor
affects expression
ISO
Vitamin K 3 affects the expression of MAF mRNA
CTD
PMID:20044591
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Maff
MAF bZIP transcription factor F
affects expression
ISO
Vitamin K 3 affects the expression of MAFF mRNA
CTD
PMID:20044591
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression affects expression
ISO
Vitamin K 3 results in increased expression of MAFG mRNA Vitamin K 3 affects the expression of MAFG mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
G
Maged1
MAGE family member D1
affects expression
ISO
Vitamin K 3 affects the expression of MAGED1 mRNA
CTD
PMID:20044591
NCBI chr X:59,422,715...59,429,381
Ensembl chr X:59,422,717...59,429,364
G
Maob
monoamine oxidase B
multiple interactions decreases activity
ISO
Vitamin K 3 inhibits the reaction [MAOB protein results in increased oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] Vitamin K 3 results in decreased activity of MAOB protein
CTD
PMID:21554916
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions
ISO
[Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein; [S 3483 co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein
CTD
PMID:19819344
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map4
microtubule-associated protein 4
affects expression
ISO
Vitamin K 3 affects the expression of MAP4 mRNA
CTD
PMID:20044591
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
affects expression
ISO
Vitamin K 3 affects the expression of MAP4K4 mRNA
CTD
PMID:20044591
NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation increases activity
EXP ISO
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein] schizandrin B promotes the reaction [Vitamin K 3 results in increased activity of MAPK1 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein]
CTD
PMID:11880281 PMID:16310883 PMID:16507596 PMID:16996477 PMID:21250784
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk10
mitogen activated protein kinase 10
decreases activity multiple interactions
ISO EXP
Vitamin K 3 results in decreased activity of MAPK10 protein Vitamin K 3 results in increased phosphorylation of and results in increased activity of MAPK10 protein
CTD
PMID:10531305 PMID:19386027
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation increases activity
EXP ISO
Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein] schizandrin B promotes the reaction [Vitamin K 3 results in increased activity of MAPK3 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein]
CTD
PMID:11880281 PMID:16310883 PMID:16507596 PMID:16996477 PMID:21250784
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases activity affects response to substance increases phosphorylation
EXP ISO
Vitamin K 3 results in increased phosphorylation of and results in increased activity of MAPK8 protein Vitamin K 3 results in increased activity of MAPK8 protein MAPK8 protein affects the susceptibility to Vitamin K 3 Vitamin K 3 results in increased phosphorylation of MAPK8 protein
CTD
PMID:12215205 PMID:16310883 PMID:19386027
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mat2a
methionine adenosyltransferase 2A
affects expression
ISO
Vitamin K 3 affects the expression of MAT2A mRNA
CTD
PMID:20044591
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
G
Mbd2
methyl-CpG binding domain protein 2
affects expression
ISO
Vitamin K 3 affects the expression of MBD2 mRNA
CTD
PMID:20829426
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mc1r
melanocortin 1 receptor
affects expression
ISO
Vitamin K 3 affects the expression of MC1R mRNA
CTD
PMID:20044591
NCBI chr19:51,452,448...51,455,375
Ensembl chr19:51,453,239...51,454,192
G
Mccc1
methylcrotonyl-CoA carboxylase subunit 1
affects expression
ISO
Vitamin K 3 affects the expression of MCCC1 mRNA
CTD
PMID:20044591
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:118,799,150...118,851,222
G
Mcf2l
MCF.2 cell line derived transforming sequence-like
affects expression
ISO
Vitamin K 3 affects the expression of MCF2L mRNA
CTD
PMID:20044591
NCBI chr16:76,507,133...76,652,893
Ensembl chr16:76,507,133...76,652,733
G
Mcm3
minichromosome maintenance complex component 3
affects expression
ISO
Vitamin K 3 affects the expression of MCM3 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm5
minichromosome maintenance complex component 5
affects expression
ISO
Vitamin K 3 affects the expression of MCM5 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
affects expression
ISO
Vitamin K 3 affects the expression of MCM6 mRNA
CTD
PMID:20044591
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcmbp
minichromosome maintenance complex binding protein
affects expression
ISO
Vitamin K 3 affects the expression of MCMBP mRNA
CTD
PMID:20044591
NCBI chr 1:183,270,598...183,316,975
Ensembl chr 1:183,271,980...183,316,975
G
Mdc1
mediator of DNA damage checkpoint 1
affects expression
ISO
Vitamin K 3 affects the expression of MDC1 mRNA
CTD
PMID:20044591
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
G
Mdm2
MDM2 proto-oncogene
multiple interactions decreases expression
ISO
EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of MDM2 protein]
CTD
PMID:25005833
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
increases expression
ISO
Vitamin K 3 results in increased expression of ME1 mRNA
CTD
PMID:12414654
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Med9
mediator complex subunit 9
affects expression
ISO
Vitamin K 3 affects the expression of MED9 mRNA
CTD
PMID:20044591
NCBI chr10:44,750,667...44,765,464
Ensembl chr10:44,750,698...44,765,464
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Vitamin K 3 results in increased expression of MET mRNA
CTD
PMID:25270620
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Metap1
methionyl aminopeptidase 1
affects expression
ISO
Vitamin K 3 affects the expression of METAP1 mRNA
CTD
PMID:20044591
NCBI chr 2:226,991,305...227,024,360
Ensembl chr 2:226,991,301...227,024,434
G
Mex3d
mex-3 RNA binding family member D
affects expression
ISO
Vitamin K 3 affects the expression of MEX3D mRNA
CTD
PMID:20044591
NCBI chr 7:9,325,575...9,332,705
Ensembl chr 7:9,325,488...9,332,096
G
Mff
mitochondrial fission factor
affects expression
ISO
Vitamin K 3 affects the expression of MFF mRNA
CTD
PMID:20044591
NCBI chr 9:84,007,798...84,036,039
Ensembl chr 9:84,007,798...84,036,039
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
affects expression
ISO
Vitamin K 3 affects the expression of MFGE8 mRNA
CTD
PMID:20044591
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mfsd1
major facilitator superfamily domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of MFSD1 mRNA
CTD
PMID:20044591
NCBI chr 2:151,846,130...151,866,168
Ensembl chr 2:151,846,146...151,867,045
G
Mfsd5
major facilitator superfamily domain containing 5
affects expression
ISO
Vitamin K 3 affects the expression of MFSD5 mRNA
CTD
PMID:20044591
NCBI chr 7:133,409,096...133,411,377
Ensembl chr 7:133,402,537...133,411,396
G
Mia2
MIA SH3 domain ER export factor 2
increases expression
ISO
Vitamin K 3 results in increased expression of MIA2 mRNA
CTD
PMID:12414654
NCBI chr 6:76,787,508...76,885,246
Ensembl chr 6:76,787,508...76,885,211
G
Mical2
microtubule associated monooxygenase, calponin and LIM domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of MICAL2 mRNA
CTD
PMID:20044591
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
G
Mindy1
MINDY lysine 48 deubiquitinase 1
affects expression
ISO
Vitamin K 3 affects the expression of MINDY1 mRNA
CTD
PMID:20044591
NCBI chr 2:182,859,977...182,873,000
Ensembl chr 2:182,860,472...182,873,015
G
Mitd1
microtubule interacting and trafficking domain containing 1
increases expression
ISO
Vitamin K 3 results in increased expression of MITD1 mRNA
CTD
PMID:25270620
NCBI chr 9:40,113,943...40,125,280
Ensembl chr 9:40,113,946...40,125,289
G
Mixl1
Mix paired-like homeobox 1
affects expression
ISO
Vitamin K 3 affects the expression of MIXL1 mRNA
CTD
PMID:23410634
NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065
G
Mlxip
MLX interacting protein
affects expression
ISO
Vitamin K 3 affects the expression of MLXIP mRNA
CTD
PMID:20044591
NCBI chr12:33,128,524...33,192,300
Ensembl chr12:33,128,520...33,192,374
G
Mmd
monocyte to macrophage differentiation-associated
affects expression
ISO
Vitamin K 3 affects the expression of MMD mRNA
CTD
PMID:20044591
NCBI chr10:75,073,278...75,101,528
Ensembl chr10:75,073,365...75,101,528
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
Vitamin K 3 results in decreased expression of MMP2 protein
CTD
PMID:31238027
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases expression
ISO
Vitamin K 3 results in decreased expression of MMP9 protein
CTD
PMID:31238027
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mnt
MAX network transcriptional repressor
affects expression
ISO
Vitamin K 3 affects the expression of MNT mRNA
CTD
PMID:20044591
NCBI chr10:59,699,208...59,714,848
Ensembl chr10:59,699,585...59,714,835
G
Mogs
mannosyl-oligosaccharide glucosidase
affects expression
ISO
Vitamin K 3 affects the expression of MOGS mRNA
CTD
PMID:20044591
NCBI chr 4:115,621,623...115,625,026
Ensembl chr 4:115,621,623...115,625,032
G
Morc4
MORC family CW-type zinc finger 4
affects expression
ISO
Vitamin K 3 affects the expression of MORC4 mRNA
CTD
PMID:20044591
NCBI chr X:103,477,366...103,529,026
Ensembl chr X:103,480,603...103,528,956
G
Mosmo
modulator of smoothened
affects expression
ISO
Vitamin K 3 affects the expression of MOSMO mRNA
CTD
PMID:20044591
NCBI chr 1:175,217,680...175,288,521
Ensembl chr 1:175,217,545...175,288,334
G
Mpc2
mitochondrial pyruvate carrier 2
affects expression
ISO
Vitamin K 3 affects the expression of MPC2 mRNA
CTD
PMID:20044591
NCBI chr13:77,728,176...77,747,664
Ensembl chr13:77,728,250...77,747,664
G
Mpnd
MPN domain containing
affects expression
ISO
Vitamin K 3 affects the expression of MPND mRNA
CTD
PMID:20044591
NCBI chr 9:839,473...846,446
Ensembl chr 9:840,143...846,439
G
Mrnip
MRN complex interacting protein
affects expression
ISO
Vitamin K 3 affects the expression of MRNIP mRNA
CTD
PMID:20044591
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
G
Mrpl33
mitochondrial ribosomal protein L33
affects expression
ISO
Vitamin K 3 affects the expression of MRPL33 mRNA
CTD
PMID:20044591
NCBI chr 6:24,825,800...24,833,994
Ensembl chr 6:24,825,827...24,833,834
G
Mrpl38
mitochondrial ribosomal protein L38
increases expression
ISO
Vitamin K 3 results in increased expression of MRPL38 mRNA
CTD
PMID:25270620
NCBI chr10:101,365,353...101,372,159
Ensembl chr10:101,365,353...101,372,171
G
Mrps12
mitochondrial ribosomal protein S12
affects expression
ISO
Vitamin K 3 affects the expression of MRPS12 mRNA
CTD
PMID:20044591
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
G
Mrs2
magnesium transporter MRS2
affects expression
ISO
Vitamin K 3 affects the expression of MRS2 mRNA
CTD
PMID:20044591
NCBI chr17:40,063,924...40,087,073
Ensembl chr17:40,063,962...40,081,887
G
Msh2
mutS homolog 2
affects expression multiple interactions
ISO
Vitamin K 3 affects the expression of MSH2 mRNA MSH2 protein inhibits the reaction [POLK protein results in decreased susceptibility to Vitamin K 3]
CTD
PMID:20044591 PMID:31294882
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
G
Msh6
mutS homolog 6
affects expression
ISO
Vitamin K 3 affects the expression of MSH6 mRNA
CTD
PMID:20044591
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
G
Msmb
microseminoprotein, beta
affects expression
ISO
Vitamin K 3 affects the expression of MSMB mRNA
CTD
PMID:20044591
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
G
Msrb2
methionine sulfoxide reductase B2
affects expression
ISO
Vitamin K 3 affects the expression of MSRB2 mRNA
CTD
PMID:20044591
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
G
Mt1
metallothionein 1
increases expression
ISO
Vitamin K 3 results in increased expression of MT1 mRNA
CTD
PMID:25270620
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt1-ps3
metallothionein 1, pseudogene 3
affects expression
ISO
Vitamin K 3 affects the expression of MT1E mRNA
CTD
PMID:20044591
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
G
Mt2A
metallothionein 2A
increases expression
ISO
Vitamin K 3 results in increased expression of MT2A mRNA
CTD
PMID:12414654
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mta2
metastasis associated 1 family, member 2
affects expression
ISO
Vitamin K 3 affects the expression of MTA2 mRNA
CTD
PMID:20044591
NCBI chr 1:205,838,181...205,846,903
Ensembl chr 1:205,837,964...205,846,946
G
Mtarc1
mitochondrial amidoxime reducing component 1
affects expression
ISO
Vitamin K 3 affects the expression of MTARC1 mRNA
CTD
PMID:23410634
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mthfd1
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
affects expression
ISO
Vitamin K 3 affects the expression of MTHFD1 mRNA
CTD
PMID:20044591
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
G
Mxd1
max dimerization protein 1
affects expression
ISO
Vitamin K 3 affects the expression of MXD1 mRNA
CTD
PMID:20044591
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myadm
myeloid-associated differentiation marker
affects expression
ISO
Vitamin K 3 affects the expression of MYADM mRNA
CTD
PMID:20044591
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression affects expression
ISO
Vitamin K 3 results in decreased expression of MYC Vitamin K 3 affects the expression of MYC mRNA
CTD
PMID:10231603 PMID:20044591
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myl6
myosin light chain 6
affects expression
ISO
Vitamin K 3 affects the expression of MYL6 mRNA
CTD
PMID:20044591
NCBI chr 7:910,764...914,062
Ensembl chr 7:910,774...933,791
G
Mylk
myosin light chain kinase
affects expression
ISO
Vitamin K 3 affects the expression of MYLK mRNA
CTD
PMID:23410634
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Myo10
myosin X
affects expression
ISO
Vitamin K 3 affects the expression of MYO10 mRNA
CTD
PMID:20044591
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
G
Myo19
myosin XIX
affects expression
ISO
Vitamin K 3 affects the expression of MYO19 mRNA
CTD
PMID:20044591
NCBI chr10:69,753,082...69,782,450
Ensembl chr10:69,753,068...69,782,450
G
Myrf
myelin regulatory factor
affects expression
ISO
Vitamin K 3 affects the expression of MYRF mRNA
CTD
PMID:20044591
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
G
N4bp3
Nedd4 binding protein 3
affects expression
ISO
Vitamin K 3 affects the expression of N4BP3 mRNA
CTD
PMID:20044591
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
G
Nab1
Ngfi-A binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of NAB1 mRNA
CTD
PMID:20044591
NCBI chr 9:49,053,579...49,093,078
Ensembl chr 9:49,053,758...49,092,098
G
Nabp1
nucleic acid binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of NABP1 mRNA
CTD
PMID:20044591
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
Nacc2
NACC family member 2
affects expression
ISO
Vitamin K 3 affects the expression of NACC2 mRNA
CTD
PMID:20044591
NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:8,883,065...8,946,660
G
Naglu
N-acetyl-alpha-glucosaminidase
affects expression
ISO
Vitamin K 3 affects the expression of NAGLU mRNA
CTD
PMID:20044591
NCBI chr10:86,001,545...86,009,049
Ensembl chr10:86,001,566...86,008,972
G
Ncapg
non-SMC condensin I complex, subunit G
affects expression
ISO
Vitamin K 3 affects the expression of NCAPG mRNA
CTD
PMID:20044591
NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
G
Ncaph
non-SMC condensin I complex, subunit H
affects expression
ISO
Vitamin K 3 affects the expression of NCAPH mRNA
CTD
PMID:20044591
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
G
Ncf1
neutrophil cytosolic factor 1
increases expression
ISO
Vitamin K 3 results in increased expression of NCF1 mRNA; Vitamin K 3 results in increased expression of NCF1 protein
CTD
PMID:16507596 PMID:25270620
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf2
neutrophil cytosolic factor 2
increases expression
ISO
Vitamin K 3 results in increased expression of NCF2 protein
CTD
PMID:16507596
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Ncor2
nuclear receptor co-repressor 2
affects expression
ISO
Vitamin K 3 affects the expression of NCOR2 mRNA
CTD
PMID:20044591
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Ncs1
neuronal calcium sensor 1
affects expression
ISO
Vitamin K 3 affects the expression of FREQ mRNA
CTD
PMID:20044591
NCBI chr 3:14,523,220...14,568,829
Ensembl chr 3:14,523,220...14,568,829
G
Ncstn
nicastrin
affects expression
ISO
Vitamin K 3 affects the expression of NCSTN mRNA
CTD
PMID:20044591
NCBI chr13:84,530,442...84,546,454
Ensembl chr13:84,530,440...84,546,454
G
Ndc1
NDC1 transmembrane nucleoporin
affects expression
ISO
Vitamin K 3 affects the expression of NDC1 mRNA
CTD
PMID:20044591
NCBI chr 5:122,155,992...122,202,295
Ensembl chr 5:122,155,967...122,202,291
G
Ndc80
NDC80 kinetochore complex component
affects expression
ISO
Vitamin K 3 affects the expression of NDC80 mRNA
CTD
PMID:23410634
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Nde1
nudE neurodevelopment protein 1
affects expression
ISO
Vitamin K 3 affects the expression of NDE1 mRNA
CTD
PMID:20044591
NCBI chr10:839,788...883,946
Ensembl chr10:839,788...883,869
G
Ndrg1
N-myc downstream regulated 1
affects expression
ISO
Vitamin K 3 affects the expression of NDRG1 mRNA
CTD
PMID:20044591
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndufb1
NADH:ubiquinone oxidoreductase subunit B1
affects expression
ISO
Vitamin K 3 affects the expression of NDUFB1 mRNA
CTD
PMID:20044591
NCBI chr 6:121,115,649...121,124,055
G
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
affects expression
ISO
Vitamin K 3 affects the expression of NDUFS2 mRNA
CTD
PMID:20044591
NCBI chr13:83,654,402...83,671,474
Ensembl chr13:83,654,406...83,671,420
G
Necap1
NECAP endocytosis associated 1
affects expression
ISO
Vitamin K 3 affects the expression of NECAP1 mRNA
CTD
PMID:23410634
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
G
Neo1
neogenin 1
affects expression
ISO
Vitamin K 3 affects the expression of NEO1 mRNA
CTD
PMID:20044591
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
G
Net1
neuroepithelial cell transforming 1
affects expression
ISO
Vitamin K 3 affects the expression of NET1 mRNA
CTD
PMID:20044591
NCBI chr17:66,341,251...66,370,445
Ensembl chr17:66,340,728...66,370,441
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
affects expression
ISO
Vitamin K 3 affects the expression of NF2 mRNA
CTD
PMID:20044591
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases expression affects response to substance affects expression
ISO
[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to Vitamin K 3 Vitamin K 3 results in increased expression of NFE2L2 mRNA [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Vitamin K 3 Vitamin K 3 affects the expression of NFE2L2 mRNA NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Vitamin K 3]
CTD
PMID:19303893 PMID:19608619 PMID:20044591 PMID:20932822 PMID:23410634 PMID:26862668 More...
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfe2l3
NFE2 like bZIP transcription factor 3
affects expression
ISO
Vitamin K 3 affects the expression of NFE2L3 mRNA
CTD
PMID:20044591
NCBI chr 4:80,506,756...80,534,629
Ensembl chr 4:80,506,756...80,534,629
G
Nfkb1
nuclear factor kappa B subunit 1
affects expression multiple interactions
ISO
Vitamin K 3 affects the expression of NFKB1 mRNA Vitamin K 3 inhibits the reaction [Nicotine results in increased activity of NFKB1 protein]
CTD
PMID:16598845 PMID:20044591
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
affects expression
ISO
Vitamin K 3 affects the expression of NFKBIA mRNA
CTD
PMID:23410634
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbie
NFKB inhibitor epsilon
affects expression
ISO
Vitamin K 3 affects the expression of NFKBIE mRNA
CTD
PMID:20044591
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfs1
NFS1 cysteine desulfurase
affects expression
ISO
Vitamin K 3 affects the expression of NFS1 mRNA
CTD
PMID:20044591
NCBI chr 3:144,637,309...144,659,660
Ensembl chr 3:144,637,309...144,659,666
G
Nif3l1
NGG1 interacting factor 3 like 1
affects expression
ISO
Vitamin K 3 affects the expression of NIF3L1 mRNA
CTD
PMID:20044591
NCBI chr 9:59,980,101...60,001,490
Ensembl chr 9:59,979,799...60,000,131
G
Nkd1
NKD inhibitor of WNT signaling pathway 1
affects expression
ISO
Vitamin K 3 affects the expression of NKD1 mRNA
CTD
PMID:23410634
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
G
Nmb
neuromedin B
affects expression
ISO
Vitamin K 3 affects the expression of NMB mRNA
CTD
PMID:20044591
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
G
Nmd3
NMD3 ribosome export adaptor
affects expression
ISO
Vitamin K 3 affects the expression of NMD3 mRNA
CTD
PMID:23410634
NCBI chr 2:154,012,973...154,038,466
Ensembl chr 2:154,013,020...154,039,259
G
Noa1
nitric oxide associated 1
affects expression
ISO
Vitamin K 3 affects the expression of NOA1 mRNA
CTD
PMID:20044591
NCBI chr14:30,835,264...30,851,294
Ensembl chr14:30,835,247...30,851,293
G
Nol7
nucleolar protein 7
affects expression
ISO
Vitamin K 3 affects the expression of NOL7 mRNA
CTD
PMID:20044591
NCBI chr17:21,303,650...21,306,924
Ensembl chr17:21,302,624...21,307,431
G
Nolc1
nucleolar and coiled-body phosphoprotein 1
affects expression
ISO
Vitamin K 3 affects the expression of NOLC1 mRNA
CTD
PMID:20044591
NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088
G
Nop16
NOP16 nucleolar protein
affects expression
ISO
Vitamin K 3 affects the expression of NOP16 mRNA
CTD
PMID:20044591
NCBI chr17:10,022,950...10,027,867
Ensembl chr17:10,022,932...10,027,867
G
Nop56
NOP56 ribonucleoprotein
affects expression
ISO
Vitamin K 3 affects the expression of NOP56 mRNA
CTD
PMID:20044591
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
G
Nop58
NOP58 ribonucleoprotein
affects expression
ISO
Vitamin K 3 affects the expression of NOP58 mRNA
CTD
PMID:20044591
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
G
Nos3
nitric oxide synthase 3
decreases activity
EXP
Vitamin K 3 results in decreased activity of NOS3 protein
CTD
PMID:11551532
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nostrin
nitric oxide synthase trafficking
affects expression
ISO
Vitamin K 3 affects the expression of NOSTRIN mRNA
CTD
PMID:20044591
NCBI chr 3:53,904,746...53,970,995
Ensembl chr 3:53,904,827...53,970,988
G
Nox1
NADPH oxidase 1
increases expression
ISO
Vitamin K 3 results in increased expression of NOX1 mRNA; Vitamin K 3 results in increased expression of NOX1 protein
CTD
PMID:16507596
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
G
Nox4
NADPH oxidase 4
increases expression
ISO
Vitamin K 3 results in increased expression of NOX4 mRNA; Vitamin K 3 results in increased expression of NOX4 protein
CTD
PMID:16507596
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Npepps
aminopeptidase puromycin sensitive
affects expression
ISO
Vitamin K 3 affects the expression of NPEPPS mRNA
CTD
PMID:20044591
NCBI chr10:82,191,454...82,273,967
Ensembl chr10:82,191,456...82,273,967
G
Nprl3
NPR3-like, GATOR1 complex subunit
affects expression
ISO
Vitamin K 3 affects the expression of NPRL3 mRNA
CTD
PMID:20044591
NCBI chr10:15,355,361...15,395,812
Ensembl chr10:15,355,355...15,395,810
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions increases response to substance
ISO EXP
Vitamin K 3 results in increased expression of NQO1 mRNA NQO1 gene mutant form promotes the reaction [Vitamin K 3 results in increased chemical synthesis of Hydrogen Peroxide] Dicumarol inhibits the reaction [NQO1 protein inhibits the reaction [Vitamin K 3 results in increased chemical synthesis of Hydrogen Peroxide]]; NAD promotes the reaction [NQO1 protein results in increased reduction of Vitamin K 3]; NADP promotes the reaction [NQO1 protein results in increased reduction of Vitamin K 3]; NQO1 protein inhibits the reaction [Vitamin K 3 results in increased chemical synthesis of Hydrogen Peroxide] NQO1 gene mutant form results in increased susceptibility to Vitamin K 3
CTD
PMID:12414654 PMID:21859103 PMID:22846377 PMID:25270620 PMID:27558805
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
increases activity increases reduction decreases response to substance affects response to substance multiple interactions
ISO
NQO2 protein results in increased activity of Vitamin K 3 NQO2 protein results in increased reduction of Vitamin K 3 NQO2 gene mutant form results in decreased susceptibility to Vitamin K 3 NQO2 affects the susceptibility to Vitamin K 3 [NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3; [NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3; Amodiaquine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; chrysoeriol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Clozapine inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; Mefenamic Acid inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; Melatonin inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; N-(2-(2-methoxy-6H-dipyrido(2,3-a-3,2-e)pyrrolizin-11-yl)ethyl)-2-furamide inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of 1-benzyl-1,4-dihydronicotinamide] which results in increased reduction of Vitamin K 3]; Resveratrol inhibits the reaction [[NQO2 protein results in increased oxidation of nicotinamide-beta-riboside] which results in increased reduction of Vitamin K 3]; Resveratrol inhibits the reaction [NQO2 protein results in increased reduction of Vitamin K 3]
CTD
PMID:12351651 PMID:17762829 PMID:20399199 PMID:21859103 PMID:29281794
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
affects expression
ISO
Vitamin K 3 affects the expression of NR0B2 mRNA
CTD
PMID:23410634
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
affects expression
ISO
Vitamin K 3 affects the expression of NR1H4 mRNA
CTD
PMID:23410634
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
affects expression
ISO
Vitamin K 3 affects the expression of NR2F2 mRNA
CTD
PMID:20044591
NCBI chr 1:124,008,282...124,022,521
Ensembl chr 1:124,009,181...124,022,031
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
Vitamin K 3 affects the expression of NR3C1 mRNA
CTD
PMID:23410634
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
affects expression increases expression
ISO
Vitamin K 3 affects the expression of NR4A1 mRNA Vitamin K 3 results in increased expression of NR4A1 mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nsmce4a
NSE4 homolog A, SMC5-SMC6 complex component
affects expression
ISO
Vitamin K 3 affects the expression of NSMCE4A mRNA
CTD
PMID:20044591
NCBI chr 1:185,102,075...185,109,166
Ensembl chr 1:185,094,360...185,109,166
G
Nsun2
NOP2/Sun RNA methyltransferase 2
affects expression
ISO
Vitamin K 3 affects the expression of NSUN2 mRNA
CTD
PMID:20044591
NCBI chr 1:33,662,139...33,685,887
Ensembl chr 1:33,662,139...33,685,862
G
Ntf3
neurotrophin 3
affects expression
ISO
Vitamin K 3 affects the expression of NTF3 mRNA
CTD
PMID:20044591
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
increases phosphorylation
ISO
Vitamin K 3 analog results in increased phosphorylation of NTRK1 protein
CTD
PMID:19273458
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
G
Nudcd2
NudC domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of NUDCD2 mRNA
CTD
PMID:20044591
NCBI chr10:25,163,247...25,168,738
Ensembl chr10:25,163,220...25,168,738
G
Nudt22
nudix hydrolase 22
affects expression
ISO
Vitamin K 3 affects the expression of NUDT22 mRNA
CTD
PMID:20044591
NCBI chr 1:204,182,797...204,186,421
Ensembl chr 1:204,182,802...204,186,280
G
Nudt6
nudix hydrolase 6
affects expression
ISO
Vitamin K 3 affects the expression of NUDT6 mRNA
CTD
PMID:23410634
NCBI chr 2:120,289,908...120,306,197
Ensembl chr 2:120,290,847...120,306,230
G
Numb
NUMB, endocytic adaptor protein
decreases expression
ISO
Vitamin K 3 results in decreased expression of NUMB protein
CTD
PMID:25005833
NCBI chr 6:103,431,400...103,553,422
Ensembl chr 6:103,431,400...103,553,354
G
Nup107
nucleoporin 107
affects expression
ISO
Vitamin K 3 affects the expression of NUP107 mRNA
CTD
PMID:20044591
NCBI chr 7:53,353,740...53,398,345
Ensembl chr 7:53,353,743...53,398,370
G
Nup160
nucleoporin 160
affects expression
ISO
Vitamin K 3 affects the expression of NUP160 mRNA
CTD
PMID:20044591
NCBI chr 3:76,665,786...76,729,296
Ensembl chr 3:76,665,786...76,724,565
G
Oat
ornithine aminotransferase
affects expression
ISO
Vitamin K 3 affects the expression of OAT mRNA
CTD
PMID:20044591
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Oaz1
ornithine decarboxylase antizyme 1
affects expression
ISO
Vitamin K 3 affects the expression of OAZ1 mRNA
CTD
PMID:20044591
NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310
G
Ocel1
occludin/ELL domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of OCEL1 mRNA
CTD
PMID:20044591
NCBI chr16:18,042,037...18,045,080
Ensembl chr16:18,043,309...18,045,078
G
Odc1
ornithine decarboxylase 1
affects expression
ISO
Vitamin K 3 affects the expression of ODC1 mRNA
CTD
PMID:20044591
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Ogdhl
oxoglutarate dehydrogenase L
affects expression
ISO
Vitamin K 3 affects the expression of OGDHL mRNA
CTD
PMID:20044591
NCBI chr16:7,578,343...7,604,385
Ensembl chr16:7,578,367...7,604,386
G
Ogfod3
2-oxoglutarate and iron-dependent oxygenase domain containing 3
affects expression
ISO
Vitamin K 3 affects the expression of OGFOD3 mRNA
CTD
PMID:20044591
NCBI chr10:106,452,334...106,480,632
Ensembl chr10:106,452,329...106,480,134
G
Ogg1
8-oxoguanine DNA glycosylase
increases response to substance increases expression
ISO
OGG1 protein SNP results in increased susceptibility to Vitamin K 3 Vitamin K 3 results in increased expression of OGG1 mRNA
CTD
PMID:17651912 PMID:23410634
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
affects expression
ISO
Vitamin K 3 affects the expression of OGT mRNA
CTD
PMID:20044591
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Ormdl2
ORMDL sphingolipid biosynthesis regulator 2
affects expression
ISO
Vitamin K 3 affects the expression of ORMDL2 mRNA
CTD
PMID:20044591
NCBI chr 7:1,247,869...1,250,999
Ensembl chr 7:1,246,479...1,250,907
G
Oser1
oxidative stress responsive serine-rich 1
affects expression
ISO
Vitamin K 3 affects the expression of OSER1 mRNA
CTD
PMID:20044591
NCBI chr 3:152,066,975...152,085,180
Ensembl chr 3:152,066,975...152,085,149
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression affects expression
ISO
Vitamin K 3 results in increased expression of OSGIN1 mRNA Vitamin K 3 affects the expression of OSGIN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
Ovol1
ovo like transcriptional repressor 1
affects expression
ISO
Vitamin K 3 affects the expression of OVOL1 mRNA
CTD
PMID:20044591
NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831
G
Pabpc1
poly(A) binding protein, cytoplasmic 1
affects expression
ISO
Vitamin K 3 affects the expression of PABPC1 mRNA
CTD
PMID:20044591
NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
G
Paics
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase
affects expression
ISO
Vitamin K 3 affects the expression of PAICS mRNA
CTD
PMID:20044591
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
G
Palld
palladin, cytoskeletal associated protein
affects expression
ISO
Vitamin K 3 affects the expression of PALLD mRNA
CTD
PMID:23410634
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
G
Pam
peptidylglycine alpha-amidating monooxygenase
affects expression
ISO
Vitamin K 3 affects the expression of PAM mRNA
CTD
PMID:20044591
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Panx1
Pannexin 1
increases expression
ISO
Vitamin K 3 results in increased expression of PANX1 mRNA
CTD
PMID:25270620
NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:11,850,730...11,889,774
G
Parg
poly (ADP-ribose) glycohydrolase
multiple interactions affects response to substance
ISO
benzamide inhibits the reaction [PARG affects the susceptibility to Vitamin K 3]
CTD
PMID:15591342
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions affects response to substance
ISO
[sodium arsenite co-treated with Vitamin K 3] results in increased cleavage of PARP1 protein PARP1 protein affects the susceptibility to Vitamin K 3
CTD
PMID:19082730 PMID:21124846
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
affects expression
ISO
Vitamin K 3 affects the expression of PAWR mRNA
CTD
PMID:23410634
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Paxip1
PAX interacting protein 1
affects expression
ISO
Vitamin K 3 affects the expression of PAXIP1 mRNA
CTD
PMID:20044591
NCBI chr 4:7,525,132...7,576,659
Ensembl chr 4:7,525,004...7,576,548
G
Pcbp1
poly(rC) binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of PCBP1 mRNA
CTD
PMID:20044591
NCBI chr 4:118,972,698...118,974,705
Ensembl chr 4:118,972,661...118,976,500
G
Pcca
propionyl-CoA carboxylase subunit alpha
affects expression
ISO
Vitamin K 3 affects the expression of PCCA mRNA
CTD
PMID:20044591
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
G
Pck1
phosphoenolpyruvate carboxykinase 1
affects expression
ISO
Vitamin K 3 affects the expression of PCK1 mRNA
CTD
PMID:20044591
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pclaf
PCNA clamp associated factor
affects expression
ISO
Vitamin K 3 affects the expression of PCLAF mRNA
CTD
PMID:20044591
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcna
proliferating cell nuclear antigen
increases expression affects expression decreases expression multiple interactions
ISO
Vitamin K 3 results in increased expression of PCNA protein Vitamin K 3 affects the expression of PCNA mRNA Vitamin K 3 results in decreased expression of PCNA protein Alpha-Amanitin inhibits the reaction [Vitamin K 3 results in decreased expression of PCNA protein]; Cycloheximide inhibits the reaction [Vitamin K 3 results in decreased expression of PCNA protein]; Dactinomycin inhibits the reaction [Vitamin K 3 results in decreased expression of PCNA protein]
CTD
PMID:20044591 PMID:20829426 PMID:21533478
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcyox1l
prenylcysteine oxidase 1 like
affects expression
ISO
Vitamin K 3 affects the expression of PCYOX1L mRNA
CTD
PMID:20044591
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
G
Pdcd4
programmed cell death 4
affects expression
ISO
Vitamin K 3 affects the expression of PDCD4 mRNA
CTD
PMID:20044591
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdia5
protein disulfide isomerase family A, member 5
affects expression
ISO
Vitamin K 3 affects the expression of PDIA5 mRNA
CTD
PMID:20044591
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdpn
podoplanin
increases expression
ISO
Vitamin K 3 results in increased expression of PDPN mRNA
CTD
PMID:19675304
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
G
Pdrg1
p53 and DNA damage regulated 1
affects expression
ISO
Vitamin K 3 affects the expression of PDRG1 mRNA
CTD
PMID:20044591
NCBI chr 3:141,477,561...141,483,730
Ensembl chr 3:141,476,501...141,483,858 Ensembl chr 3:141,476,501...141,483,858
G
Pdxdc1
pyridoxal-dependent decarboxylase domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of PDXDC1 mRNA
CTD
PMID:20044591
NCBI chr10:2,025,056...2,113,712
Ensembl chr10:2,025,360...2,113,520
G
Pdzk1
PDZ domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of PDZK1 mRNA
CTD
PMID:20044591
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
G
Pepd
peptidase D
affects expression
ISO
Vitamin K 3 affects the expression of PEPD mRNA
CTD
PMID:20044591
NCBI chr 1:87,536,650...87,681,233
Ensembl chr 1:87,536,609...87,681,231
G
Per2
period circadian regulator 2
affects expression
ISO
Vitamin K 3 affects the expression of PER2 mRNA
CTD
PMID:20044591
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Perp
p53 apoptosis effector related to PMP22
increases expression
ISO
Vitamin K 3 results in increased expression of PERP mRNA
CTD
PMID:21382384
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
G
Pfkp
phosphofructokinase, platelet
decreases expression
ISO
Vitamin K 3 results in decreased expression of PFKP mRNA
CTD
PMID:25270620
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pgap6
post-GPI attachment to proteins 6
affects expression
ISO
Vitamin K 3 affects the expression of PGAP6 mRNA
CTD
PMID:20044591
NCBI chr10:15,138,918...15,148,431
Ensembl chr10:15,138,959...15,148,431
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
Vitamin K 3 results in increased expression of PGD mRNA
CTD
PMID:25270620
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pggt1b
protein geranylgeranyltransferase type I subunit beta
increases expression
ISO
Vitamin K 3 results in increased expression of PGGT1B mRNA
CTD
PMID:12414654
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
G
Pgk1
phosphoglycerate kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of PGK1 mRNA
CTD
PMID:20044591
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
G
Pgrmc1
progesterone receptor membrane component 1
increases expression
ISO
Vitamin K 3 results in increased expression of PGRMC1 mRNA
CTD
PMID:25270620
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
G
Phb1
prohibitin 1
affects expression
ISO
Vitamin K 3 affects the expression of PHB1 mRNA
CTD
PMID:20044591
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Phf10
PHD finger protein 10
affects expression
ISO
Vitamin K 3 affects the expression of PHF10 mRNA
CTD
PMID:20044591
NCBI chr 1:55,952,249...55,968,994
Ensembl chr 1:55,952,253...55,969,038
G
Phf21a
PHD finger protein 21A
decreases expression
ISO
Vitamin K 3 results in decreased expression of PHF21A mRNA
CTD
PMID:25270620
NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865
G
Phlda1
pleckstrin homology-like domain, family A, member 1
affects expression
ISO
Vitamin K 3 affects the expression of PHLDA1 mRNA
CTD
PMID:20044591
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phlda2
pleckstrin homology-like domain, family A, member 2
affects expression
ISO
Vitamin K 3 affects the expression of PHLDA2 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
G
Pik3c2b
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
affects expression
ISO
Vitamin K 3 affects the expression of PIK3C2B mRNA
CTD
PMID:20044591
NCBI chr13:44,494,673...44,555,663
Ensembl chr13:44,495,050...44,555,612
G
Pimreg
PICALM interacting mitotic regulator
affects expression
ISO
Vitamin K 3 affects the expression of PIMREG mRNA
CTD
PMID:20044591
NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791
G
Pitx2
paired-like homeodomain 2
affects expression
ISO
Vitamin K 3 affects the expression of PITX2 mRNA
CTD
PMID:20044591
NCBI chr 2:217,717,738...217,737,293
Ensembl chr 2:217,717,693...217,737,293
G
Pla2g12b
phospholipase A2, group XIIB
affects expression
ISO
Vitamin K 3 affects the expression of PLA2G12B mRNA
CTD
PMID:20044591
NCBI chr20:27,369,196...27,389,517
Ensembl chr20:27,370,266...27,388,743
G
Pla2g7
phospholipase A2 group VII
increases expression
ISO
Vitamin K 3 results in increased expression of PLA2G7 mRNA
CTD
PMID:25270620
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Pla2r1
phospholipase A2 receptor 1
increases expression
ISO
Vitamin K 3 results in increased expression of PLA2R1 mRNA
CTD
PMID:12414654
NCBI chr 3:44,883,943...45,013,793
Ensembl chr 3:44,883,943...45,013,660
G
Plagl2
PLAG1 like zinc finger 2
affects expression
ISO
Vitamin K 3 affects the expression of PLAGL2 mRNA
CTD
PMID:20044591
NCBI chr 3:141,695,322...141,708,516
Ensembl chr 3:141,695,322...141,708,503
G
Plbd1
phospholipase B domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of PLBD1 mRNA
CTD
PMID:20044591
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plce1
phospholipase C, epsilon 1
affects expression
ISO
Vitamin K 3 affects the expression of PLCE1 mRNA
CTD
PMID:20044591
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
G
Pld3
phospholipase D family, member 3
affects expression
ISO
Vitamin K 3 affects the expression of PLD3 mRNA
CTD
PMID:20044591
NCBI chr 1:82,821,863...82,844,280
Ensembl chr 1:82,821,875...82,844,072
G
Plekha1
pleckstrin homology domain containing A1
affects expression
ISO
Vitamin K 3 affects the expression of PLEKHA1 mRNA
CTD
PMID:20044591
NCBI chr 1:185,427,982...185,479,157
Ensembl chr 1:185,428,048...185,479,156
G
Plekha6
pleckstrin homology domain containing A6
affects expression
ISO
Vitamin K 3 affects the expression of PLEKHA6 mRNA
CTD
PMID:20044591
NCBI chr13:44,614,740...44,754,951
Ensembl chr13:44,615,011...44,754,673
G
Plekho1
pleckstrin homology domain containing O1
affects expression
ISO
Vitamin K 3 affects the expression of PLEKHO1 mRNA
CTD
PMID:23410634
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
G
Plekho2
pleckstrin homology domain containing O2
affects expression
ISO
Vitamin K 3 affects the expression of PLEKHO2 mRNA
CTD
PMID:20044591
NCBI chr 8:66,079,106...66,105,283
Ensembl chr 8:66,078,448...66,105,266
G
Plk1
polo-like kinase 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of PLK1 mRNA
CTD
PMID:12414654
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk3
polo-like kinase 3
affects expression
ISO
Vitamin K 3 affects the expression of PLK3 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plpp1
phospholipid phosphatase 1
affects expression
ISO
Vitamin K 3 affects the expression of PLPP1 mRNA
CTD
PMID:20044591
NCBI chr 2:44,439,002...44,500,430
Ensembl chr 2:44,438,994...44,501,268
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
affects expression
ISO
Vitamin K 3 affects the expression of PMAIP1 mRNA
CTD
PMID:23410634
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pmepa1
prostate transmembrane protein, androgen induced 1
affects expression
ISO
Vitamin K 3 affects the expression of PMEPA1 mRNA
CTD
PMID:20044591
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pmpcb
peptidase, mitochondrial processing subunit beta
affects expression
ISO
Vitamin K 3 affects the expression of PMPCB mRNA
CTD
PMID:20044591
NCBI chr 4:13,297,583...13,310,363
Ensembl chr 4:13,297,559...13,310,367
G
Pnn
pinin, desmosome associated protein
affects expression
ISO
Vitamin K 3 affects the expression of PNN mRNA
CTD
PMID:20044591
NCBI chr 6:76,758,138...76,766,451
Ensembl chr 6:76,758,117...76,766,889
G
Pnp
purine nucleoside phosphorylase
affects expression
ISO
Vitamin K 3 affects the expression of PNP mRNA
CTD
PMID:20044591
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Pnpt1
polyribonucleotide nucleotidyltransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of PNPT1 mRNA
CTD
PMID:20044591
NCBI chr14:102,877,553...102,908,696
Ensembl chr14:102,877,553...102,908,696
G
Podxl
podocalyxin-like
affects expression
ISO
Vitamin K 3 affects the expression of PODXL mRNA
CTD
PMID:20044591
NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899
G
Pold4
DNA polymerase delta 4, accessory subunit
affects expression
ISO
Vitamin K 3 affects the expression of POLD4 mRNA
CTD
PMID:23410634
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
G
Pole2
DNA polymerase epsilon 2, accessory subunit
decreases expression
ISO
Vitamin K 3 results in decreased expression of POLE2 mRNA
CTD
PMID:12414654
NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305
G
Polk
DNA polymerase kappa
multiple interactions
ISO
MSH2 protein inhibits the reaction [POLK protein results in decreased susceptibility to Vitamin K 3]
CTD
PMID:31294882
NCBI chr 2:27,822,228...27,882,331
Ensembl chr 2:27,822,679...27,882,313
G
Polr1c
RNA polymerase I and III subunit C
affects expression
ISO
Vitamin K 3 affects the expression of POLR1C mRNA
CTD
PMID:20044591
NCBI chr 9:14,735,740...14,739,852
Ensembl chr 9:14,735,714...14,739,852
G
Polr3e
RNA polymerase III subunit E
affects expression
ISO
Vitamin K 3 affects the expression of POLR3E mRNA
CTD
PMID:20044591
NCBI chr 1:175,466,091...175,494,679
Ensembl chr 1:175,466,127...175,494,667
G
Pon3
paraoxonase 3
affects expression
ISO
Vitamin K 3 affects the expression of PON3 mRNA
CTD
PMID:20044591
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
G
Pop7
POP7 homolog, ribonuclease P/MRP subunit
affects expression
ISO
Vitamin K 3 affects the expression of POP7 mRNA
CTD
PMID:20044591
NCBI chr12:19,189,384...19,190,425
Ensembl chr12:19,189,138...19,190,674
G
Por
cytochrome p450 oxidoreductase
increases expression multiple interactions
ISO EXP
Vitamin K 3 results in increased expression of POR mRNA NADP promotes the reaction [POR protein results in increased reduction of Vitamin K 3]; POR protein promotes the reaction [Vitamin K 3 results in increased chemical synthesis of Hydrogen Peroxide]
CTD
PMID:27558805
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Ppargc1b
PPARG coactivator 1 beta
affects expression
ISO
Vitamin K 3 affects the expression of PPARGC1B mRNA
CTD
PMID:20044591
NCBI chr18:54,758,891...54,861,103
Ensembl chr18:54,758,902...54,861,194
G
Ppcs
phosphopantothenoylcysteine synthetase
affects expression
ISO
Vitamin K 3 affects the expression of PPCS mRNA
CTD
PMID:20044591
NCBI chr 5:133,023,077...133,026,899
Ensembl chr 5:133,023,121...133,026,933
G
Ppdpf
pancreatic progenitor cell differentiation and proliferation factor
affects expression
ISO
Vitamin K 3 affects the expression of PPDPF mRNA
CTD
PMID:20044591
NCBI chr 3:168,299,309...168,301,040
Ensembl chr 3:168,299,791...168,301,036
G
Ppic
peptidylprolyl isomerase C
affects expression
ISO
Vitamin K 3 affects the expression of PPIC mRNA
CTD
PMID:20044591
NCBI chr18:46,842,410...46,855,016
Ensembl chr18:46,842,409...46,855,017
G
Ppif
peptidylprolyl isomerase F
affects expression
ISO
Vitamin K 3 affects the expression of PPIF mRNA
CTD
PMID:20044591
NCBI chr16:1,257,197...1,263,919
Ensembl chr16:1,257,106...1,263,913
G
Ppil1
peptidylprolyl isomerase like 1
affects expression
ISO
Vitamin K 3 affects the expression of PPIL1 mRNA
CTD
PMID:20044591
NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
Vitamin K 3 results in increased expression of PPM1D mRNA
CTD
PMID:12414654
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
affects expression
ISO
Vitamin K 3 affects the expression of PPP1R15A mRNA
CTD
PMID:20044591
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r16a
protein phosphatase 1, regulatory subunit 16A
affects expression
ISO
Vitamin K 3 affects the expression of PPP1R16A mRNA
CTD
PMID:20044591
NCBI chr 7:108,391,664...108,414,812
Ensembl chr 7:108,391,656...108,419,509
G
Ppp1r26
protein phosphatase 1, regulatory subunit 26
affects expression
ISO
Vitamin K 3 affects the expression of PPP1R26 mRNA
CTD
PMID:20044591
NCBI chr 3:11,781,504...11,790,076
Ensembl chr 3:11,781,295...11,790,073
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
affects expression
ISO
Vitamin K 3 affects the expression of PPP1R3C mRNA
CTD
PMID:23410634
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
affects expression
ISO
Vitamin K 3 affects the expression of PPP1R9A mRNA
CTD
PMID:20044591
NCBI chr 4:32,970,501...33,292,360
Ensembl chr 4:33,024,450...33,286,907
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
ISO
Vitamin K 3 results in increased expression of PPP2CB mRNA
CTD
PMID:12414654
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
affects expression
ISO
Vitamin K 3 affects the expression of PPP3CC mRNA
CTD
PMID:23410634
NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832
G
Pprc1
PPARG related coactivator 1
affects expression
ISO
Vitamin K 3 affects the expression of PPRC1 mRNA
CTD
PMID:20044591
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
G
Prdx1
peroxiredoxin 1
increases expression
ISO
Vitamin K 3 results in increased expression of PRDX1 mRNA
CTD
PMID:9506838
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prep
prolyl endopeptidase
affects expression
ISO
Vitamin K 3 affects the expression of PREP mRNA
CTD
PMID:20044591
NCBI chr20:48,556,211...48,653,165
Ensembl chr20:48,556,280...48,654,466
G
Prkab2
protein kinase AMP-activated non-catalytic subunit beta 2
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of PRKAB2 mRNA Vitamin K 3 results in decreased expression of PRKAB2 mRNA
CTD
PMID:20044591 PMID:25270620
NCBI chr 2:185,257,218...185,272,846
Ensembl chr 2:185,257,213...185,269,872
G
Prkg1
protein kinase cGMP-dependent 1
increases oxidation multiple interactions
EXP
Vitamin K 3 results in increased oxidation of PRKG1 protein Resveratrol promotes the reaction [Vitamin K 3 results in increased oxidation of PRKG1 protein]
CTD
PMID:31116951
NCBI chr 1:228,409,605...229,638,794
Ensembl chr 1:228,408,947...229,639,080
G
Prmt8
protein arginine methyltransferase 8
decreases expression
ISO
Vitamin K 3 results in decreased expression of PRMT8 mRNA
CTD
PMID:25270620
NCBI chr 4:160,535,813...160,618,193
Ensembl chr 4:160,535,813...160,617,930
G
Prss22
serine protease 22
affects expression
ISO
Vitamin K 3 affects the expression of PRSS22 mRNA
CTD
PMID:20044591
NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863
G
Psat1
phosphoserine aminotransferase 1
affects expression
ISO
Vitamin K 3 affects the expression of PSAT1 mRNA
CTD
PMID:20044591
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
G
Psma6
proteasome 20S subunit alpha 6
affects expression
ISO
Vitamin K 3 affects the expression of PSMA6 mRNA
CTD
PMID:20044591
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
G
Psmb3
proteasome 20S subunit beta 3
affects expression
ISO
Vitamin K 3 affects the expression of PSMB3 mRNA
CTD
PMID:20044591
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
Vitamin K 3 results in increased expression of PSMD12 mRNA
CTD
PMID:12414654
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
Psmg1
proteasome assembly chaperone 1
affects expression
ISO
Vitamin K 3 affects the expression of PSMG1 mRNA
CTD
PMID:20044591
NCBI chr11:35,276,080...35,285,541
Ensembl chr11:35,276,011...35,285,622
G
Psph
phosphoserine phosphatase
affects expression
ISO
Vitamin K 3 affects the expression of PSPH mRNA
CTD
PMID:20044591
NCBI chr12:26,882,524...26,905,084
Ensembl chr12:26,883,133...26,905,074
G
Ptcd3
Pentatricopeptide repeat domain 3
affects expression
ISO
Vitamin K 3 affects the expression of PTCD3 mRNA
CTD
PMID:20044591
NCBI chr 4:103,922,440...103,957,445
Ensembl chr 4:103,920,566...103,957,538
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
Vitamin K 3 results in increased expression of PTGR1 mRNA
CTD
PMID:23410634 PMID:25270620
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
affects expression
ISO
Vitamin K 3 affects the expression of PTPN11 mRNA
CTD
PMID:20044591
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
G
Ptpra
protein tyrosine phosphatase, receptor type, A
affects expression
ISO
Vitamin K 3 affects the expression of PTPRA mRNA
CTD
PMID:20044591
NCBI chr 3:117,650,146...117,759,744
Ensembl chr 3:117,650,183...117,759,728
G
Ptprm
protein tyrosine phosphatase, receptor type, M
affects expression
ISO
Vitamin K 3 affects the expression of PTPRM mRNA
CTD
PMID:20044591
NCBI chr 9:106,639,573...107,343,698
Ensembl chr 9:106,639,573...107,343,698
G
Ptrh1
peptidyl-tRNA hydrolase 1 homolog
affects expression
ISO
Vitamin K 3 affects the expression of PTRH1 mRNA
CTD
PMID:20044591
NCBI chr 3:16,064,867...16,071,098
Ensembl chr 3:16,064,880...16,070,648
G
Pudp
pseudouridine 5'-phosphatase
affects expression
ISO
Vitamin K 3 affects the expression of PUDP mRNA
CTD
PMID:20044591
NCBI chr18:43,878,374...43,880,756
Ensembl chr18:43,878,080...43,880,791
G
Puf60
poly-U binding splicing factor 60
affects expression
ISO
Vitamin K 3 affects the expression of PUF60 mRNA
CTD
PMID:20044591
NCBI chr 7:107,782,799...107,793,759
Ensembl chr 7:107,782,770...107,794,531
G
Pum3
pumilio RNA-binding family member 3
affects expression
ISO
Vitamin K 3 affects the expression of PUM3 mRNA
CTD
PMID:20044591
NCBI chr 1:225,074,332...225,113,995
Ensembl chr 1:225,074,333...225,114,025
G
Pura
purine rich element binding protein A
decreases expression
ISO
Vitamin K 3 results in decreased expression of PURA mRNA
CTD
PMID:25270620
NCBI chr18:27,885,071...27,905,509
Ensembl chr18:27,884,556...27,905,513
G
Pus7
pseudouridine synthase 7
affects expression
ISO
Vitamin K 3 affects the expression of PUS7 mRNA
CTD
PMID:20044591
NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172
G
Pxmp4
peroxisomal membrane protein 4
affects expression
ISO
Vitamin K 3 affects the expression of PXMP4 mRNA
CTD
PMID:20044591
NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651
G
Pxylp1
2-phosphoxylose phosphatase 1
affects expression
ISO
Vitamin K 3 affects the expression of PXYLP1 mRNA
CTD
PMID:20044591
NCBI chr 8:97,419,766...97,485,163
Ensembl chr 8:97,419,776...97,485,064
G
R3hdm2
R3H domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of R3HDM2 mRNA
CTD
PMID:20044591
NCBI chr 7:63,212,519...63,340,574
Ensembl chr 7:63,232,346...63,340,540
G
Rab11fip1
RAB11 family interacting protein 1
affects expression
ISO
Vitamin K 3 affects the expression of RAB11FIP1 mRNA
CTD
PMID:20044591
NCBI chr16:64,886,902...64,917,491
Ensembl chr16:64,884,676...64,917,491
G
Rab11fip4
RAB11 family interacting protein 4
affects expression
ISO
Vitamin K 3 affects the expression of RAB11FIP4 mRNA
CTD
PMID:20044591
NCBI chr10:64,550,109...64,658,123
Ensembl chr10:64,550,177...64,654,759
G
Rab3gap1
RAB3 GTPase activating protein catalytic subunit 1
affects expression
ISO
Vitamin K 3 affects the expression of RAB3GAP1 mRNA
CTD
PMID:20044591
NCBI chr13:39,355,698...39,429,154
Ensembl chr13:39,352,247...39,429,169
G
Rab5c
RAB5C, member RAS oncogene family
affects expression
ISO
Vitamin K 3 affects the expression of RAB5C mRNA
CTD
PMID:20044591
NCBI chr10:85,642,553...85,666,142
Ensembl chr10:85,642,809...85,666,103
G
Rack1
receptor for activated C kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of RACK1 mRNA
CTD
PMID:20044591
NCBI chr10:33,169,415...33,174,896
Ensembl chr10:33,169,169...33,174,975
G
Rad23b
RAD23 homolog B, nucleotide excision repair protein
affects expression
ISO
Vitamin K 3 affects the expression of RAD23B mRNA
CTD
PMID:20044591
NCBI chr 5:70,090,232...70,128,340
Ensembl chr 5:70,090,232...70,128,319
G
Rad51
RAD51 recombinase
affects expression
ISO
Vitamin K 3 affects the expression of RAD51 mRNA
CTD
PMID:20044591
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rai1
retinoic acid induced 1
affects expression
ISO
Vitamin K 3 affects the expression of RAI1 mRNA
CTD
PMID:20044591
NCBI chr10:44,913,231...45,008,232
Ensembl chr10:44,947,909...45,008,232
G
Ralgdsl1
ral guanine nucleotide dissociation stimulator like 1
affects expression
ISO
Vitamin K 3 affects the expression of RGL1 mRNA
CTD
PMID:20044591
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
G
Ramp1
receptor activity modifying protein 1
affects expression
ISO
Vitamin K 3 affects the expression of RAMP1 mRNA
CTD
PMID:20044591
NCBI chr 9:91,765,481...91,816,152
Ensembl chr 9:91,781,285...91,816,151
G
Ranbp1
RAN binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of RANBP1 mRNA
CTD
PMID:20044591
NCBI chr11:82,742,603...82,750,836
Ensembl chr11:82,742,600...82,750,838
G
Ranbp9
RAN binding protein 9
affects expression
ISO
Vitamin K 3 affects the expression of RANBP9 mRNA
CTD
PMID:23410634
NCBI chr17:21,220,807...21,303,009
Ensembl chr17:21,220,618...21,303,004
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
Vitamin K 3 results in increased expression of RAP1GAP mRNA
CTD
PMID:23410634
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rasd1
ras related dexamethasone induced 1
affects expression
ISO
Vitamin K 3 affects the expression of RASD1 mRNA
CTD
PMID:20044591
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rasl11a
RAS-like family 11 member A
affects expression
ISO
Vitamin K 3 affects the expression of RASL11A mRNA
CTD
PMID:20044591
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576
G
Rassf1
Ras association domain family member 1
affects expression
ISO
Vitamin K 3 affects the expression of RASSF1 mRNA
CTD
PMID:20044591
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
G
Rb1
RB transcriptional corepressor 1
increases expression
ISO
Vitamin K 3 results in increased expression of RB1 mRNA
CTD
PMID:16010434
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
affects expression
ISO
Vitamin K 3 affects the expression of RBBP4 mRNA
CTD
PMID:20829426
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284
G
Rbbp6
RB binding protein 6, ubiquitin ligase
affects expression
ISO
Vitamin K 3 affects the expression of RBBP6 mRNA
CTD
PMID:20044591
NCBI chr 1:177,503,988...177,537,397
Ensembl chr 1:177,503,313...177,535,678
G
Rbm17
RNA binding motif protein 17
affects expression
ISO
Vitamin K 3 affects the expression of RBM17 mRNA
CTD
PMID:20044591
NCBI chr17:66,937,140...66,954,034
Ensembl chr17:66,937,140...66,954,014
G
Rbms1
RNA binding motif, single stranded interacting protein 1
affects expression
ISO
Vitamin K 3 affects the expression of RBMS1 mRNA
CTD
PMID:20044591
NCBI chr 3:45,195,828...45,420,406
Ensembl chr 3:45,197,972...45,420,376
G
Rbmx
RNA binding motif protein, X-linked
affects expression
ISO
Vitamin K 3 affects the expression of RBMX mRNA
CTD
PMID:20044591
NCBI chr X:135,305,237...135,314,806
Ensembl chr X:135,305,325...135,314,743
G
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
decreases expression
ISO
Vitamin K 3 results in decreased expression of RBPJ mRNA
CTD
PMID:25270620
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
G
Rcan1
regulator of calcineurin 1
increases phosphorylation
ISO
Vitamin K 3 results in increased phosphorylation of RCAN1 protein
CTD
PMID:12927602
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rcn1
reticulocalbin 1
affects expression
ISO
Vitamin K 3 affects the expression of RCN1 mRNA
CTD
PMID:20044591
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rcor3
REST corepressor 3
affects expression
ISO
Vitamin K 3 affects the expression of RCOR3 mRNA
CTD
PMID:23410634
NCBI chr13:103,624,966...103,665,565
Ensembl chr13:103,624,971...103,665,565
G
Reep1
receptor accessory protein 1
affects expression
ISO
Vitamin K 3 affects the expression of REEP1 mRNA
CTD
PMID:20044591
NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338
G
Reep4
receptor accessory protein 4
affects expression
ISO
Vitamin K 3 affects the expression of REEP4 mRNA
CTD
PMID:23410634
NCBI chr15:45,620,317...45,623,524
Ensembl chr15:45,619,941...45,623,526
G
Reep6
receptor accessory protein 6
affects expression
ISO
Vitamin K 3 affects the expression of REEP6 mRNA
CTD
PMID:20044591
NCBI chr 7:9,373,927...9,380,845
Ensembl chr 7:9,373,927...9,380,597
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Vitamin K 3 inhibits the reaction [TNF protein affects the localization of RELA protein]
CTD
PMID:20030669
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
affects expression
ISO
Vitamin K 3 affects the expression of RELB mRNA
CTD
PMID:20044591
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Retreg1
reticulophagy regulator 1
affects expression
ISO
Vitamin K 3 affects the expression of RETREG1 mRNA
CTD
PMID:20044591
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
G
Retreg2
reticulophagy regulator family member 2
affects expression
ISO
Vitamin K 3 affects the expression of RETREG2 mRNA
CTD
PMID:20044591
NCBI chr 9:76,640,282...76,646,400
Ensembl chr 9:76,640,319...76,646,395
G
Rex1bd
required for excision 1-B domain containing
affects expression
ISO
Vitamin K 3 affects the expression of REX1BD mRNA
CTD
PMID:20044591
NCBI chr16:18,922,050...18,924,521
Ensembl chr16:18,922,037...18,924,526
G
Rexo2
RNA exonuclease 2
affects expression
ISO
Vitamin K 3 affects the expression of REXO2 mRNA
CTD
PMID:20044591
NCBI chr 8:48,811,900...48,823,622
Ensembl chr 8:48,811,900...48,823,622
G
Rfc4
replication factor C subunit 4
affects expression
ISO
Vitamin K 3 affects the expression of RFC4 mRNA
CTD
PMID:20044591
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
Rgcc
regulator of cell cycle
affects expression
ISO
Vitamin K 3 affects the expression of RGCC mRNA
CTD
PMID:20044591
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rgs16
regulator of G-protein signaling 16
affects expression
ISO
Vitamin K 3 affects the expression of RGS16 mRNA
CTD
PMID:20044591
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs3
regulator of G-protein signaling 3
affects expression
ISO
Vitamin K 3 affects the expression of RGS3 mRNA
CTD
PMID:23410634
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
G
Rhbdd3
rhomboid domain containing 3
affects expression
ISO
Vitamin K 3 affects the expression of RHBDD3 mRNA
CTD
PMID:20044591
NCBI chr14:79,994,111...80,000,294
Ensembl chr14:79,994,158...80,000,175
G
Rhbg
Rh family B glycoprotein
affects expression
ISO
Vitamin K 3 affects the expression of RHBG mRNA
CTD
PMID:20044591
NCBI chr 2:173,704,852...173,717,380
Ensembl chr 2:173,704,562...173,717,321
G
Rhoa
ras homolog family member A
multiple interactions decreases prenylation
ISO
tempol inhibits the reaction [Vitamin K 3 inhibits the reaction [RHOA protein binds to Guanosine Triphosphate]]; tempol inhibits the reaction [Vitamin K 3 results in decreased prenylation of RHOA protein]; Vitamin K 3 inhibits the reaction [RHOA protein binds to Guanosine Triphosphate]
CTD
PMID:21257924
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
Rhoc
ras homolog family member C
affects expression
ISO
Vitamin K 3 affects the expression of RHOC mRNA
CTD
PMID:20044591
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Ribc2
RIB43A domain with coiled-coils 2
affects expression
ISO
Vitamin K 3 affects the expression of RIBC2 mRNA
CTD
PMID:20044591
NCBI chr 7:116,242,863...116,257,868
Ensembl chr 7:116,242,863...116,257,863
G
Rictor
RPTOR independent companion of MTOR, complex 2
affects expression
ISO
Vitamin K 3 affects the expression of RICTOR mRNA
CTD
PMID:23410634
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
G
Rita1
RBPJ interacting and tubulin associated 1
affects expression
ISO
Vitamin K 3 affects the expression of RITA1 mRNA
CTD
PMID:20044591
NCBI chr12:35,950,090...35,953,960
Ensembl chr12:35,950,373...35,953,960
G
Rmi2
RecQ mediated genome instability 2
affects expression
ISO
Vitamin K 3 affects the expression of RMI2 mRNA
CTD
PMID:20044591
NCBI chr10:4,829,333...4,837,264
Ensembl chr10:4,830,553...4,837,235
G
Rnf114
ring finger protein 114
affects expression
ISO
Vitamin K 3 affects the expression of RNF114 mRNA
CTD
PMID:20044591
NCBI chr 3:156,222,487...156,234,263
Ensembl chr 3:156,222,498...156,234,256
G
Rnf122
ring finger protein 122
affects expression
ISO
Vitamin K 3 affects the expression of RNF122 mRNA
CTD
PMID:20044591
NCBI chr16:61,009,879...61,027,429
Ensembl chr16:61,009,879...61,027,448
G
Rnf128
ring finger protein 128
affects expression
ISO
Vitamin K 3 affects the expression of RNF128 mRNA
CTD
PMID:20044591
NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423
G
Rnf130
ring finger protein 130
affects expression
ISO
Vitamin K 3 affects the expression of RNF130 mRNA
CTD
PMID:20044591
NCBI chr10:34,342,835...34,456,048
Ensembl chr10:34,342,830...34,456,062
G
Rnf43
ring finger protein 43
affects expression
ISO
Vitamin K 3 affects the expression of RNF43 mRNA
CTD
PMID:20044591
NCBI chr10:72,461,508...72,537,301
Ensembl chr10:72,464,348...72,536,977
G
Rnf44
ring finger protein 44
affects expression
ISO
Vitamin K 3 affects the expression of RNF44 mRNA
CTD
PMID:20044591
NCBI chr17:9,919,982...9,934,376
Ensembl chr17:9,919,993...9,932,193
G
Rom1
retinal outer segment membrane protein 1
affects expression
ISO
Vitamin K 3 affects the expression of ROM1 mRNA
CTD
PMID:20044591
NCBI chr 1:205,824,050...205,826,058
Ensembl chr 1:205,824,052...205,826,175
G
Rpa1
replication protein A1
affects expression
ISO
Vitamin K 3 affects the expression of RPA1 mRNA
CTD
PMID:20044591
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpgr
retinitis pigmentosa GTPase regulator
affects expression
ISO
Vitamin K 3 affects the expression of RPGR mRNA
CTD
PMID:23410634
NCBI chr X:12,566,447...12,628,171
Ensembl chr X:12,566,645...12,747,882
G
Rpl27a
ribosomal protein L27A
affects expression
ISO
Vitamin K 3 affects the expression of RPL27A mRNA
CTD
PMID:23410634
NCBI chr 1:163,539,732...163,542,771
G
Rpp25l
ribonuclease P/MRP subunit p25 like
affects expression
ISO
Vitamin K 3 affects the expression of RPP25L mRNA
CTD
PMID:20044591
NCBI chr 5:56,878,420...56,879,956
Ensembl chr 5:56,876,316...56,880,013
G
Rps6ka3
ribosomal protein S6 kinase A3
affects expression
ISO
Vitamin K 3 affects the expression of RPS6KA3 mRNA
CTD
PMID:20044591
NCBI chr X:35,517,306...35,623,296
Ensembl chr X:35,517,306...35,623,207
G
Rptor
regulatory associated protein of MTOR, complex 1
affects expression
ISO
Vitamin K 3 affects the expression of RPTOR mRNA
CTD
PMID:20044591
NCBI chr10:104,878,487...105,176,986
Ensembl chr10:104,878,487...105,176,983
G
Rras2
RAS related 2
increases expression
ISO
Vitamin K 3 results in increased expression of RRAS2 mRNA
CTD
PMID:23410634
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rrbp1
ribosome binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of RRBP1 mRNA
CTD
PMID:20044591
NCBI chr 3:131,314,996...131,376,930
Ensembl chr 3:131,314,998...131,376,981
G
Rrm1
ribonucleotide reductase catalytic subunit M1
affects expression
ISO
Vitamin K 3 affects the expression of RRM1 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rsad1
radical S-adenosyl methionine domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of RSAD1 mRNA
CTD
PMID:20044591
NCBI chr10:79,485,253...79,499,616
Ensembl chr10:79,489,909...79,499,573
G
Rsrp1
arginine and serine rich protein 1
affects expression
ISO
Vitamin K 3 affects the expression of RSRP1 mRNA
CTD
PMID:20044591
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Vitamin K 3 affects the expression of HLA-E mRNA
CTD
PMID:20044591
NCBI chr20:4,870,939...4,910,183
G
RT1-Ba
RT1 class II, locus Ba
affects expression
ISO
Vitamin K 3 affects the expression of HLA-DQA1 mRNA
CTD
PMID:20829426
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
affects expression
ISO
Vitamin K 3 affects the expression of HLA-DQB1 mRNA
CTD
PMID:20829426
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
Rtl6
retrotransposon Gag like 6
affects expression
ISO
Vitamin K 3 affects the expression of RTL6 mRNA
CTD
PMID:20044591
NCBI chr 7:115,684,812...115,689,897
Ensembl chr 7:115,684,739...115,690,052
G
Rusf1
RUS family member 1
affects expression
ISO
Vitamin K 3 affects the expression of RUSF1 mRNA
CTD
PMID:20044591
NCBI chr 1:182,852,257...182,881,652
Ensembl chr 1:182,852,262...182,880,732
G
Rxra
retinoid X receptor alpha
affects expression
ISO
Vitamin K 3 affects the expression of RXRA mRNA
CTD
PMID:20044591
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Ryr1
ryanodine receptor 1
affects expression
ISO
Vitamin K 3 affects the expression of RYR1 mRNA
CTD
PMID:20044591
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
S100a6
S100 calcium binding protein A6
affects expression
ISO
Vitamin K 3 affects the expression of S100A6 mRNA
CTD
PMID:20044591
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
Sapcd2
suppressor APC domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of SAPCD2 mRNA
CTD
PMID:23410634
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sash1
SAM and SH3 domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of SASH1 mRNA
CTD
PMID:20044591
NCBI chr 1:3,119,915...3,418,536
Ensembl chr 1:3,121,332...3,439,870
G
Sc5d
sterol-C5-desaturase
affects expression
ISO
Vitamin K 3 affects the expression of SC5D mRNA
CTD
PMID:20044591
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
G
Scand1
SCAN domain-containing 1
affects expression
ISO
Vitamin K 3 affects the expression of SCAND1 mRNA
CTD
PMID:20044591
NCBI chr 3:144,818,615...144,819,479
Ensembl chr 3:144,818,611...144,820,025
G
Scap
SREBF chaperone
affects expression
ISO
Vitamin K 3 affects the expression of SCAP mRNA
CTD
PMID:20044591
NCBI chr 8:110,306,026...110,360,677
Ensembl chr 8:110,306,031...110,360,666
G
Scrn2
secernin 2
affects expression
ISO
Vitamin K 3 affects the expression of SCRN2 mRNA
CTD
PMID:20044591
NCBI chr10:82,016,604...82,020,676
Ensembl chr10:82,016,649...82,020,675
G
Sec14l4
SEC14-like lipid binding 4
increases expression
ISO
Vitamin K 3 results in increased expression of SEC14L4 mRNA
CTD
PMID:25270620
NCBI chr14:78,912,750...78,928,799
Ensembl chr14:78,912,750...78,956,099
G
Sec24b
SEC24 homolog B, COPII coat complex component
affects expression
ISO
Vitamin K 3 affects the expression of SEC24B mRNA
CTD
PMID:23410634
NCBI chr 2:218,562,670...218,632,753
Ensembl chr 2:218,562,676...218,632,699
G
Sec61g
Sec61 translocon subunit gamma
affects expression
ISO
Vitamin K 3 affects the expression of SEC61G mRNA
CTD
PMID:20044591
NCBI chr14:90,899,766...90,906,143
Ensembl chr14:90,899,768...90,906,162
G
Sec63
SEC63 homolog, protein translocation regulator
affects expression
ISO
Vitamin K 3 affects the expression of SEC63 mRNA
CTD
PMID:20044591
NCBI chr20:46,245,101...46,314,055
Ensembl chr20:46,245,101...46,314,055
G
Seh1l
SEH1-like nucleoporin
affects expression
ISO
Vitamin K 3 affects the expression of SEH1L mRNA
CTD
PMID:20044591
NCBI chr18:61,346,986...61,369,987
G
Selenop
selenoprotein P
affects expression
ISO
Vitamin K 3 affects the expression of SELENOP mRNA
CTD
PMID:20044591
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Selenos
selenoprotein S
affects expression
ISO
Vitamin K 3 affects the expression of SELENOS mRNA
CTD
PMID:20044591
NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:119,659,751...119,669,833
G
Selenow
selenoprotein W
affects expression
ISO
Vitamin K 3 affects the expression of SELENOW mRNA
CTD
PMID:20044591
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sema4g
semaphorin 4G
affects expression
ISO
Vitamin K 3 affects the expression of SEMA4G mRNA
CTD
PMID:20044591
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
G
Sema6a
semaphorin 6A
affects expression
ISO
Vitamin K 3 affects the expression of SEMA6A mRNA
CTD
PMID:20044591
NCBI chr18:40,050,623...40,171,954
Ensembl chr18:40,050,624...40,171,954
G
Sephs2
selenophosphate synthetase 2
affects expression
ISO
Vitamin K 3 affects the expression of SEPHS2 mRNA
CTD
PMID:20044591
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
G
Serbp1
Serpine1 mRNA binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of SERBP1 mRNA
CTD
PMID:20044591
NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813
G
Serpinb1a
serpin family B member 1A
affects expression
ISO
Vitamin K 3 affects the expression of SERPINB1 mRNA
CTD
PMID:20044591
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Serpinb5
serpin family B member 5
increases expression
ISO
Vitamin K 3 results in increased expression of SERPINB5 mRNA
CTD
PMID:12414654
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Setd6
SET domain containing 6, protein lysine methyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of SETD6 mRNA
CTD
PMID:20044591
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
G
Sgk2
serum/glucocorticoid regulated kinase 2
affects expression
ISO
Vitamin K 3 affects the expression of SGK2 mRNA
CTD
PMID:23410634
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Sh2d5
SH2 domain containing 5
affects expression
ISO
Vitamin K 3 affects the expression of SH2D5 mRNA
CTD
PMID:23410634
NCBI chr 5:150,469,738...150,480,615
Ensembl chr 5:150,467,728...150,479,955
G
Sh3bgrl3
SH3 domain binding glutamate-rich protein like 3
affects expression
ISO
Vitamin K 3 affects the expression of SH3BGRL3 mRNA
CTD
PMID:20044591
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
G
Sh3pxd2a
SH3 and PX domains 2A
affects expression
ISO
Vitamin K 3 affects the expression of SH3PXD2A mRNA
CTD
PMID:20044591
NCBI chr 1:246,153,660...246,359,806
Ensembl chr 1:246,160,502...246,360,166
G
Sh3rf1
SH3 domain containing ring finger 1
increases expression
ISO
Vitamin K 3 results in increased expression of SH3RF1 mRNA
CTD
PMID:25270620
NCBI chr16:28,735,522...28,901,261
Ensembl chr16:28,735,440...28,901,644
G
Sh3yl1
SH3 and SYLF domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of SH3YL1 mRNA
CTD
PMID:20044591
NCBI chr 6:47,522,098...47,565,858
Ensembl chr 6:47,522,091...47,565,858
G
Shank2
SH3 and multiple ankyrin repeat domains 2
affects expression
ISO
Vitamin K 3 affects the expression of SHANK2 mRNA
CTD
PMID:20044591
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
G
Siah1
siah E3 ubiquitin protein ligase 1
affects expression
ISO
Vitamin K 3 affects the expression of SIAH1 mRNA
CTD
PMID:23410634
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Sidt2
SID1 transmembrane family, member 2
affects expression
ISO
Vitamin K 3 affects the expression of SIDT2 mRNA
CTD
PMID:20044591
NCBI chr 8:46,232,379...46,248,913
Ensembl chr 8:46,232,383...46,248,700
G
Sik1
salt-inducible kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of SIK1 mRNA
CTD
PMID:20044591
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Sinhcaf
SIN3-HDAC complex associated factor
affects expression
ISO
Vitamin K 3 affects the expression of SINHCAF mRNA
CTD
PMID:20044591
NCBI chr 4:181,888,301...181,913,294
Ensembl chr 4:181,888,312...181,910,276
G
Sirpa
signal-regulatory protein alpha
affects expression
ISO
Vitamin K 3 affects the expression of SIRPA mRNA
CTD
PMID:20044591
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
G
Sirt1
sirtuin 1
multiple interactions
ISO
[[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]; Vitamin K 3 inhibits the reaction [sodium arsenite promotes the reaction [ELAVL1 protein binds to and results in decreased degradation of SIRT1 mRNA]]; Vitamin K 3 inhibits the reaction [sodium arsenite results in decreased degradation of SIRT1 mRNA]
CTD
PMID:24106086
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Ska3
spindle and kinetochore associated complex subunit 3
affects expression
ISO
Vitamin K 3 affects the expression of SKA3 mRNA
CTD
PMID:23410634
NCBI chr15:31,951,812...31,971,010
Ensembl chr15:31,951,825...31,971,010
G
Skil
SKI-like proto-oncogene
decreases expression
ISO
Vitamin K 3 results in decreased expression of SKIL mRNA
CTD
PMID:25270620
NCBI chr 2:112,247,047...112,275,176
Ensembl chr 2:112,247,051...112,275,080
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression
ISO
Vitamin K 3 results in increased expression of SLAMF1 mRNA
CTD
PMID:12414654
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
G
Slbp
stem-loop histone mRNA binding protein
affects expression
ISO
Vitamin K 3 affects the expression of SLBP mRNA
CTD
PMID:20044591
NCBI chr14:77,071,441...77,081,911
Ensembl chr14:77,071,632...77,081,906
G
Slc10a3
solute carrier family 10, member 3
affects expression
ISO
Vitamin K 3 affects the expression of SLC10A3 mRNA
CTD
PMID:20044591
NCBI chr X:152,154,757...152,158,563
Ensembl chr X:152,151,076...152,162,958
G
Slc12a7
solute carrier family 12 member 7
affects expression
ISO
Vitamin K 3 affects the expression of SLC12A7 mRNA
CTD
PMID:20044591
NCBI chr 1:29,472,692...29,554,246
Ensembl chr 1:29,472,692...29,554,302
G
Slc12a9
solute carrier family 12, member 9
affects expression
ISO
Vitamin K 3 affects the expression of SLC12A9 mRNA
CTD
PMID:20044591
NCBI chr12:19,368,990...19,385,881
Ensembl chr12:19,369,004...19,385,877
G
Slc15a4
solute carrier family 15 member 4
affects expression
ISO
Vitamin K 3 affects the expression of SLC15A4 mRNA
CTD
PMID:20044591
NCBI chr12:29,048,634...29,082,480
Ensembl chr12:29,063,015...29,082,480
G
Slc16a3
solute carrier family 16 member 3
affects expression
ISO
Vitamin K 3 affects the expression of SLC16A3 mRNA
CTD
PMID:20044591
NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
G
Slc17a2
solute carrier family 17, member 2
affects expression
ISO
Vitamin K 3 affects the expression of SLC17A2 mRNA
CTD
PMID:23410634
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc19a3
solute carrier family 19 member 3
affects expression
ISO
Vitamin K 3 affects the expression of SLC19A3 mRNA
CTD
PMID:20044591
NCBI chr 9:84,275,722...84,299,368
Ensembl chr 9:84,277,024...84,299,337
G
Slc1a1
solute carrier family 1 member 1
affects expression
ISO
Vitamin K 3 affects the expression of SLC1A1 mRNA
CTD
PMID:20044591
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc20a1
solute carrier family 20 member 1
affects expression
ISO
Vitamin K 3 affects the expression of SLC20A1 mRNA
CTD
PMID:20044591
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc20a2
solute carrier family 20 member 2
affects expression
ISO
Vitamin K 3 affects the expression of SLC20A2 mRNA
CTD
PMID:20044591
NCBI chr16:69,460,850...69,551,418
Ensembl chr16:69,460,462...69,521,711
G
Slc22a23
solute carrier family 22, member 23
affects expression
ISO
Vitamin K 3 affects the expression of SLC22A23 mRNA
CTD
PMID:20044591
NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790
G
Slc22a3
solute carrier family 22 member 3
affects expression
ISO
Vitamin K 3 affects the expression of SLC22A3 mRNA
CTD
PMID:23410634
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc25a3
solute carrier family 25 member 3
affects expression
ISO
Vitamin K 3 affects the expression of SLC25A3 mRNA
CTD
PMID:20044591
NCBI chr 7:25,611,937...25,619,401
Ensembl chr 7:25,586,725...25,667,727
G
Slc25a36
solute carrier family 25 member 36
affects expression
ISO
Vitamin K 3 affects the expression of SLC25A36 mRNA
CTD
PMID:20044591
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
G
Slc25a5
solute carrier family 25 member 5
affects expression
ISO
Vitamin K 3 affects the expression of SLC25A5 mRNA
CTD
PMID:20044591
NCBI chr X:116,031,896...116,034,963
Ensembl chr X:116,031,803...116,034,967
G
Slc26a2
solute carrier family 26 member 2
affects expression
ISO
Vitamin K 3 affects the expression of SLC26A2 mRNA
CTD
PMID:20044591
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
G
Slc27a2
solute carrier family 27 member 2
affects expression
ISO
Vitamin K 3 affects the expression of SLC27A2 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc2a1
solute carrier family 2 member 1
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of SLC2A1 mRNA Vitamin K 3 results in decreased expression of SLC2A1 mRNA
CTD
PMID:20044591 PMID:25270620
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a3
solute carrier family 2 member 3
decreases expression
ISO
Vitamin K 3 results in decreased expression of SLC2A3 mRNA
CTD
PMID:25270620
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc2a4rg
SLC2A4 regulator
affects expression
ISO
Vitamin K 3 affects the expression of SLC2A4RG mRNA
CTD
PMID:20044591
NCBI chr 3:168,493,975...168,497,616
G
Slc38a10
solute carrier family 38, member 10
affects expression
ISO
Vitamin K 3 affects the expression of SLC38A10 mRNA
CTD
PMID:20044591
NCBI chr10:105,386,836...105,436,636
Ensembl chr10:105,386,836...105,436,636
G
Slc39a13
solute carrier family 39 member 13
affects expression
ISO
Vitamin K 3 affects the expression of SLC39A13 mRNA
CTD
PMID:20044591
NCBI chr 3:77,039,411...77,047,528
Ensembl chr 3:77,037,565...77,049,226
G
Slc39a14
solute carrier family 39 member 14
affects expression
ISO
Vitamin K 3 affects the expression of SLC39A14 mRNA
CTD
PMID:20044591
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc44a4
solute carrier family 44, member 4
affects expression
ISO
Vitamin K 3 affects the expression of SLC44A4 mRNA
CTD
PMID:23410634
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc6a14
solute carrier family 6 member 14
affects expression
ISO
Vitamin K 3 affects the expression of SLC6A14 mRNA
CTD
PMID:23410634
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Vitamin K 3 results in increased expression of SLC7A11 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slmap
sarcolemma associated protein
affects expression
ISO
Vitamin K 3 affects the expression of SLMAP mRNA
CTD
PMID:20829426
NCBI chr16:1,667,205...1,785,200
Ensembl chr16:1,667,208...1,785,149
G
Slx9
SLX9 ribosome biogenesis factor
affects expression
ISO
Vitamin K 3 affects the expression of SLX9 mRNA
CTD
PMID:20044591
NCBI chr20:11,114,632...11,147,532
Ensembl chr20:11,114,589...11,147,521
G
Smad3
SMAD family member 3
affects expression
ISO
Vitamin K 3 affects the expression of SMAD3 mRNA
CTD
PMID:20044591
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smarcc2
SWI/SNF related BAF chromatin remodeling complex subunit C2
affects expression
ISO
Vitamin K 3 affects the expression of SMARCC2 mRNA
CTD
PMID:20044591
NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978
G
Smc1a
structural maintenance of chromosomes 1A
affects expression
ISO
Vitamin K 3 affects the expression of SMC1A mRNA
CTD
PMID:20044591 PMID:20829426
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
G
Smc4
structural maintenance of chromosomes 4
affects expression
ISO
Vitamin K 3 affects the expression of SMC4 mRNA
CTD
PMID:23410634
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Smim19
small integral membrane protein 19
affects expression
ISO
Vitamin K 3 affects the expression of SMIM19 mRNA
CTD
PMID:23410634
NCBI chr16:69,551,507...69,564,323
Ensembl chr16:69,553,916...69,567,245
G
Smim29
small integral membrane protein 29
affects expression
ISO
Vitamin K 3 affects the expression of SMIM29 mRNA
CTD
PMID:20044591
NCBI chr20:5,618,845...5,620,856
Ensembl chr20:5,618,845...5,620,813
G
Smo
smoothened, frizzled class receptor
affects expression
ISO
Vitamin K 3 affects the expression of SMO mRNA
CTD
PMID:20044591
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Smoc2
SPARC related modular calcium binding 2
affects expression
ISO
Vitamin K 3 affects the expression of SMOC2 mRNA
CTD
PMID:20044591
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
G
Smox
spermine oxidase
affects expression
ISO
Vitamin K 3 affects the expression of SMOX mRNA
CTD
PMID:20044591
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
affects expression
ISO
Vitamin K 3 affects the expression of SMPDL3A mRNA
CTD
PMID:20044591
NCBI chr20:37,132,592...37,155,567
Ensembl chr20:37,132,592...37,155,567
G
Smyd2
SET and MYND domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of SMYD2 mRNA
CTD
PMID:20044591
NCBI chr13:101,425,270...101,466,576
Ensembl chr13:101,425,273...101,466,576
G
Snai1
snail family transcriptional repressor 1
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of SNAI1 mRNA Vitamin K 3 results in decreased expression of SNAI1 protein
CTD
PMID:20044591 PMID:31238027
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
G
Snrnp200
small nuclear ribonucleoprotein U5 subunit 200
affects expression
ISO
Vitamin K 3 affects the expression of SNRNP200 mRNA
CTD
PMID:20044591
NCBI chr 3:114,428,854...114,458,194
Ensembl chr 3:114,428,854...114,458,182
G
Snrnp70
small nuclear ribonucleoprotein U1 subunit 70
affects expression
ISO
Vitamin K 3 affects the expression of SNRNP70 mRNA
CTD
PMID:20044591
NCBI chr 1:95,856,038...95,876,434
Ensembl chr 1:95,856,036...95,876,392
G
Snrpd1
small nuclear ribonucleoprotein D1 polypeptide
affects expression
ISO
Vitamin K 3 affects the expression of SNRPD1 mRNA
CTD
PMID:20044591
NCBI chr18:1,696,838...1,707,400
Ensembl chr18:1,696,852...1,708,256
G
Snta1
syntrophin, alpha 1
affects expression
ISO
Vitamin K 3 affects the expression of SNTA1 mRNA
CTD
PMID:20044591
NCBI chr 3:142,876,285...142,906,737
Ensembl chr 3:142,876,296...142,906,709
G
Sntb1
syntrophin, beta 1
affects expression
ISO
Vitamin K 3 affects the expression of SNTB1 mRNA
CTD
PMID:20044591
NCBI chr 7:87,060,926...87,329,315
Ensembl chr 7:87,060,926...87,329,315
G
Snx14
sorting nexin 14
affects expression
ISO
Vitamin K 3 affects the expression of SNX14 mRNA
CTD
PMID:20044591
NCBI chr 8:89,283,673...89,390,597
Ensembl chr 8:89,298,114...89,390,580
G
Snx15
sorting nexin 15
decreases expression
ISO
Vitamin K 3 results in decreased expression of SNX15 mRNA
CTD
PMID:25270620
NCBI chr 1:203,417,029...203,426,173
Ensembl chr 1:203,417,029...203,426,247
G
Snx21
sorting nexin family member 21
affects expression
ISO
Vitamin K 3 affects the expression of SNX21 mRNA
CTD
PMID:20044591
NCBI chr 3:153,522,474...153,532,235
Ensembl chr 3:153,522,486...153,532,221
G
Snx9
sorting nexin 9
affects expression
ISO
Vitamin K 3 affects the expression of SNX9 mRNA
CTD
PMID:20044591
NCBI chr 1:46,424,897...46,510,096
Ensembl chr 1:46,423,553...46,509,036
G
Soat2
sterol O-acyltransferase 2
affects expression
ISO
Vitamin K 3 affects the expression of SOAT2 mRNA
CTD
PMID:20044591
NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
G
Sod1
superoxide dismutase 1
multiple interactions affects response to substance
ISO
[CAT protein co-treated with SOD1 protein] results in decreased susceptibility to Vitamin K 3 SOD1 protein affects the susceptibility to Vitamin K 3
CTD
PMID:10698074 PMID:12633745
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases response to substance increases response to substance multiple interactions increases activity
ISO EXP
SOD2 protein results in decreased susceptibility to Vitamin K 3 SOD2 protein results in increased susceptibility to Vitamin K 3 [CAT protein co-treated with SOD2 protein] results in decreased susceptibility to Vitamin K 3 Vitamin K 3 results in increased activity of SOD2 protein Acetaminophen inhibits the reaction [Vitamin K 3 results in increased activity of SOD2 protein]
CTD
PMID:12633745 PMID:14660625 PMID:15986238 PMID:19265712
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sorl1
sortilin related receptor 1
affects expression
ISO
Vitamin K 3 affects the expression of SORL1 mRNA
CTD
PMID:20044591
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
G
Sp5
Sp5 transcription factor
affects expression
ISO
Vitamin K 3 affects the expression of SP5 mRNA
CTD
PMID:20044591
NCBI chr 3:55,274,931...55,277,733
Ensembl chr 3:55,274,931...55,277,733
G
Spag5
sperm associated antigen 5
affects expression
ISO
Vitamin K 3 affects the expression of SPAG5 mRNA
CTD
PMID:20044591 PMID:23410634
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Spata20
spermatogenesis associated 20
affects expression
ISO
Vitamin K 3 affects the expression of SPATA20 mRNA
CTD
PMID:20044591
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
G
Spdl1
spindle apparatus coiled-coil protein 1
affects expression
ISO
Vitamin K 3 affects the expression of SPDL1 mRNA
CTD
PMID:23410634
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Sphk1
sphingosine kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of SPHK1 mRNA
CTD
PMID:20044591
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spink1
serine peptidase inhibitor, Kazal type 1
affects expression
ISO
Vitamin K 3 affects the expression of SPINK1 mRNA
CTD
PMID:20044591
NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642
G
Spry2
sprouty RTK signaling antagonist 2
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of SPRY2 mRNA Vitamin K 3 results in decreased expression of SPRY2 mRNA
CTD
PMID:20044591 PMID:25270620
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Spry4
sprouty RTK signaling antagonist 4
affects expression
ISO
Vitamin K 3 affects the expression of SPRY4 mRNA
CTD
PMID:23410634
NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,436,443...30,453,004
G
Spsb2
splA/ryanodine receptor domain and SOCS box containing 2
affects expression
ISO
Vitamin K 3 affects the expression of SPSB2 mRNA
CTD
PMID:20044591
NCBI chr 4:157,613,404...157,615,293
Ensembl chr 4:157,613,401...157,615,284
G
Sqor
sulfide quinone oxidoreductase
affects expression
ISO
Vitamin K 3 affects the expression of SQOR mRNA
CTD
PMID:23410634
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
G
Sqstm1
sequestosome 1
increases expression
ISO
Vitamin K 3 results in increased expression of SQSTM1 mRNA
CTD
PMID:23410634 PMID:25270620
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srgap2
SLIT-ROBO Rho GTPase activating protein 2
affects expression
ISO
Vitamin K 3 affects the expression of SRGAP2 mRNA
CTD
PMID:20044591
NCBI chr13:42,745,956...42,967,091
Ensembl chr13:42,745,947...42,967,058
G
Sri
sorcin
affects expression
ISO
Vitamin K 3 affects the expression of SRI mRNA
CTD
PMID:20044591
NCBI chr 4:25,973,493...25,997,879
Ensembl chr 4:25,966,750...25,998,077
G
Srpk1
SRSF protein kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of SRPK1 mRNA
CTD
PMID:20044591
NCBI chr20:6,645,809...6,682,448
Ensembl chr20:6,645,809...6,682,134
G
Srrm2
serine/arginine repetitive matrix 2
affects expression
ISO
Vitamin K 3 affects the expression of SRRM2 mRNA
CTD
PMID:20044591
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
G
Srsf11
serine and arginine rich splicing factor 11
affects expression
ISO
Vitamin K 3 affects the expression of SRSF11 mRNA
CTD
PMID:20044591
NCBI chr 2:247,074,623...247,101,460
Ensembl chr 2:247,074,631...247,101,425
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Vitamin K 3 results in increased expression of SRXN1 mRNA
CTD
PMID:23410634 PMID:25270620
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Sst
somatostatin
decreases expression
ISO
Vitamin K 3 results in decreased expression of SST mRNA
CTD
PMID:12414654
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
G
St14
ST14 transmembrane serine protease matriptase
affects expression
ISO
Vitamin K 3 affects the expression of ST14 mRNA
CTD
PMID:20044591
NCBI chr 8:29,540,805...29,581,704
Ensembl chr 8:29,540,811...29,581,517
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
affects expression
ISO
Vitamin K 3 affects the expression of ST3GAL6 mRNA
CTD
PMID:20044591
NCBI chr11:42,061,282...42,121,801
Ensembl chr11:42,077,621...42,121,776
G
Stag3
STAG3 cohesin complex component
increases expression
ISO
Vitamin K 3 results in increased expression of STAG3 mRNA
CTD
PMID:25270620
NCBI chr12:17,284,677...17,314,936
Ensembl chr12:17,284,794...17,314,935
G
Stk36
serine/threonine kinase 36
increases expression
ISO
Vitamin K 3 results in increased expression of STK36 mRNA
CTD
PMID:25270620
NCBI chr 9:76,176,922...76,204,423
Ensembl chr 9:76,176,920...76,204,422
G
Strap
serine/threonine kinase receptor associated protein
affects expression
ISO
Vitamin K 3 affects the expression of STRAP mRNA
CTD
PMID:20044591
NCBI chr 4:170,646,042...170,660,291
Ensembl chr 4:170,646,001...170,660,828
G
Suox
sulfite oxidase
affects expression
ISO
Vitamin K 3 affects the expression of SUOX mRNA
CTD
PMID:23410634
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
G
Susd1
sushi domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of SUSD1 mRNA
CTD
PMID:20044591
NCBI chr 5:74,157,653...74,281,171
Ensembl chr 5:74,157,773...74,276,291
G
Susd6
sushi domain containing 6
affects expression
ISO
Vitamin K 3 affects the expression of SUSD6 mRNA
CTD
PMID:20044591
NCBI chr 6:100,437,834...100,531,621
Ensembl chr 6:100,437,642...100,531,606
G
Syne3
spectrin repeat containing, nuclear envelope family member 3
affects expression
ISO
Vitamin K 3 affects the expression of SYNE3 mRNA
CTD
PMID:20044591
NCBI chr 6:123,872,895...123,964,773
Ensembl chr 6:123,873,174...123,953,409
G
Tacc1
transforming, acidic coiled-coil containing protein 1
affects expression
ISO
Vitamin K 3 affects the expression of TACC1 mRNA
CTD
PMID:20044591
NCBI chr16:66,812,232...66,895,736
Ensembl chr16:66,812,295...66,895,733
G
Tacc2
transforming, acidic coiled-coil containing protein 2
affects expression
ISO
Vitamin K 3 affects the expression of TACC2 mRNA
CTD
PMID:20044591
NCBI chr 1:185,139,223...185,327,881
Ensembl chr 1:185,116,111...185,327,881
G
Taf15
TATA-box binding protein associated factor 15
affects expression
ISO
Vitamin K 3 affects the expression of TAF15 mRNA
CTD
PMID:20044591
NCBI chr10:68,272,921...68,304,951
Ensembl chr10:68,272,969...68,304,949
G
Tbc1d9b
TBC1 domain family member 9B
affects expression
ISO
Vitamin K 3 affects the expression of TBC1D9B mRNA
CTD
PMID:20044591
NCBI chr10:34,459,930...34,497,146
Ensembl chr10:34,459,953...34,497,145
G
Tbl1xr1
TBL1X/Y related 1
affects expression
ISO
Vitamin K 3 affects the expression of TBL1XR1 mRNA
CTD
PMID:23410634
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tbx2
T-box transcription factor 2
affects expression
ISO
Vitamin K 3 affects the expression of TBX2 mRNA
CTD
PMID:20044591
NCBI chr10:70,679,670...70,688,868
Ensembl chr10:70,679,518...70,688,529
G
Tcf7l2
transcription factor 7 like 2
decreases expression
ISO
Vitamin K 3 results in decreased expression of TCF7L2 protein
CTD
PMID:31238027
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
G
Tcof1
treacle ribosome biogenesis factor 1
affects expression
ISO
Vitamin K 3 affects the expression of TCOF1 mRNA
CTD
PMID:20044591
NCBI chr18:54,267,015...54,300,324
Ensembl chr18:54,267,026...54,300,324
G
Tead4
TEA domain transcription factor 4
affects expression
ISO
Vitamin K 3 affects the expression of TEAD4 mRNA
CTD
PMID:23410634
NCBI chr 4:161,474,122...161,572,837
Ensembl chr 4:161,497,851...161,572,323
G
Tecpr2
tectonin beta-propeller repeat containing 2
affects expression
ISO
Vitamin K 3 affects the expression of TECPR2 mRNA
CTD
PMID:20044591
NCBI chr 6:129,899,541...130,001,975
Ensembl chr 6:129,899,636...130,001,974
G
Tenm3
teneurin transmembrane protein 3
affects expression
ISO
Vitamin K 3 affects the expression of TENM3 mRNA
CTD
PMID:20044591
NCBI chr16:41,251,909...43,978,594
Ensembl chr16:41,252,182...43,978,594
G
Tent2
terminal nucleotidyltransferase 2
affects expression
ISO
Vitamin K 3 affects the expression of TENT2 mRNA
CTD
PMID:23410634
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Tepsin
TEPSIN, adaptor related protein complex 4 accessory protein
affects expression
ISO
Vitamin K 3 affects the expression of TEPSIN mRNA
CTD
PMID:20044591
NCBI chr10:105,373,939...105,381,310
Ensembl chr10:105,373,941...105,382,266
G
Tesk1
testis associated actin remodelling kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of TESK1 mRNA
CTD
PMID:20044591
NCBI chr 5:57,691,922...57,697,698
Ensembl chr 5:57,691,969...57,697,698
G
Tfap2c
transcription factor AP-2 gamma
increases expression
ISO
Vitamin K 3 results in increased expression of TFAP2C mRNA
CTD
PMID:25270620
NCBI chr 3:161,315,114...161,322,998
Ensembl chr 3:161,315,031...161,322,995
G
Tfe3
transcription factor binding to IGHM enhancer 3
affects expression
ISO
Vitamin K 3 affects the expression of TFE3 mRNA
CTD
PMID:20044591
NCBI chr X:14,729,547...14,742,830
Ensembl chr X:14,729,550...14,742,571
G
Tff1
trefoil factor 1
affects expression
ISO
Vitamin K 3 affects the expression of TFF1 mRNA
CTD
PMID:20044591
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tff3
trefoil factor 3
affects expression
ISO
Vitamin K 3 affects the expression of TFF3 mRNA
CTD
PMID:20044591
NCBI chr20:9,193,259...9,197,969
Ensembl chr20:9,193,262...9,198,054
G
Tfrc
transferrin receptor
affects expression
ISO
Vitamin K 3 affects the expression of TFRC mRNA
CTD
PMID:20044591
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
affects expression
ISO
Vitamin K 3 affects the expression of TGFB1I1 mRNA
CTD
PMID:23410634
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tgfbr2
transforming growth factor, beta receptor 2
affects expression
ISO
Vitamin K 3 affects the expression of TGFBR2 mRNA
CTD
PMID:20044591
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Thap1
THAP domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of THAP1 mRNA
CTD
PMID:23410634
NCBI chr16:65,905,348...65,909,942
Ensembl chr16:65,904,230...65,909,942
G
Thap4
THAP domain containing 4
affects expression
ISO
Vitamin K 3 affects the expression of THAP4 mRNA
CTD
PMID:20044591
NCBI chr 9:94,242,581...94,282,312
Ensembl chr 9:94,242,581...94,282,306
G
Thra
thyroid hormone receptor alpha
affects expression
ISO
Vitamin K 3 affects the expression of THRA mRNA
CTD
PMID:20044591
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Ticam1
TIR domain containing adaptor molecule 1
affects expression
ISO
Vitamin K 3 affects the expression of TICAM1 mRNA
CTD
PMID:20044591
NCBI chr 9:1,102,559...1,111,023
Ensembl chr 9:1,102,366...1,123,147
G
Timeless
timeless circadian regulator
affects expression
ISO
Vitamin K 3 affects the expression of TIMELESS mRNA
CTD
PMID:20044591
NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738
G
Timm22
translocase of inner mitochondrial membrane 22
affects expression
ISO
Vitamin K 3 affects the expression of TIMM22 mRNA
CTD
PMID:20044591
NCBI chr10:61,253,459...61,261,217
Ensembl chr10:61,253,450...61,261,755
G
Timm23
translocase of inner mitochondrial membrane 23
affects expression
ISO
Vitamin K 3 affects the expression of TIMM23 mRNA
CTD
PMID:20044591
NCBI chr16:7,410,308...7,436,392
Ensembl chr16:7,409,688...7,436,379
G
Timm9
translocase of inner mitochondrial membrane 9
affects expression
ISO
Vitamin K 3 affects the expression of TIMM9 mRNA
CTD
PMID:20044591
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Timp2
TIMP metallopeptidase inhibitor 2
affects expression
ISO
Vitamin K 3 affects the expression of TIMP2 mRNA
CTD
PMID:20044591
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
affects expression
ISO
Vitamin K 3 affects the expression of TIPARP mRNA
CTD
PMID:20044591 PMID:20829426
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tjp1
tight junction protein 1
increases expression
ISO
Vitamin K 3 results in increased expression of TJP1 protein
CTD
PMID:31238027
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tjp2
tight junction protein 2
affects expression
ISO
Vitamin K 3 affects the expression of TJP2 mRNA
CTD
PMID:20044591
NCBI chr 1:221,709,745...221,838,291
Ensembl chr 1:221,709,745...221,838,295
G
Tk1
thymidine kinase 1
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of TK1 mRNA Vitamin K 3 results in decreased expression of TK1 mRNA
CTD
PMID:12414654 PMID:20044591
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tlk1
tousled-like kinase 1
affects expression
ISO
Vitamin K 3 affects the expression of TLK1 mRNA
CTD
PMID:20829426
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
G
Tm2d3
TM2 domain containing 3
affects expression
ISO
Vitamin K 3 affects the expression of TM2D3 mRNA
CTD
PMID:20044591
NCBI chr 1:119,267,194...119,277,094
Ensembl chr 1:119,264,576...119,277,099
G
Tm7sf2
transmembrane 7 superfamily member 2
affects expression
ISO
Vitamin K 3 affects the expression of TM7SF2 mRNA
CTD
PMID:20044591
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tmed10
transmembrane p24 trafficking protein 10
affects expression
ISO
Vitamin K 3 affects the expression of TMED10 mRNA
CTD
PMID:20044591
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmem125
transmembrane protein 125
affects expression
ISO
Vitamin K 3 affects the expression of TMEM125 mRNA
CTD
PMID:20044591
NCBI chr 5:132,063,162...132,064,566
Ensembl chr 5:132,059,554...132,079,297 Ensembl chr 5:132,059,554...132,079,297
G
Tmem177
transmembrane protein 177
affects expression
ISO
Vitamin K 3 affects the expression of TMEM177 mRNA
CTD
PMID:20044591
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem18
transmembrane protein 18
affects expression
ISO
Vitamin K 3 affects the expression of TMEM18 mRNA
CTD
PMID:20044591
NCBI chr 6:47,206,845...47,214,294
Ensembl chr 6:47,206,845...47,214,294
G
Tmem237
transmembrane protein 237
affects expression
ISO
Vitamin K 3 affects the expression of TMEM237 mRNA
CTD
PMID:20044591
NCBI chr 9:60,533,348...60,569,253
Ensembl chr 9:60,535,233...60,572,567
G
Tmem245
transmembrane protein 245
affects expression
ISO
Vitamin K 3 affects the expression of TMEM245 mRNA
CTD
PMID:20044591
NCBI chr 5:71,570,952...71,647,915
Ensembl chr 5:71,514,858...71,647,763
G
Tmem37
transmembrane protein 37
affects expression
ISO
Vitamin K 3 affects the expression of TMEM37 mRNA
CTD
PMID:20044591
NCBI chr13:31,184,322...31,191,477
Ensembl chr13:31,171,355...31,191,077
G
Tmem42
transmembrane protein 42
affects expression
ISO
Vitamin K 3 affects the expression of TMEM42 mRNA
CTD
PMID:20044591
NCBI chr 8:122,674,793...122,677,290
Ensembl chr 8:122,674,070...122,677,276
G
Tmem45b
transmembrane protein 45b
affects expression
ISO
Vitamin K 3 affects the expression of TMEM45B mRNA
CTD
PMID:20044591
NCBI chr 8:29,865,276...29,910,453
Ensembl chr 8:29,865,278...29,910,453
G
Tmem79
transmembrane protein 79
affects expression
ISO
Vitamin K 3 affects the expression of TMEM79 mRNA
CTD
PMID:20044591
NCBI chr 2:173,798,267...173,803,151
Ensembl chr 2:173,798,267...173,803,046
G
Tmpo
thymopoietin
decreases expression
ISO
Vitamin K 3 results in decreased expression of TMPO mRNA
CTD
PMID:12414654
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmprss13
transmembrane serine protease 13
affects expression
ISO
Vitamin K 3 affects the expression of TMPRSS13 mRNA
CTD
PMID:20044591
NCBI chr 8:45,625,759...45,653,943
Ensembl chr 8:45,625,626...45,653,938
G
Tmtc4
transmembrane O-mannosyltransferase targeting cadherins 4
affects expression
ISO
Vitamin K 3 affects the expression of TMTC4 mRNA
CTD
PMID:20044591
NCBI chr15:100,000,157...100,056,573
Ensembl chr15:100,000,152...100,056,543
G
Tnf
tumor necrosis factor
multiple interactions increases secretion increases expression
EXP ISO
Acetaminophen inhibits the reaction [Vitamin K 3 results in increased expression of TNF mRNA]; Acetaminophen inhibits the reaction [Vitamin K 3 results in increased secretion of TNF protein] Vitamin K 3 inhibits the reaction [Lipopolysaccharides affects the localization of TNF protein]; Vitamin K 3 inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] [Asbestos, Amosite co-treated with TNF protein] results in increased susceptibility to Vitamin K 3; [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Vitamin K 3; Vitamin K 3 inhibits the reaction [TNF protein affects the localization of RELA protein]; Vitamin K 3 promotes the reaction [[Asbestos, Amosite co-treated with TNF protein] results in increased metabolism of Adenosine Triphosphate]
CTD
PMID:8817062 PMID:19265712 PMID:19362101 PMID:20030669
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf11b
TNF receptor superfamily member 11B
increases expression
ISO
Vitamin K 3 results in increased expression of TNFRSF11B mRNA
CTD
PMID:19675304
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf12a
TNF receptor superfamily member 12A
affects expression
ISO
Vitamin K 3 affects the expression of TNFRSF12A mRNA
CTD
PMID:20044591
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf19
TNF receptor superfamily member 19
affects expression
ISO
Vitamin K 3 affects the expression of TNFRSF19 mRNA
CTD
PMID:20829426
NCBI chr15:35,092,206...35,158,472
Ensembl chr15:35,092,206...35,180,795
G
Tnfsf11
TNF superfamily member 11
decreases expression
ISO
Vitamin K 3 results in decreased expression of TNFSF11 mRNA
CTD
PMID:19675304
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Tnxb
tenascin XB
affects expression
ISO
Vitamin K 3 affects the expression of TNXB mRNA
CTD
PMID:20044591
G
Tom1
target of myb1 membrane trafficking protein
increases expression
ISO
Vitamin K 3 results in increased expression of TOM1 mRNA
CTD
PMID:12414654
NCBI chr19:13,405,482...13,440,384
Ensembl chr19:13,405,501...13,440,384
G
Tomm22
translocase of outer mitochondrial membrane 22
affects expression
ISO
Vitamin K 3 affects the expression of TOMM22 mRNA
CTD
PMID:20044591
NCBI chr 7:111,223,508...111,228,671
Ensembl chr 7:111,216,571...111,246,799
G
Top1
DNA topoisomerase I
affects expression
ISO
Vitamin K 3 affects the expression of TOP1 mRNA
CTD
PMID:20044591
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
G
Top2a
DNA topoisomerase II alpha
affects expression
ISO
Vitamin K 3 affects the expression of TOP2A mRNA
CTD
PMID:20044591
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Top2b
DNA topoisomerase II beta
affects expression
ISO
Vitamin K 3 affects the expression of TOP2B mRNA
CTD
PMID:20044591
NCBI chr15:9,051,340...9,111,721
Ensembl chr15:9,051,341...9,112,085
G
Tp53
tumor protein p53
multiple interactions affects activity increases expression
ISO
[sodium arsenite co-treated with Vitamin K 3] results in increased phosphorylation of TP53 protein; EUK-134 inhibits the reaction [Vitamin K 3 results in increased expression of TP53 protein]; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased phosphorylation of TP53 protein] Vitamin K 3 affects the activity of TP53 protein
CTD
PMID:19082730 PMID:21533478 PMID:25005833 PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpx2
TPX2, microtubule nucleation factor
affects expression
ISO
Vitamin K 3 affects the expression of TPX2 mRNA
CTD
PMID:20044591
NCBI chr 3:141,318,428...141,360,684
Ensembl chr 3:141,318,455...141,360,468
G
Tradd
TNFRSF1A-associated via death domain
affects expression
ISO
Vitamin K 3 affects the expression of TRADD mRNA
CTD
PMID:20044591
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
G
Traf3ip2
Traf3 interacting protein 2
affects expression
ISO
Vitamin K 3 affects the expression of TRAF3IP2 mRNA
CTD
PMID:20044591
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
G
Trem2
triggering receptor expressed on myeloid cells 2
affects expression
ISO
Vitamin K 3 affects the expression of TREM2 mRNA
CTD
PMID:20829426
NCBI chr 9:12,647,605...12,654,190
Ensembl chr 9:12,647,259...12,654,170
G
Trib3
tribbles pseudokinase 3
increases expression
ISO
Vitamin K 3 results in increased expression of TRIB3 mRNA
CTD
PMID:25270620
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim14
tripartite motif-containing 14
affects expression
ISO
Vitamin K 3 affects the expression of TRIM14 mRNA
CTD
PMID:20044591
NCBI chr 5:60,800,568...60,824,858
Ensembl chr 5:60,800,032...60,824,858
G
Trim2
tripartite motif-containing 2
affects expression
ISO
Vitamin K 3 affects the expression of TRIM2 mRNA
CTD
PMID:20044591
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trim26
tripartite motif-containing 26
affects expression
ISO
Vitamin K 3 affects the expression of TRIM26 mRNA
CTD
PMID:20044591
NCBI chr20:1,708,297...1,731,176
Ensembl chr20:1,709,788...1,731,120
G
Trmt61a
tRNA methyltransferase 61A
affects expression
ISO
Vitamin K 3 affects the expression of TRMT61A mRNA
CTD
PMID:20044591
NCBI chr 6:130,737,230...130,743,251
Ensembl chr 6:130,737,219...130,743,243
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity
ISO
Vitamin K 3 results in increased activity of TRPA1 protein
CTD
PMID:21591660
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trrap
transformation/transcription domain-associated protein
affects expression
ISO
Vitamin K 3 affects the expression of TRRAP mRNA
CTD
PMID:20044591
NCBI chr12:9,738,006...9,827,708
Ensembl chr12:9,738,006...9,827,674
G
Tsc22d2
TSC22 domain family, member 2
affects expression
ISO
Vitamin K 3 affects the expression of TSC22D2 mRNA
CTD
PMID:23410634
NCBI chr 2:142,646,778...142,697,977
Ensembl chr 2:142,644,744...142,693,606
G
Tspan3
tetraspanin 3
affects expression
ISO
Vitamin K 3 affects the expression of TSPAN3 mRNA
CTD
PMID:20044591
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
G
Tspan5
tetraspanin 5
affects expression
ISO
Vitamin K 3 affects the expression of TSPAN5 mRNA
CTD
PMID:20044591
NCBI chr 2:227,294,180...227,469,361
Ensembl chr 2:227,294,217...227,465,664
G
Tspan6
tetraspanin 6
affects expression
ISO
Vitamin K 3 affects the expression of TSPAN6 mRNA
CTD
PMID:20044591
NCBI chr X:97,092,394...97,099,659
Ensembl chr X:97,092,388...97,099,309
G
Tspyl2
TSPY-like 2
affects expression
ISO
Vitamin K 3 affects the expression of TSPYL2 mRNA
CTD
PMID:20044591
NCBI chr X:21,439,478...21,445,208
Ensembl chr X:21,439,478...21,445,089
G
Tst
thiosulfate sulfurtransferase
affects expression
ISO
Vitamin K 3 affects the expression of TST mRNA
CTD
PMID:20044591
NCBI chr 7:109,948,061...109,955,378
Ensembl chr 7:109,948,062...109,957,216
G
Ttc3
tetratricopeptide repeat domain 3
affects expression
ISO
Vitamin K 3 affects the expression of TTC3 mRNA
CTD
PMID:20829426
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
Vitamin K 3 results in decreased expression of TUBA1A mRNA
CTD
PMID:12414654
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tulp3
TUB like protein 3
affects expression
ISO
Vitamin K 3 affects the expression of TULP3 mRNA
CTD
PMID:20044591
NCBI chr 4:161,590,478...161,632,244
Ensembl chr 4:161,590,479...161,632,149
G
Tulp4
TUB like protein 4
affects expression
ISO
Vitamin K 3 affects the expression of TULP4 mRNA
CTD
PMID:20044591
NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688
G
Twf2
twinfilin actin-binding protein 2
decreases expression
ISO
Vitamin K 3 results in decreased expression of TWF2 mRNA
CTD
PMID:25270620
NCBI chr 8:106,845,253...106,858,298
Ensembl chr 8:106,845,253...106,858,298
G
Txnip
thioredoxin interacting protein
affects expression
ISO
Vitamin K 3 affects the expression of TXNIP mRNA
CTD
PMID:20044591
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
Vitamin K 3 results in increased expression of TXNRD1 mRNA
CTD
PMID:12414654
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tyk2
tyrosine kinase 2
affects expression
ISO
Vitamin K 3 affects the expression of TYK2 mRNA
CTD
PMID:20044591
NCBI chr 8:19,641,881...19,667,157
Ensembl chr 8:19,641,884...19,667,044
G
Tyms
thymidylate synthetase
affects expression
ISO
Vitamin K 3 affects the expression of TYMS mRNA
CTD
PMID:20044591
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ubb
ubiquitin B
affects expression
ISO
Vitamin K 3 affects the expression of UBB mRNA
CTD
PMID:20044591
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
G
Ubc
ubiquitin C
affects expression
ISO
Vitamin K 3 affects the expression of UBC mRNA
CTD
PMID:20044591
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
Vitamin K 3 results in decreased expression of UBE2C mRNA
CTD
PMID:12414654
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
affects expression
ISO
Vitamin K 3 affects the expression of UBR4 mRNA
CTD
PMID:20044591
NCBI chr 5:151,635,825...151,743,931
Ensembl chr 5:151,635,868...151,743,784
G
Ucp2
uncoupling protein 2
affects expression
ISO
Vitamin K 3 affects the expression of UCP2 mRNA
CTD
PMID:20044591
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ugcg
UDP-glucose ceramide glucosyltransferase
affects expression
ISO
Vitamin K 3 affects the expression of UGCG mRNA
CTD
PMID:20829426
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions increases expression increases activity
EXP
Acetylcysteine inhibits the reaction [Vitamin K 3 results in increased activity of UGT1A6 promoter] Vitamin K 3 results in increased expression of UGT1A6 mRNA
CTD
PMID:15336321 PMID:22846377
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
affects expression
ISO
Vitamin K 3 affects the expression of UHRF1 mRNA
CTD
PMID:20044591
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
Vitamin K 3 results in decreased expression of UNG mRNA
CTD
PMID:12414654
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Upf3a
UPF3A, regulator of nonsense mediated mRNA decay
affects expression
ISO
Vitamin K 3 affects the expression of UPF3A mRNA
CTD
PMID:20044591
NCBI chr16:75,757,442...75,768,478
Ensembl chr16:75,757,441...75,769,345
G
Upp1
uridine phosphorylase 1
affects expression decreases expression
ISO
Vitamin K 3 affects the expression of UPP1 mRNA Vitamin K 3 results in decreased expression of UPP1 mRNA
CTD
PMID:20044591 PMID:25270620
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Ush1c
USH1 protein network component harmonin
affects expression
ISO
Vitamin K 3 affects the expression of USH1C mRNA
CTD
PMID:20044591
NCBI chr 1:96,695,303...96,743,671
Ensembl chr 1:96,695,307...96,743,671
G
Ushbp1
USH1 protein network component harmonin binding protein 1
increases expression
ISO
Vitamin K 3 results in increased expression of USHBP1 mRNA
CTD
PMID:25270620
NCBI chr16:18,057,321...18,067,933
Ensembl chr16:18,057,326...18,067,877
G
Usp10
ubiquitin specific peptidase 10
affects expression
ISO
Vitamin K 3 affects the expression of USP10 mRNA
CTD
PMID:20044591
NCBI chr19:47,972,858...48,014,900
Ensembl chr19:47,972,611...48,014,897
G
Usp7
ubiquitin specific peptidase 7
affects expression
ISO
Vitamin K 3 affects the expression of USP7 mRNA
CTD
PMID:20044591
NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355
G
Usp9x
ubiquitin specific peptidase 9, X-linked
affects expression
ISO
Vitamin K 3 affects the expression of USP9X mRNA
CTD
PMID:20044591
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
G
Vars2
valyl-tRNA synthetase 2, mitochondrial
affects expression
ISO
Vitamin K 3 affects the expression of VARS2 mRNA
CTD
PMID:20044591
NCBI chr20:3,077,132...3,087,994
Ensembl chr20:3,077,132...3,087,994
G
Vasn
vasorin
affects expression
ISO
Vitamin K 3 affects the expression of VASN mRNA
CTD
PMID:20044591
NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357
G
Vdac1
voltage-dependent anion channel 1
affects expression
ISO
Vitamin K 3 affects the expression of VDAC1 mRNA
CTD
PMID:20044591
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
G
Vezf1
vascular endothelial zinc finger 1
affects expression
ISO
Vitamin K 3 affects the expression of VEZF1 mRNA
CTD
PMID:20044591
NCBI chr10:72,859,669...72,876,111
Ensembl chr10:72,859,877...72,876,111
G
Vgll4
vestigial-like family member 4
affects expression
ISO
Vitamin K 3 affects the expression of VGLL4 mRNA
CTD
PMID:20044591
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:147,927,034...148,038,471
G
Vhl
von Hippel-Lindau tumor suppressor
multiple interactions
ISO
[[Vitamin K 3 results in increased phosphorylation of JAK3 protein] which results in increased phosphorylation of and affects the localization of ELAVL1 protein] inhibits the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]; Vitamin K 3 inhibits the reaction [sodium arsenite promotes the reaction [ELAVL1 protein binds to and results in decreased degradation of VHL mRNA]]; Vitamin K 3 inhibits the reaction [sodium arsenite results in decreased degradation of VHL mRNA]
CTD
PMID:24106086
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
G
Vim
vimentin
decreases expression
ISO
Vitamin K 3 results in decreased expression of VIM protein
CTD
PMID:31238027
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vkorc1l1
vitamin K epoxide reductase complex, subunit 1-like 1
affects expression
ISO
Vitamin K 3 affects the expression of VKORC1L1 mRNA
CTD
PMID:20044591
NCBI chr12:26,717,959...26,768,193
Ensembl chr12:26,623,976...26,768,225
G
Vps28
VPS28 subunit of ESCRT-I
affects expression
ISO
Vitamin K 3 affects the expression of VPS28 mRNA
CTD
PMID:20044591
NCBI chr 7:108,341,989...108,345,837
Ensembl chr 7:108,341,989...108,345,837
G
Vps39
VPS39 subunit of HOPS complex
decreases expression
ISO
Vitamin K 3 results in decreased expression of VPS39 mRNA
CTD
PMID:25270620
NCBI chr 3:107,266,846...107,304,884
Ensembl chr 3:107,267,310...107,304,975
G
Vsnl1
visinin-like 1
affects expression
ISO
Vitamin K 3 affects the expression of VSNL1 mRNA
CTD
PMID:23410634
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Vtn
vitronectin
affects expression
ISO
Vitamin K 3 affects the expression of VTN mRNA
CTD
PMID:20044591
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
G
Vwa1
von Willebrand factor A domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of VWA1 mRNA
CTD
PMID:20044591
NCBI chr 5:166,377,451...166,382,784
Ensembl chr 5:166,377,455...166,382,637
G
Wbp1
WW domain binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of WBP1 mRNA
CTD
PMID:20044591
NCBI chr 4:115,625,168...115,627,567
Ensembl chr 4:115,625,168...115,627,624
G
Wdr3
WD repeat domain 3
affects expression
ISO
Vitamin K 3 affects the expression of WDR3 mRNA
CTD
PMID:20044591
NCBI chr 2:187,505,816...187,528,432
Ensembl chr 2:187,505,816...187,528,432
G
Wdr59
WD repeat domain 59
affects expression
ISO
Vitamin K 3 affects the expression of WDR59 mRNA
CTD
PMID:20044591
NCBI chr19:39,416,432...39,483,773
Ensembl chr19:39,416,429...39,483,698
G
Wdr81
WD repeat domain 81
affects expression
ISO
Vitamin K 3 affects the expression of WDR81 mRNA
CTD
PMID:20044591
NCBI chr10:60,281,969...60,295,374
Ensembl chr10:60,281,972...60,295,296
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
affects expression
ISO
Vitamin K 3 affects the expression of WIPI1 mRNA
CTD
PMID:20044591
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Wwc1
WW and C2 domain containing 1
affects expression
ISO
Vitamin K 3 affects the expression of KIBRA mRNA
CTD
PMID:20044591
NCBI chr10:20,300,735...20,454,393
Ensembl chr10:20,300,833...20,454,497
G
Wwox
WW domain-containing oxidoreductase
affects expression
ISO
Vitamin K 3 affects the expression of WWOX mRNA
CTD
PMID:20044591
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Wwtr1
WW domain containing transcription regulator 1
increases expression
ISO
Vitamin K 3 results in increased expression of WWTR1 mRNA
CTD
PMID:25270620
NCBI chr 2:141,651,159...141,766,919
Ensembl chr 2:141,648,108...141,766,968
G
Xbp1
X-box binding protein 1
affects expression
ISO
Vitamin K 3 affects the expression of XBP1 mRNA
CTD
PMID:20044591
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xist
X inactive specific transcript
affects expression
ISO
Vitamin K 3 affects the expression of XIST mRNA
CTD
PMID:20829426
NCBI chr X:68,474,987...68,492,500
G
Xpo1
exportin 1
affects expression
ISO
Vitamin K 3 affects the expression of XPO1 mRNA
CTD
PMID:20044591
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
G
Xpo5
exportin 5
affects expression
ISO
Vitamin K 3 affects the expression of XPO5 mRNA
CTD
PMID:20044591
NCBI chr 9:14,740,182...14,778,171
Ensembl chr 9:14,740,182...14,778,171
G
Yeats4
YEATS domain containing 4
affects expression
ISO
Vitamin K 3 affects the expression of YEATS4 mRNA
CTD
PMID:20044591
NCBI chr 7:52,858,313...52,865,454
Ensembl chr 7:52,858,305...52,865,635
G
Ykt6
YKT6 v-SNARE homolog
affects expression
ISO
Vitamin K 3 affects the expression of YKT6 mRNA
CTD
PMID:20044591
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
G
Yrdc
yrdC N(6)-threonylcarbamoyltransferase domain containing
affects expression
ISO
Vitamin K 3 affects the expression of YRDC mRNA
CTD
PMID:20044591
NCBI chr 5:137,110,244...137,115,127
Ensembl chr 5:137,110,279...137,115,120
G
Ywhab
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
affects expression
ISO
Vitamin K 3 affects the expression of YWHAB mRNA
CTD
PMID:20044591
NCBI chr 3:152,659,663...152,682,105
Ensembl chr 3:152,659,651...152,682,105
G
Zc3h12a
zinc finger CCCH type containing 12A
affects expression
ISO
Vitamin K 3 affects the expression of ZC3H12A mRNA
CTD
PMID:20044591
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zcchc14
zinc finger CCHC-type containing 14
affects expression
ISO
Vitamin K 3 affects the expression of ZCCHC14 mRNA
CTD
PMID:20044591
NCBI chr19:49,674,185...49,718,004
Ensembl chr19:49,674,195...49,718,029
G
Zeb1
zinc finger E-box binding homeobox 1
decreases expression
ISO
Vitamin K 3 results in decreased expression of ZEB1 protein
CTD
PMID:31238027
NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214
G
Zfand2a
zinc finger AN1-type containing 2A
affects expression
ISO
Vitamin K 3 affects the expression of ZFAND2A mRNA
CTD
PMID:20044591
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfhx3
zinc finger homeobox 3
affects expression
ISO
Vitamin K 3 affects the expression of ZFHX3 mRNA
CTD
PMID:20044591
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
G
Zfp133
zinc finger protein 133
affects expression
ISO
Vitamin K 3 affects the expression of ZNF133 mRNA
CTD
PMID:20044591
NCBI chr 3:131,829,404...131,847,552
Ensembl chr 3:131,829,404...131,847,550
G
Zfp217
zinc finger protein 217
affects expression
ISO
Vitamin K 3 affects the expression of ZNF217 mRNA
CTD
PMID:23410634
NCBI chr 3:158,890,464...158,931,148
Ensembl chr 3:158,892,265...158,913,040
G
Zfp36l1
zinc finger protein 36, C3H type-like 1
affects expression
ISO
Vitamin K 3 affects the expression of ZFP36L1 mRNA
CTD
PMID:20044591
NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:98,930,718...98,935,748
G
Zfp36l2
zinc finger protein 36, C3H type-like 2
affects expression
ISO
Vitamin K 3 affects the expression of ZFP36L2 mRNA
CTD
PMID:20044591
NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
G
Zfp395
zinc finger protein 395
affects expression
ISO
Vitamin K 3 affects the expression of ZNF395 mRNA
CTD
PMID:20044591
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
G
Zfp462
zinc finger protein 462
affects expression
ISO
Vitamin K 3 affects the expression of ZNF462 mRNA
CTD
PMID:20044591
NCBI chr 5:69,670,085...69,810,729
Ensembl chr 5:69,670,328...69,810,327
G
Zfp524
zinc finger protein 524
affects expression
ISO
Vitamin K 3 affects the expression of ZNF524 mRNA
CTD
PMID:20044591
NCBI chr 1:68,824,803...68,828,363
Ensembl chr 1:68,824,803...68,828,594
G
Zfp593
zinc finger protein 593
affects expression
ISO
Vitamin K 3 affects the expression of ZNF593 mRNA
CTD
PMID:20044591
NCBI chr 5:146,462,670...146,464,998
Ensembl chr 5:146,462,670...146,465,198
G
Zfp62
zinc finger protein 62
affects expression
ISO
Vitamin K 3 affects the expression of ZFP62 mRNA
CTD
PMID:20044591
NCBI chr10:33,522,618...33,539,446
Ensembl chr10:33,500,323...33,542,013
G
Zfp706
zinc finger protein 706
affects expression
ISO
Vitamin K 3 affects the expression of ZNF706 mRNA
CTD
PMID:20044591
NCBI chr 7:68,167,496...68,174,121
Ensembl chr 7:68,166,323...68,174,148
G
Zfp707
zinc finger protein 707
affects expression
ISO
Vitamin K 3 affects the expression of ZNF707 mRNA
CTD
PMID:20044591
NCBI chr 7:107,679,597...107,686,556
Ensembl chr 7:107,650,217...107,703,459
G
Zfp830
zinc finger protein 830
affects expression
ISO
Vitamin K 3 affects the expression of ZNF830 mRNA
CTD
PMID:20044591
NCBI chr10:67,701,340...67,702,804
Ensembl chr10:67,701,073...67,704,523
G
Zftraf1
zinc finger TRAF type containing 1
affects expression
ISO
Vitamin K 3 affects the expression of ZFTRAF1 mRNA
CTD
PMID:20044591
NCBI chr 7:108,363,989...108,377,428
Ensembl chr 7:108,364,381...108,380,021
G
Zfyve21
zinc finger FYVE-type containing 21
affects expression
ISO
Vitamin K 3 affects the expression of ZFYVE21 mRNA
CTD
PMID:20044591
NCBI chr 6:130,873,979...130,894,618
Ensembl chr 6:130,873,912...130,894,411
G
Zmiz1
zinc finger, MIZ-type containing 1
affects expression
ISO
Vitamin K 3 affects the expression of ZMIZ1 mRNA
CTD
PMID:20044591
NCBI chr16:1,027,083...1,232,616
Ensembl chr16:1,027,325...1,232,597
G
Znrd2
zinc ribbon domain containing 2
affects expression
ISO
Vitamin K 3 affects the expression of ZNRD2 mRNA
CTD
PMID:20044591
NCBI chr 1:203,017,682...203,019,465
Ensembl chr 1:203,017,682...203,019,465
G
Znrf1
zinc and ring finger 1
affects expression
ISO
Vitamin K 3 affects the expression of ZNRF1 mRNA
CTD
PMID:20044591
NCBI chr19:39,496,414...39,581,600
Ensembl chr19:39,496,527...39,580,969
G
Zswim3
zinc finger, SWIM-type containing 3
affects expression
ISO
Vitamin K 3 affects the expression of ZSWIM3 mRNA
CTD
PMID:20044591
NCBI chr 3:153,542,741...153,558,022
Ensembl chr 3:153,542,743...153,558,018
G
Zwint
ZW10 interacting kinetochore protein
affects expression
ISO
Vitamin K 3 affects the expression of ZWINT mRNA
CTD
PMID:20044591
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
G
Zyx
zyxin
affects expression
ISO
Vitamin K 3 affects the expression of ZYX mRNA
CTD
PMID:23410634
NCBI chr 4:71,236,767...71,246,553
Ensembl chr 4:71,237,451...71,246,553
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all